書籍詳細

未契約

書籍名	臨床精神医学講座(全24巻) 第4巻気分障害
出版社	中山書店
発行日	1998-05-30
著者	広瀬徹也(責任編集) 樋口輝彦(責任編集) 松下正明(総編集) 浅井昌弘(編集) 牛島定信(編集) 倉知正佳(編集) 小山司(編集) 中根允文(編集) 三好功峰(編集)
ISBN	4521490719
ページ数	557
版刷巻号	第2刷
分野	臨床医学：内科精神医学
シリーズ
閲覧制限	未契約

従来の躁うつ病や抑うつ神経症、情動性人格異常などの総称として米国精神医学会、WHOが決定した新しい疾患概念・分類である「気分障害」の最新知見を臨床に即して解説。

表紙
閲覧
本巻の執筆者
閲覧
目次
閲覧
総論
P.1閲覧
- I. 歴史・概念・分類
- II. 疫学
- III. 成因・病態・病理
- IV. 診断・鑑別診断
- V. 治療総論
各論
P.181閲覧
- I. 大うつ病性障害
- II. 双極I型障害
- III. 双極II型障害
- IV. 混合状態
- V. 気分変調症
- VI. 気分循環症
- VII. 非定型うつ病
- VIII. 季節性感情障害
- IX. ラピッド・サイクラー
- X. 産後うつ病
- XI. 軽症うつ病 (仮面うつ病)
- XII. recurrent brief depressive disorder
- XIII. 難治性うつ病・慢性うつ病
- XIV. double depression
- XV. comorbidity
- XVI. 身体疾患に伴ううつ状態
- XVII. 中年期のうつ病
- XVIII. 老年期うつ病
- XIX. 小児・思春期のうつ病
- XX. 薬物によるうつ病 ― 特にインターフェロンについて
索引
P.527閲覧
- 和文索引
- 欧文索引
奥付
閲覧

参考文献

総論

P.17 掲載の参考文献

1) Abraham K (1911):Notes on the psycho-analytical investigation and treatment of manic-depressive insanity and allied conditions. The Meaning of Despair, Gaylin W (ed), pp 26-49, Science House, New York (1968)

2) Akiskal H:Mood disorders. Comprehensive Textbook of Psychiatry 6th ed, Kaplan HL, Sadock BJ (ed), Vol 1, pp 1067-1072, Williams & Wilkins, Baltimore (1995)

3) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, 2nd edition (DSM-II). Washington DC (1968)

4) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, 3rd edition (DSM-III). Washington DC (1980)

5) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, 3rd edition-revised (DSM-III-R). Washington DC (1987)
pubmed

6) American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) Washington DC (1994)

7) Andreasen N:Concepts, diagnosis and classification. Handbook of Affective Disorders, Paykel E (ed), pp 24-44, Churchill Livingstone, Edinburgh (1982)

8) Angst J:Zur Atiologie und Nosologie endogener depressiver Psychosen. Springer, Berlin (1966)

9) Arieti S:The manifest symptomatology of adults. Severe and Mild Depression, Arieti S, Bemporad J (ed), pp 57-86, Basic Books, New York (1978)

10) Baillarger JF:'De la folie a double-forme'. Annales Medico-Psychologiques 6:367-369 (1854)

11) Burger-Prinz H:Psychopathologische Bemerkungen zu den cyclischen Psychosen. Nervenarzt 21:505-507 (1950)
pubmed

12) Burton R (1621):The Anatomy of Melancholy. Dell F, Jordan-Smith P (ed), Tudor, New York (1948)

13) Cullen W:Jackson SW:Melancholia and Depression-From Hippocratic Times to Modern Times. Yale Univ Press, New Haven (1986)

14) Esquirol E:De Maladies Mentales. Raillire, Paris (1838)

15) Falret JP:Memoire sur la folie circulaire. Bulletin de l'Academie de Medicine 19:382-415 (1854)

16) Flemming CF:Uber Klassifikation der Seelenstorungen. Allg Zeitschr Psychiatr 1:97-103 (1844)

17) Freud S (1917):Mourning and melancholia. The Meaning of Despair, Gaylin W (ed), pp 50-69, Science House, New York (1968)-井村恒郎, 小此木啓吾ほか(訳):フロイト著作集6, pp 137-149, 人文書院, 京都 (1970)

18) Galen:Jackson SW:Melancholia and Depression-From Hippocratic Times to Modern Times. Yale Univ Press, New Haven (1986)

19) Griesinger W:Die Pathologie und Therapie der psychischen Krankheiten. Krabbe, Stuttgart (1861)

20) Grinker RR, Miller J, Sabshin M, et al:The Phenomena of Depression. Hoeber, New York (1961)

21) Ishaq Ibn Imran:Akiskal H:Mood disorders. Comprehensive Textbook of Psychiatry 6th ed, Kaplan HL, Sadock BJ (ed), Vol 1, pp 1067-1072, Williams & Wilkins, Baltimore (1995)

22) Jackson SW:Melancholia and Depression-From Hippocratic Times to Modern Times. Yale Univ Press, New Haven (1986)

23) Kahlbaum KL:Die Gruppierung der psychischen Krankheiten und die Einteilung der Seelenstorungen. Kafemann, Danzig (1863)

24) 笠原嘉, 木村敏:うつ状態の臨床分類に関する研究. 精神経誌77:715-735 (1975)

25) Kielholz P:Klassifizierung der depressiven Verstimmungszustande. Das depressive Syndrom, Hippius H, Selbach H (hrsg), pp 341-346, Urban & Schwarzenberg, Munchen (1969)

26) Klein D:Differential diagnosis and treatment of depression. Depression, Galant M, Simpson G (ed), pp 127-154, Spectrum Publication, New York (1976)

27) Kraepelin E:Psychiatrie, 2 Aufl. Barth, Leipzig (1887)

28) Kraepelin E:Psychiatrie, 6 Aufl. Barth, Leipzig (1899)

29) Kraepelin E:Psychiatrie, 8 Aufl. Barth, Leipzig (1913)

30) Kretschmer E:Korperbau und Charakter, 1 Aufl. Spinger, Berlin (1921)-相場均(訳):体格と性格. 文光堂, 東京 (1960)

31) Lange J:Die endogenen und reaktiven Gemutserkankungen und die manischdepressive Konstitution. Handbuch der Geisteskrankheiten, Bumke O (hrsg), Bd. IV, Teil II, Springer, Berlin (1928)

32) Leonhard K:Die Aufteilung der endogenen Psychosen, Akademie, Berlin (1957)

33) Mapother E:Discussion on manic-depressive psychosis. Br Med J 2:872-876 (1926)

34) Maudsley H:The Pathology of Mind-A study of its distempers, deformities and disorders. Macmillan, London (1895)

35) Meyer A:The problems of mental reaction types. Psychol Bull 5:245-261 (1908)

36) Munro A:Some familial and social factors in depressive illness. Br J Psychiatry 112:429-441 (1966)

37) Neumann H:Lehrbuch der Psychiatrie. Enke, Erlangen (1859)

38) Perris C:A study of bipolar and unipolar recurrent depressive psychoses. Acta Psychiatr Scand 42 (Suppl):194 (1966)

39) Pichot P:La nosologie des depressions-小口徹(訳):うつ病の疾病分類について. 精神医学20:592-608 (1978)

40) Roth M, Gurney C, Garside PF, et al:Studies in the classification of affective disorders, the relationship between anxiety states and depressive illnesses-I. Br J Psychiatry 121:147-161 (1972)

41) Rush B:Medical Inquiries and Observations upon Diseases of the Mind, 3rd ed. Grigg, Philadelphia (1827)

42) Schulte W:Die Entlastungssituation als Wetterwinkel fur Pathogenese und Manifestation neurologischer und psychiatrischer Krankheiten. Nervenarzt 22:140-149 (1951)
pubmed

43) Sydenham T:Jackson SW:Melancholia and Depression-From Hippocratic Times to Modern Times. Yale Univ Press, New Haven (1986)

44) Tellenbach H:Melancholie. Springer, Berlin (1961/1976)-木村敏(訳):メランコリー. みすず書房, 東京 (1978)

45) Weitbrecht HJ:Zur Typologie depressiver Psychosen. Fortschr Neurol 20:247-267 (1952)

46) Whytt R:Jackson SW:Melancholia and Depression-From Hippocratic Times to Modern Times. Yale Univ Press, New Haven (1986)

47) Winokur G:Types (classification) of depressive disorders-荒井由美子(訳):うつ病の下位分類. 精神科診断学1:147-155 (1990)

48) World Health Organization:The ICD-10 Classification of Mental and Behavioural Disorders. Geneva (1992)

49) Zeller A:Vorwort und Zusatze zu L. Guislain; Abhandlung uber die Phrenopathien oder neues System der Seelenstorungen. Stuttgart u. Leipzig (1938)

50) Berrios G:Mood disorders. A History of Clinical Psychiatry, Berrios G, Porter R (ed), pp 384-408, Athlone, London (1995)

51) 石井厚, 浅野弘毅:躁うつ病研究の歴史. 躁うつ病の臨床と理論, 大熊輝雄 (編), pp 1-12, 医学書院, 東京 (1990)

52) Lanczik M, Beckmann H:Historical aspects of affective disorders. The Diagnosis of Depression, Feigner JP, Boyer WF (ed), pp 1-16, Wiley, Chichester (1991)

P.37 掲載の参考文献

1) Angst J:The epidemiology of depressive disorders. Eur Neuropsychopharmacol Suppl:95-98 (1995)

2) Bebbington P, Hurry J, Tennant C, et al:Epidemiology of mental disorders in Camberwell. Psychol Med 11:561-579 (1981)
pubmed

3) Bebbington P, Ramana R:The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol 30:279-292 (1995)
pubmed

4) Beekman ATF, Deeg DJH, van Tilburg T, et al:Major and minor depression in later life:a study of prevalence and risk factors. J Affect Disord 36:65-75 (1995)

5) Bland RC, Orn H, Newman SC:Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand 77 (suppl 338):24-32 (1988)

6) Bland RC, Newman SC, Orn H:Period prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand 77 (suppl 338):33-42 (1988)

7) Bland RC, Newman SC, Orn H:Age of onset of psychiatric disorders. Acta Psychiatr Scand 77 (suppl 338):43-49 (1988)

8) Bland RC, Newman SC, Orn H:Prevalence of psychiatric disorders in the elderly in Edmonton. Acta Psychiatr Scand 77 (suppl 338):57-63 (1988)

9) Blazer D, Williams CD:Epidemiology of dysphoria and depression in an elderly population. Am J Psychiatry 137:439-444 (1980)

10) Blazer D, George LK, Landerman R, et al:Psychiatric disorders. Arch Gen Psychiatry 42:651-656 (1985)
pubmed

11) Blazer DG, Kessler RC, McGonagle KA, et al:The prevalence and distribution of major depression in a national community sample:The National Comorbidity Survey. Am J Psychiatry 151:979-986 (1994)

12) Boyd JH, Weissman MM:Epidemiology. Handbook of affective disorders, Paykel ES (ed), pp 109-125, Churchill Livingstone, Edinburgh (1982)

13) Burke KC, Burke JD Jr, Regier DA, et al:Age at onset of selected mental disorders in five community populations. Arch Gen Psychiatry 47:511-518 (1990)
pubmed

14) Burke KC, Burke JD Jr, Rae DS, et al:Comparing age at onset of major depression and other psychiatric disorders by birth cohorts in five US community populations. Arch Gen Psychiatry 48:789-795 (1991)
pubmed

15) Canino GJ, Bird HR, Shrout PE, et al:The prevalence of specific psychiatric disorders in Puerto Rico. Arch Gen Psychiatry 44:727-735 (1987)
pubmed

16) Carpiniello B, Carta MG, Rudas N:Depression among elderly people. Acta Psychiatr Scand 80:445-450 (1989)
pubmed

17) Carta MG, Carpiniello B, Morosini PL, et al:Prevalence of mental disorders in Sardinia:a community study in an inland mining district. Psychol Med 21:1061-1071 (1991)

18) Carta MG, Carpiniello B, Kovess V, et al:Lifetime prevalence of major depression and dysthymia:results of a community survey in Sardinia. Eur Neuropsychopharmacol Suppl:103-107 (1995)

19) Chen CN, Wong J, Lee N, et al:The Shatin community mental health survey in Hong Kong. Arch Gen Psychiatry 50:125-133 (1993)

20) Copeland JRM, Dewey ME, Wood N, et al:Range of mental illness among the elderly in the community. Br J Psychiatry 150:815-823 (1987)

21) Cross-National Collaborative Group:The changing rate of major depression. JAMA 268:3098-3105 (1992)

22) Crowell BA Jr, George LK, Blazer D, et al:Psychosocial risk factors and urban/rural differences in the prevalence of major depression. Br J Psychiatry 149:307-314 (1986)

23) Dean C, Surtees PG, Sashidharan SP:Comparison of research diagnostic systems in an Edinburgh community sample. Br J Psychiatry 142:247-256 (1983)

24) Duncan-Jones P, Henderson S:The use of a two-phase design in a prevalence survey. Soc Psychiatry 13:231-237 (1978)

25) Eaton WW, Kramer M, Anthony JC, et al:The incidence of specific DIS/DSM-III mental disorders:data from the NIMH Epidemiologic Catchment Area Program. Acta Psychiatr Scand 79:163-178 (1989)
pubmed

26) Faravelli C, Guerrini Degl'Innocenti B, Aiazzi L, et al:Epidemiology of mood disorders:a community survey in Florence. J Affect Disord 20:135-141 (1990)

27) Fichter MM, Narrow WE, Roper MT, et al:Prevalence of mental illness in Germany and the United States. J Nerv Ment Dis 184:598-606 (1996)
pubmed

28) 藤原茂樹, 北村俊則:甲府市の一地区における精神科疫学調査:軽度精神障害の頻度及び発症要因に関する研究. 厚生省精神・神経疾患委託研究精神・神経・筋疾患の頻度, 発症要因及び予防に関する研究平成4年度研究報告書, pp 50-54 (1992)

29) 古川壽亮:チューリッヒ・コホート研究. 季刊精神科診断学5 (1):23-37 (1994)

30) Gershon ES, Hamovit JH, Guroff JJ, et al:Birth-cohort changes in manic and depressive disorders in relatives of bipolar and schizoaffective patients. Arch Gen Psychiatry 44:314-319 (1987)
pubmed

31) Hallstrom T:Point prevalence of major depressive disorder in a Swedish urban female population. Acta Psychiatr Scand 69:52-59 (1984)

32) Hasegawa K:The epidemiological study of depression in late life. J Affect Disord Suppl 1:S3-S6 (1985)

33) Henderson S, Duncan-Jones P, Byrne DG, et al:Psychiatric disorder in Canberra. Acta Psychiatr Scand 60:355-374 (1979)
pubmed

34) Henderson AS:Does ageing protect against depression? Soc Psychiatry Psychiatr Epidemiol 29:107-109 (1994)
pubmed

35) Hodiamont P, Peer N, Syben N:Epidemiological aspects of psychiatric disorder in a Dutch health area. Psychol Med 17:495-505 (1987)

36) Horwath E, Johnson J, Klerman GL, et al:Depressive symptoms as relative and attributable risk factors for first-onset major depression. Arch Gen Psychiatry 49:817-823 (1992)
pubmed

37) Hwu HG, Yeh EK, Chang LY:Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatr Scand 79:136-147 (1989)
pubmed

38) 井原一成, 芳賀博, 柴田博ほか:高齢者における感情障害の有病率:大うつ病を中心にして. 老年精神医学雑誌4 (6):703 (1993)

39) Isometsa E, Aro S, Aro H:Depression in Finland:a computer assisted telephone interview study. Acta Psychiatr Scand 96:122-128 (1997)
pubmed

40) 川上憲人, 井戸正代, 清水弘之:地域の高齢者における大うつ病エピソードの有病率および関連要因. 日公衛誌42 (9):792-798 (1995)

41) Kay DWK, Henderson AS, Scott R, et al:Dementia and depression among the elderly living in the Hobart community:the effect of the diagnostic criteria on the prevalence rates. Psychol Med 15:771-788 (1985)

42) Kessler RC, McGonagle KA, Swartz M, et al:Sex and depression in the National Comorbidity Survey I:lifetime prevalence, chronicity and recurrence. J Affect Disord 29:85-96 (1993)
pubmed

43) Kessler RC, McGonagle KA, Zhao S, et al:Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 51:8-19 (1994)
pubmed

44) Kessler RC, McGonagle KA, Nelson CB, et al:Sex and depression in the National Comorbidity Survey II:cohort effects. J Affect Disord 30:15-26 (1994)
pubmed

45) Kessler RC, Nelson CB, McGonagle KA, et al:Comorbidity of DSM-III-R major depressive disorder in the general population:results from the US National-Comorbidity Survey. Br J Psychiatry 168 (suppl 30):17-30 (1996)

46) Klerman GL, Lavori PW, Rice J, et al:Birth-cohort trends in rates of major depressive disorder among relatives of patients with affective disorder. Arch Gen Psychiatry 42:689-693 (1985)
pubmed

47) Klerman GL, Weissman MM:Increasing rates of depression. JAMA 261:2229-2235 (1989)
pubmed

48) Komahashi T, Ohmori K, Nakano T, et al:Epidemiological survey of dementia and depression among the aged living in the community in Japan. Jpn J Psychiatry Neurol 48:517-526 (1994)
pubmed

49) Kovess V, Murphy HBM, Tousignant M:Urban-rural comparisons of depressive disorders in French Canada. J Nerv Ment Dis 175:457-465 (1987)

50) Lasch K, Weissman M, Wickramaratne P, et al:Birth-cohort changes in the rates of mania. Psychiatry Res 33:31-37 (1990)
pubmed

51) Lavori PW, Klerman GL, Keller MB, et al:Age-period-cohort analysis of secular trends in onset of major depression:findings in siblings of patients with major affective disorder. J Psychiatr Res 21:23-35 (1987)
pubmed

52) Lee CK, Kwak YS, Yamamoto J, et al:Psychiatric epidemiology in Korea Part I:gender and age differences in Seoul. J Nerv Ment Dis 178:242-246 (1990)
pubmed

53) Lee CK, Kwak YS, Yamamoto J, et al:Psychiatric epidemiology in Korea Part II:urban and rural differences. J Nerv Ment Dis 178:247-252 (1990)

54) Lehtinen V, Lindholm T, Veijola J, et al:The prevalence of PSE-CATEGO disorders in a Finnish adult population cohort. Soc Psychiatry Psychiatr Epidemiol 25:187-192 (1990)

55) Lehtinen V, Joukamaa M:Epidemiology of depression:prevalence, risk factors and treatment situation. Acta Psychiatr Scand Suppl 377:7-10 (1994)
pubmed

56) Leonhard K:Aufteilung der endogenen Psychosen. Akademie-Verlag, Berlin (1957)

57) Lepine JP, Lellouch J, Lovell A, et al:Anxiety and depressive disorders in a French population:methodology and preliminary results. Psychiatr Psychobiol 4:267-274 (1989)

58) Madianos MG, Gournas G, Stefanis CN:Depressive symptoms and depression among elderly people in Athens. Acta Psychiatr Scand 86:320-326 (1992)
pubmed

59) Mavreas VG, Beis A, Mouyias A, et al:Prevalence of psychiatric disorders in Athens. Soc Psychiatry 21:172-181 (1986)
pubmed

60) Mavreas VG, Bebbington PE:Greeks, British Greek Cypriots and Londoners:a comparison of morbidity. Psychol Med 18:433-442 (1988)
pubmed

61) Murphy JM:Continuities in community-based psychiatric epidemiology. Arch Gen Psychiatry 37:1215-1223 (1980)
pubmed

62) Myers JK, Weissman MM, Tischler GL, et al:Six-month prevalence of psychiatric disorders in three communities. Arch Gen Psychiatry 41:959-967 (1984)
pubmed

63) 中根允文:精神医学における疫学. 現代精神医学大系, 懸田克躬ほか(編), 年刊版, 87-A, pp 31-57, 中山書店, 東京 (1987)

64) 中根允文, 塚原美佐子, 道辻俊一郎:うつ病の日本的特性. 臨床精神医学23 (1):5-12 (1994)

65) 中根允文, 菅崎弘之:社会・文化的諸問題, 疫学的諸問題. 感情障害-基礎と臨床, 笠原嘉, 松下正明, 岸本英爾 (編), pp 466-476, 朝倉書店, 東京 (1997)

66) Newman SC, Bland RC, Orn H:Morbidity risk of psychiatric disorders. Acta Psychiatr Scand 77 (suppl 338):50-56 (1988)

67) Oakley-Browne MA, Joyce PR, Wells JE, et al:Christchurch psychiatric epidemiology study, part II:six month and other period prevalence of specific psychiatric disorders. Aus NZ J Psychiatry 23:327-340 (1989)

68) Offord DR, Boyle MH, Campbell D, et al:One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry 41:559-563 (1996)
pubmed

69) 大熊輝雄:躁うつ病. 現代臨床精神医学, pp 390-413, 金原出版, 東京 (1980)

70) Orley J, Wing JK:Psychiatric disorders in two African villages. Arch Gen Psychiatry 36:513-520 (1979)
pubmed

71) Regier DA, Boyd JH, Burke JD Jr, et al:One-month prevalence of mental disorders in the United States. Arch Gen Psychiatry 45:977-986 (1988)
pubmed

72) Regier DA, Narrow WE, Rae DS, et al:The de facto US mental and addictive disorders service system. Arch Gen Psychiatry 50:85-94 (1993)

73) Robins LN, Helzer JE, Weissman MM, et al:Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 41:949-958 (1984)
pubmed

74) 清水將之:児童期, 青年期の躁うつ病. 躁うつ病の臨床と理論, 大熊輝雄 (編), pp 239-253, 医学書院, 東京 (1990)

75) Spitzer RL, Endicott J, Robins E:Clinical criteria for psychiatric diagnosis and DSM-III. Am J Psychiatry 132:1187-1192 (1975)
pubmed

76) Stefansson JG, Lindal E, Bjornsson JK, et al:Lifetime prevalence of specific mental disorders among people born in Iceland in 1931. Acta Psychiatr Scand 84:142-149 (1991)
pubmed

77) 須賀良一, 小熊隆夫, 熊谷敬一ほか:老年期うつ病をめぐって. 社会精神医学14 (3):218-222 (1991)

78) Uhlenhuth EH, Balter MB, Mellinger GD, et al:Symptom checklist syndromes in the general population. Arch Gen Psychiatry 40:1167-1173 (1983)
pubmed

79) Vazquez-Barquero JL, Diez-Manrique JF, Pena C, et al:Two stage design in a community survey. Br J Psychiatry 149:88-97 (1986)

80) Wacker HR, Mullejans R, Klein KH, et al:Identification of cases of anxiety disorders and affective disorders in the community according to ICD-10 and DSM-III-R by using the Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2:91-100 (1992)

81) Warshaw MG, Klerman GL, Lavori PW:The use of conditional probabilities to examine age-period-cohort date:further evidence for a period effect in major depressive disorder. J Affect Disord 23:119-129 (1991)

82) Weissman MM, Klerman GL:Sex differences and the epidemiology of depression. Arch Gen Psychiatry 34:98-111 (1977)
pubmed

83) Weissman MM, Myers JK:Affective disorders in a US urban community. Arch Gen Psychiatry 35:1304-1311 (1978)

84) Weissman MM, Leaf PJ, Tischler GL, et al:Affective disorders in five United States communities. Psychol Med 18:141-153 (1988)
pubmed

85) Weissman MM, Bland RC, Canino GJ, et al:Cross-national epidemiology of major depression and bipolar disorder. JAMA 276:293-299 (1996)
pubmed

86) Wells KB, Golding JM, Burnam MA:Psychiatric disorders and limitations in physical functioning in a sample of the Los Angeles general population. Am J Psychiatry 145:712-717 (1988)

87) Wells KB, Golding JM, Burnam MA:Psychiatric disorders in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 145:976-981 (1988)

88) Wickramaratne PJ, Weissman MM, Leaf PJ, et al:Age, period and cohort effects on the risk of major depression:results from five United States communities. J Clin Epidemiol 42:333-343 (1989)
pubmed

89) Wing JK, Mann SA, Leff JP, et al:The concept of a 'case' in psychiatric population surveys. Psychol Med 8:203-217 (1978)
pubmed

90) Wittchen H-U, Essau CA, von Zerssen D, et al:Lifetime and six-month prevalence of mental disorders in the Munich follow-up study. Eur Arch Psychiatry Clin Neurosci 241:247-258 (1992)
pubmed

P.54 掲載の参考文献

1) Amsterdam JD, Winokur A, Abelman E:Cosyntropin (ACTH 1-24) stimulation test in depressed patients and healthy subjects. Am J Psychiatry 140:907-909 (1983)
pubmed

2) Aprison MH, Takahashi R, Tachiki K:Hypersensitive serotonergic receptors involved in clinical depression-A theory. Neuropharmacology and Behavior, Haber B, Aprison MH (ed), pp 23-53, Plenum Press, New York (1978)

3) Arango V, Ernsberger P, Marzuk PM, et al:Autoradiographic demonstration of increased serotonin 5-HT2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47:1038-1047 (1990)

4) Ashcroft V, Crawford TBB, Eccleston D, et al:5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet ii:1049-1052 (1966)

5) Austin MP, Dougall N, Ross M, et al:Single photon emission tomography with 99mTc-exametazine with SPECT in major depression and the pattern of brain activity underlying the psychotic/neurotic continum. J Affective Disord 26:31 (1992)

6) Avissar S, Schreiber G, Danon A, et al:Lithium inhibits adrenergic and cholinergic increases GTP binding in rat cortex. Nature 331:440-442 (1988)
pubmed

7) Baxter LR, Phelps ME, Mazziotta JC, et al:Cerebral metabolic rates for glucose in mood disorders. Arch Gen Psychiatry 42:441 (1985)
pubmed

8) Baxter LR, Schwartz JM, Phelps ME, et al:Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 46:243 (1989)
pubmed

9) Bench CJ, Frison KJ, Brown RG, et al:The anatomy of melancholia-focal abnormalities of cerebral blood flow in depression. Psychol Med 22:607 (1992)

10) Bench CJ, Frison KJ, Brown RG, et al:Regional cerebral blood flow in depression measured by PET; The relationship with clinical dimensions. Psychol Med 23:579 (1993)

11) Bench CJ, Frackowiak RS, Dolan RJ, et al:Changes in regional cerebral blood flow on recovery from depression. Psychol Med 25:247-261 (1995)
pubmed

12) Biegon A. Israeli M:Regionally selective increases in β-adrenergic receptor density in the brains of suicide victims. Brain Res 442:199-203 (1988)

13) Buchsbaum MS, Delisi LE, Holcomb HH, et al:Antero-posterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 41:1159 (1984)

14) Buchsbaum MS, Wu J, Delisi LE, et al:Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F] 22-deoxyglucose in affective illness. J Affective Disord 10:137 (1986)

15) Buchsbaum MS, Wu J, Siegel BV, et al:Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 41:15-22 (1997)
pubmed

16) Carroll BJ:The dexamethasone suppression test for melancholia. Br J Psychiatry 140:292-304 (1982)
pubmed

17) Checkley SA, Crammer JL:Hormone responses to methylamphetamine in depression;a new approach to the noradrenaline depletion hypothesis. Br J Psychiatry 131:582-586 (1979)

18) Claustrat B, Chazot G, Brun J, et al:A chronobiological study of melatonin and cortisol secretion in depressed subjects;plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 19:1215-1228 (1984)

19) Coffey CE, Figiel GS, Djang WT, et al:Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiatry 24:143-161 (1988)
pubmed

20) Daimon K, Yamada N, Tsujimoto T, et al:Circadian rhythm abnormalities of deep body temperature in depressive disorders. J Affective Disord 26:191-198 (1992)

21) de Goeij DCE, Jezova D, Tilders FJH:Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus. Brain Res 577:165-168 (1992)

22) Dolan RJ, Calloway SP, Thacker PF, et al:The cerebral cortical appearance in depressed subjects. Psychol Med 16:775-779 (1986)
pubmed

23) Dolan RJ, Bench CL, Liddle KJ, et al:Dorsolateral prefrontal cortex dysfunction in the major psychosis;symptom or disease specificity? J Neuro Psychiatry 56:1290 (1993)

24) Extein I, Tallman J, Smith CC, et al:Changes in lymphocyte beta-adrenergic receptors in depression and mania. Psychiatry Res 1:191-197 (1979)
pubmed

25) Flugge G:Dynamics of central nervous 5-HT-1A receptors under psychosocial stress. J Neuroscience 15:7132-7140 (1995)

26) Frazer A, Brown R, Kocsis J, et al:Patterns of melatonin rhythms in depression. J Neurol Transm 21 (suppl):269-290 (1986)

27) Garcia-Sevilla JA, Zis AP, Hollingsworth PJ, et al:Platelet α2-adrenergic receptors in major depressive disorder. Binding of tritiated clonidine before and after tricyclic antidepressant drug treatment. Arch Gen Psychiatry 38:1327 (1981)

28) Gold PW, Goodwin FK, Chrousos, GP:Clinical and biochemical manifestations of depression. N Engl J Med 319:413 (1988)
pubmed

29) Goodwin FK, Jamison KP:Manic-Depressive Illness. Oxford Univ Press, Oxford (1990)

30) Goodwin GM, Austin MP, Dougall N, et al:State changes in brain activity shown by the uptake of 99mTc-exametazine with SPECT in major depression before and after treatment. J Affective Disord 29:243 (1993)

31) Halberg F:Physiologic considerations underlying rhythmometry with special reference to emotional illness. Cycles Biologiques et Psychiatrie, de Ajuriaguerra J (ed), pp 73-126, Masson et Cie, Paris (1968)

32) Halbreich U, Asnis GM, Shindledecker R, et al:Cortisol secretion in endogenous depression. II. Time-related functions. Arch Gen Psychiatry 42:909-914 (1985)
pubmed

33) Hariharasubramanian N, Nair NPV, Pilapil C, et al:Effect of imipramine on the circadian rhythm of plasma melatonin in unipolar depression. Chronobiol Int 3:65-69 (1986)

34) Heath RG, Franklin DE, Walker CF, et al:Cerebellar vermal atrophy in psychiatric patients. Biol Psychiatry 17:569-583 (1982)
pubmed

35) 樋口輝彦, 井田逸朗:感情障害の生理学-画像研究の視点から. 感情障害と神経・免疫・内分泌, 山脇成人 (編), pp 3-19, 新興医学出版社, 東京 (1997)

36) Holsboer F, Gerken A, von Bardeleben U, et al:Human corticotropin-releasing hormone in depression. Biol Psychiatry 21:609-611 (1986)

37) Holsboer F:The hypothalamic-pituitary-adrenocortical system. Handbook of Affective Disorders, Paykel ES (ed), pp 267-187, Churchill Livingstone, Edinburgh (1992)

38) Holsboer F, Spengler D, Heuser I:The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog Brain Res 93:385-417 (1992)
pubmed

39) Holsboer-Trachsler E, Stohler R, Hatzinger M:Repeated administration of the combined dexamethasone/hCRH stimulation test during treatment of depression. Psychiatry Res 38:163-171 (1991)
pubmed

40) Horton RW, Katona CLE, Theodorou AE, et al:Antidepressants and Receptor function. p 84, Interscience Publication, New York (1986)

41) Kanaya T, Yonekawa M:Regional cerebral blood flow in depression. Jpn J Psychiatr Neurol 44:571 (1990)

42) Kazim M, Kapucu O, Erbas B, et al:Assessment of changes in regional cerebral blood flow in patients with major depression using the 99mTc-HMPAO SPECT method. Eur J Nucl Med 19:1038 (1992)

43) Krishnan KRR, Goli V, Ellinwood EH, et al:Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry 23:519-522 (1988)

44) Kuhl DE, Metter EJ, Riege WH, et al:Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease. Brain Imaging and Brain Function, Socoloff I (ed), p 211, Raven Press, New York (1985)

45) Kupfer DJ, Foster FG, Cobel P, et al:The application of EEG sleep for the differential diagnosis of affective disorders. Am J Psychiatry 135:64-74 (1978)

46) Kuroda Y, Mikuni M, Ogawa T, et al:Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors. Psychopharmacol 108:27-32 (1992)

47) Lesch KP, Manji HK:Signal-transduction G proteins and Antidepressant drugs;evidence for modulation of a subunit gene expression in rat brain. Biol Psychiatry 32:549-579 (1992)
pubmed

48) Linkowski P, Mendlewicz J, Leclercq R, et al:The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab 61:429-438 (1985)
pubmed

49) Martinot JL, Hardy P, Feline A, et al:Left prefrontal glucose hypometabolism in the depressed state; A confirmation. Am J Psychiatry 147:1313 (1990)
pubmed

50) Menkes DB, Rasenick MM, Wheeler MA, et al:Guanosine triphosphate activation of brain adenylate cyclase; Enhancement by long term antidepressant treatment. Science 219:65-67 (1983)
pubmed

51) 三国雅彦:気分障害と受容体-細胞内情報伝達系機能異常. 臨床精神医学25:1293-1301 (1996)

52) Monk TH, Buysse DJ, Frank E, et al:Nocturnal and circadian body temperatures of depressed outpatients during symptomatic and recovered states. Psychiatry Res 51:297-311 (1994)
pubmed

53) Nemeroff CB, Owens MJ, Bisstte G, et al:Reduced corticotropin-releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 45:577-579 (1988)

54) Nemeroff CB, Bissette G, Akil H, et al:Neuropeptide concentrations in the CSF of depressed patients treated with electroconvulsive therapy. Br J Psychiatry 158:59-63 (1991)
pubmed

55) Nemeroff CB, Krishman KRR, Reed D, et al:Adrenal gland enlargement in major depression. Arch Gen Psychiatry 49:384-387 (1992)

56) Newman ME, Lerer B:Post-receptor mediated increases in adenylate cyclase activity after chronic antidepressant treatment;relationship to receptor desensitization. Eur J Pharmacol 162:345-352 (1989)
pubmed

57) Nobler MS, Sackeim HA, Prohovnik I, et al:Regional cerebral blood flow in mood disorders. III. Treatment and clinical response. Arch Gen Psychiatry 51:884-897 (1994)
pubmed

58) O'Connell RA, Van Heertum RL, Billick SB, et al:Single photon emission computed tomography (SPECT) with 123I-IMP in the differential diagnosis of psychiatric disorders. J Neuropsychiatry 1:145 (1989)
pubmed

59) 大井健, 高橋清久, 山田尚登ほか:うつ病患者の24時間体温リズム-非感情病性精神病患者との比較から. 臨床精神医学16:1297-1304 (1987)

60) Owen M, Nemeroff CB:Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473 (1991)

61) Ozawa H, Rasenick MM:Coupling of the stimulatory GTP-binding protein Gs to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment. Mol Pharmacol 36:803-809 (1989)
pubmed

62) Ozawa H, Rasenick MM:Chronic electro convulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylate cyclase in a manner similar that seen with chronic antidepressant drugs. J Neurochem 56:330-338 (1991)

63) 小澤寛樹:G蛋白と躁うつ病の成因と治療. 躁うつ病の脳科学, 神庭重信 (編), pp 175-205, 星和書店, 東京 (1995)

64) Pfohl B, Sherman B, Schlechte J, et al:Pituitary-adrenal axis rhythm disturbances in psychiatric depression. Arch Gen Psychiatry 42:897-903 (1985)
pubmed

65) Philpot MP, Banerjee S, Needham-Bennet H, et al:99mTc-HMPAO SPECT in late life depression;a pilot study of regional cerebral blood flow at rest and during a verbal fluency task. J Affective Disord 28:233 (1993)

66) Post RM, Delisi LE, Holcomb HH, et al:Glucose utilization in the temporal cortex of affectively ill patients;Positron emission tomography, Biol Psychiatry 22:545 (1987)
pubmed

67) Reiman EM, Lane RD, Ahern GL, et al:Neuroanatomical correlates of normal human emotion. (Abstract 155. 1) Society Neuroscience Abstracts 19:371 (1993)

68) Rubin RT, Poland RE, Lesser IM, et al:Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry 44:328-336 (1987)
pubmed

69) Rubin RT, Heist EK, McGeoy SS, et al:Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects. Arch Gen Psychiatry 49:558-567 (1992)
pubmed

70) Rupprecht R, Lesch KP, Muller U, et al:Blunted adrenocorticotropin but normal β-endorphin release after depression. J Clin Endocrinol Metab 69:600-603 (1989)

71) Saito N, Guitart X, Hayward M, et al:Corticosterone differentially regulates the expression of Gsα and Giα messenger RNA and protein in rat cerebral cortex. Proc Natl Acad Sci USA 86:3906-3910 (1989)

72) Scott AIF, Dougall N, Ross M, et al:Short-term effects of electroconvulsive treatment on the uptake of 99mTc-exametazine into brain in major depression shown with single photon emission tomography. J Affective Disord 30:27-34 (1994)

73) Segal DS, Kuczenski R, Mandell AJ:Theoretical implications of drug-induced adaptive regulation for a biogenic amine hypothesis of affective disorder. Biol Psychiatry 9:147-159 (1974)
pubmed

74) 仙波純一, 本橋伸高:躁うつ病のGABA仮説. 躁うつ病の薬理生化学[I], 躁うつ病の薬理・生化学的研究懇話会 (編), pp 89-114 (1989)

75) Shima S, Shikano T, Kitamura T, et al:Depression and ventricular enlargement. Acta Psychiatr Scand 70:275-277 (1984
pubmed

76) Siever LJ, Kafka MS, Tergum S, et al:Platelet α2-adrenergic binding and biochemical responsiveness in depressed patients and controls. Psychiatry Res 11:287 (1984)

77) Siever LJ, Uhde TW:New studies and perspectives on the noradrenergic receptor system in depression;effects of the α2-adrenergic agonist clonidine. Biol Psychiatry 19:131 (1984)

78) Souetre E, Salvati E, Belugou JL, et al:Circadian rhythms in depression and recovery;evidence for blunted amplitude and the main chronobiological abnormality. Psychiatry Res 28:263-278 (1989)
pubmed

79) Stephan FK, Zucker I:Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci USA 69:1583-1586 (1972)
pubmed

80) 高橋清久:躁うつ病における神経内分泌機能の変化. 躁うつ病と神経内分泌, 野村純一, 前田潔 (編), pp 15-33, 学会出版センター, 東京 (1993)

81) 高橋義人, 小山司:感情障害のモノアミン仮説-ドーパミン仮説の再検証. 感情障害と神経・免疫・内分泌, 山脇成人 (編), pp 21-29, 新興医学出版社, 東京 (1997)

82) Thomas P, Vaiva G, Samaille E, et al:CBF in major depression and dysthymia. J Affective Disord 29:235 (1993)

83) 辻本哲士, 山田尚登, 下田和孝ほか:うつ病患者における体温リズム異常. 精神医学30:1115-1121 (1988)

84) Tsujimoto T, Yamada N, Shimoda K, et al:Circadian rhythms in depression. Part II:Circadian rhythms in impatients with various mental disorders. J Affective Disord 18:199-210 (1990)

85) Van Praag HM, Korf J:Endogenous depression with and without disturbances in 5-hydroxytryptamine metabolism;A biochemical classification? Psychopharmacologia 19:148 (1971)

86) von Bardeleben U, Holsboer F:Cortisol response to a combined dexamethasone-human corticotropin-releasing hormone challenge in patients with depression. Neuroendocrinology 1:485-488 (1989)

87) von Bardeleben U, Holsboer F:Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients with dexamethasone. Biol Psychiatry 29:1042-1050 (1991)
pubmed

88) Wachtel H:The second-messenger dysbalance hypothesis of affective disorders. Pharmacopsychiatry 23:27 (1990)
pubmed

89) Wehr TA, Muscettola JG, Goodwin FK:Urinary 3-methoxy-4-hydroxy-phenylglycol circadian rhythm. Early timing (phase-advance) in manic-depressives compared with normal subjects. Arch Gen Psychiatry 37:257 (1980)

90) Wehr TA, Wirz-Justice A:Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatry 15:31-39 (1982)

91) Wu JC, Gillin JC, Buchsbaum MS, et al:Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 149:538-543 (1992)
pubmed

P.81 掲載の参考文献

1) 阿部隆明:「妄想型うつ病」の精神病理学的検討-うつ病妄想の成立条件-病前性格との関連. 精神経誌92:435-467 (1990)

2) 阿部隆明:うつ病軽症化の社会文化的背景. 臨床精神医学22:291-297 (1993)

3) Abraham K:Notes on the psychoanalytic treatment of manic-depressive insanity and allied conditions. Selected Papers on Psychoanalysis, pp 137-156, Basic Books, New York (1960/orig. 1911)

4) Abraham K:The first pregenital stage of the libido. Selected Papers on Psychoanalysis, pp 247-279, Basic Books, New York (1960/orig. 1916)

5) Abraham K:A short study of the development of libido, viewed in the light of mental disorders. Selected Papers on Psychoanalysis, pp 137-156, Basic Books, New York (1960/orig. 1924)

6) Abraham K:Die manisch-depressiven Zustande und die pragenitalen Organisationstufen der Libido. Psychoanalytische Studien 1, Fischer (1969)-細木照敏, 飯田眞(訳):躁うつ状態とリビドーの前性器的体制段階. 季刊精神療法 1:266-272 (1975), 2:72-81, 278-285, 375-381 (1976)

7) 赤田豊治:内因性鬱病とヒステリー. 精神経誌60:1436-1471 (1958)

8) Akiskal HS:Dysthymic Disorder;Psychopathology of Proposed Chronic Depression Subtypes. Am J Psychiatry 140:11-20 (1983)
pubmed

9) Akiskal HS:Diagnosis and classification of affective disorders;New insights from clinical and laboratory approaches. Psychiatr Dev 2:123-160 (1983)
pubmed

10) Akiskal HS:Ambulatory and soft forms of manic-depressive Illness. -加藤定 (監訳) 外来における軽症の躁うつ病. 学術講演会記録集, pp 35-52, カネボウ薬品, 東京 (1993)

11) Akiskal HS, Bitar AH, Puzantian VR, et al:The nosological status of neurotic depression;A prospective 3-4 year follow-up examination in the light of the primary-secondary and the unipolar-bipolar dichotomies. Arch Gen Psychiatry 35:756-766 (1978)

12) Akiskal HS, Rosenthal TL, Haykal RF, et al:Characterological depression. Arch Gen Psychiatry 37:777-783 (1980)
pubmed

13) Akiskal HS, Hirschfeld RMA, Yerevanian BI:The relationship of personality to affective disorder;A critical review. Arch Gen Psychiatry 40:801-810 (1983)

14) American Psychiatric Association:DSM-IV;Diagnostic and Statistical Manual of Mental Disorders, 4th ed. APA, Washington DC (1994)

15) Angst J:Zur Atiologie und Nosologie endogener depressiver Psychosen. Springer, Berlin/Heidelberg/New York (1966)

16) Angst J:The course of affective disorders;II, Typology of bipolar manic depressive illness. Arch Psychiatr Nervenkr 226:65-73 (1978)
pubmed

17) Angst J, Perris C:Zur Nosologie endogener Depressionen. Arch Psychiatr Z Ges Neurol 210:373-386 (1968)

18) Angst J, Felder W, Frey R, et al:The course of affective disorders:I, Change of diagnosis of monopolar unipolar and bipolar illness. Arch Psychiatr Nervenkr 226:57-64 (1978)
pubmed

19) Arieti S:Affective disorders;Manic-depressive psychosis and psychotic depression;Manifest symptomatology, psychodynamics, sociological factors, and psychotherapy. American Handbook of Psychiatry, Arieti S (ed), Vol 3, Basic Books, New York (1974)

20) Arieti S, Bemporad J:Severe and Mild Depression. Basic Books, New York (1978)

21) Baeyer Wv:Situation, Jetztsein, Psychose, Conditio Humana. Springer, Berlin/Heidelberg/New York (1966)

22) Beck A:Depression;Clinical, Experimental, and Theoretical Aspects. Paul B Hoeber, New York (1967)

23) Bibring E:The mechanism of depression. Affective Disorders;Psychoanalytic Contribution to their Study, Greenacre P (ed), International Univ Press, New York (1953)

24) Binswanger L:Traum und Existenz. Neue Schweizer Rundschau (1930)-荻野恒一(訳):夢と実存. みすず書房, 東京 (1960)

25) Binswanger L:Melancholie und Manie. Neske, Pfullingen (1960)-山本巌夫, 宇野昌人, 森山公夫 (訳):うつ病と躁病. みすず書房, 東京 (1972)

26) Birnbaum K:Der Aufbau der Psychose. Handbuch der Geistkrankenheiten, Bumke (Hrsg), Bd. V, Spez. Teil. I, S. 1-18 (1928)-千谷七郎 (訳):精神医学17:975-991 (1975)

27) Blankenburg W:Lebensgeschitliche Faktoren bei manischen Psychosen. Nervenarzt 35:536-539 (1964)
pubmed

28) Blankenburg W:Wahnhafte und nichtwahnhafte Depression. Daseinsanalyse 6:40-56 (1989)

29) Brown GW, Harris T, Copeland JR:Depression and loss. Br J Psychiatry 130:1-18 (1977)
pubmed

30) Burger-Prinz H:Psychopathologische Bemerkungen zu den cyclischen Psychosen. Nervenarzt 21:505-507 (1950)
pubmed

31) 千谷七郎:うつ病像の構造分析. 精神医学3:252-266 (1961)

32) Cohen MB, Blake G, Cohen RA, et al:An intensive study of twelve cases of manic-depressive psychosis. Psychiatry 17:103-138 (1954)

33) 土居健郎:うつ病の精神力学. 精神医学8:978-983 (1966)

34) Freud S:Mourning and melancholia. Standard Edition 14, pp 243-258, Hogarth Press, London (1957/orig. 1917)

35) 藤縄昭:両相性躁うつ病の長期経過と病前性格についての予備調査. 躁うつ病の精神病理1, 笠原嘉 (編), 弘文堂, 東京 (1976)

36) Gebsattel Wv:Die Storungen des Werdens und des Zeiterlebens im Rahmen psychiatrischer Erkrankungen;Prolegomena zu einer medizinischen Anthropologie, pp 128-144, Springer, Berlin (1954)

37) Glatzel J:Klinische Anmerkungen zum 'Typus Melancholicus' Tellenbach. Arch Psychiatr Nervenkr 219:197-206 (1974)

38) Glatzel J:Endogene Depression. Thieme, Stuttgart (1982)

39) Hafner H:Die existentielle Depression. Arch Psychiatr Z Neurol 191:351-364 (1954)

40) Hafner H:Struktur und Verlaufsgestalt manischer Verstimmungsphasen. Jb Psychother 9:196-217 (1962)

41) 平沢一:軽症うつ病の臨床と予後. 医学書院, 東京 (1966)

42) 広瀬徹也:「逃避型抑うつ」について. 躁うつ病の精神病理2, 宮本忠雄 (編), 弘文堂, 東京 (1977)

43) 広瀬徹也:軽症うつ病をめぐって-軽症化との関連において. 臨床精神医学22:261-267 (1993)

44) 飯田眞:躁うつ病の状況論と今後の課題. 精神経誌75:274-279 (1973)

45) 飯田眞:躁うつ病の状況論再説. 臨床精神医学7:1035-1047 (1978)

46) 飯田眞:メランコリー型の発達史論. 躁うつ病の精神病理3, 飯田眞 (編), 弘文堂, 東京 (1979)

47) 飯田眞:状況論. 躁うつ病, 飯田眞 (編), 国際医書出版, 東京 (1983)

48) 飯田眞:双生児研究と精神病理学. 臨床精神病理18:91-103 (1997)

49) 飯田眞, 松浪克文, 町沢静夫ほか:うつ病と現代-うつ病の全体像の変遷をめぐって. 臨床精神医学9:23-33 (1980)

50) 飯田眞, 松浪克文, 林直樹:うつ病の状況論. 躁うつ病の臨床と理論, 大熊輝雄 (編), 医学書院, 東京 (1990)

51) 飯田眞, 横山知行, 佐藤新ほか:双生児研究から見た躁うつ病の発症モデル. Pharma Medica 15(10):27-34 (1997)

52) 井上晴雄:内因性うつ病における罪責感情の基盤. 精神経誌62:745-746 (1960)

53) Jacobson E:Depression-Comparative studies of normal, neurotic, and psychotic conditions. International Univ Press, New York (1971)-牛島定信, 奥村幸夫, 安岡誉ほか(訳):うつ病の精神分析. 岩崎学術出版社, 東京 (1983)

54) Janzarik W:Der lebensgeschichtliche und personlichkeitseigene Hintergrund des cyclothymen Verarmungswahns. Arch Psychiatr Nervenkr 195:219-234 (1956/1957)

55) Janzarik W:Die hypochondrischen Inhalte der cyclothymen Depression in ihren Beziehungen zum Krankheitstyp und zur Personlichkeit. Arch Psychiatr Nervenkr 195:351-372 (1956/1957)

56) Janzarik W:Die zyklothyme Schuldthematik und das individuelle Wertgehuge. Schweiz Arch Neurol Psychiatr 80:173-208 (1957)
pubmed

57) Janzarik W:Strukturdynamische Grundlagen der Psychiatrie. Enke, Stuttgart (1988)-岩井一正, 古城慶子, 西村勝治 (訳):精神医学の構造力動的基礎. 学樹書院, 東京 (1996)

58) Jaspers K:Allgemeine Psychopathologie, 4 Aufl. Springer, Berlin/Heidelberg (1949)-内村祐之, 西丸四方, 岡田敬蔵ほか(訳):精神病理学総論, 上・中・下. 岩波書店, 東京 (1953/1955/1956)

59) Judd LL, Rapaport MH, Paulus MP, et al:Subsyndromal symptomatic depression;A new mood disorder? J Clin Psychiatry 55(suppl 4):18-28 (1994)

60) 梶谷哲男:うつ病性罪責体験について. 精神医学10:380-386 (1968)

61) Kaplan HI, Saddock BJ, Grebb JA:Synopsis of Psychiatry, 7th ed. Williams & Wilkins, Baltimore (1994)

62) 笠原嘉:内因性精神病の発病に直接前駆する「心的要因」について. 精神医学 9:403-412 (1967)

63) 笠原嘉:精神医学における人間学の方法. 精神医学10:5-19 (1968)

64) 笠原嘉:うつ病の病前性格について. 躁うつ病の精神病理1, 笠原嘉 (編), 弘文堂, 東京 (1976)

65) 笠原嘉:ティーンエイジャーのうつ病. 躁うつ病の精神病理2, 宮本忠雄 (編), 弘文堂, 東京 (1977)

66) 笠原嘉:各科を訪れる可能性のあるデプレッション. 心身医学24:6-12 (1984)

67) 笠原嘉:二十歳台のうつ状態-いわゆる葛藤反応型うつ病をめぐって. 躁うつ病の精神病理5, 笠原嘉 (編), 弘文堂, 東京 (1987)

68) 笠原嘉, 木村敏:うつ病の臨床的分類に関する研究. 精神経誌77:715-735 (1975)

69) 加藤敏:うつ病の妄想形成-妄想主題の複数性とその進行をめぐって. 臨床精神医学9:331-340 (1980)

70) Kielholz P:Diagnostik und Therapie der depressiven Zustandsbilder. Schweiz Med Wochenschr 87:107-110 (1957)
pubmed

71) Kiloh LG, Garside RE:The independence of neurotic and endogenous depression. Br J Psychiatry 109:451-463 (1963)

72) 木村敏:うつ病と罪責体験. 精神医学10:375-380 (1968)

73) 木村敏:いわゆる「鬱病性自閉」をめぐって. 躁うつ病の精神病理1, 笠原嘉 (編), 弘文堂, 東京 (1976)

74) 木村敏:鬱病と躁鬱病の関係についての人間学的・時間論的考察. 躁うつ病の精神病理4, 木村敏 (編), 弘文堂, 東京 (1981)

75) 木村敏:躁とうつ. 異常心理学講座6, 神経症と精神病3, みすず書房, 東京 (1990)

76) Klages L:Die Grundlagen der Charakterikunde. Barth, Munchen (1951)-千谷七郎 (訳):性格学の基礎. 岩波書店, 東京 (1968)

77) Klein DF:Endogenomorphic depression patients;A conceptual and terminological revision. Arch Gen Psychiatry 31:447-454 (1974)

78) Klein M:Mourning and its relation to manic-depressive states. Contributions to Psychoanalysis, 1921-1945, Klein M (ed), Hogarth Press, London (1948/orig. 1940)

79) 近藤喬一:罪責体験. 躁うつ病, 飯田眞 (編), 国際医書出版, 東京 (1983)

80) Kraepelin E:Psychiatrie, 8 Aufl. J. A. Barth, Leipzig (1913)-西丸四方, 西丸甫夫 (訳):躁うつ病とてんかん. みすず書房, 東京 (1986)

81) Kral VA:Masked depression in middle aged men. Can Med Assoc J 79:1-5 (1958)
pubmed

82) Kraus A:Sozialverhalten und Psychose Manisch-Depressiver. Enke, Stuttgart (1977)-岡本進 (訳):躁うつ病と対人行動. みすず書房, 東京 (1983)

83) Kretschmer E:Korperbau und Charakter, 20 Aufl. Springer, Berlin/Gottingen/Heidelberg (1951)-相場均 (訳):体格と性格. 文光堂, 東京 (1960)

84) 栗野龍:内因性鬱病と強迫症, 恐怖症. 精神経誌60:675-699 (1958)

85) Lange J:Uber Melancholie. Z ges Neurol Psychiatr 101:293-319 (1926)

86) Lorenzer A:Die Verlust-Depression. Verlust und existentielle Krise. Arch Psychiatr Nervenkr 198:649-658 (1959)

87) 松本雅彦, 大森和宏:感情障害とその周辺-「逃避型抑うつ・中年型」について. 精神医学32:829-838 (1990)

88) 松浪克文:秩序指向性と反復. imago 2:67-75, 青土社, 東京 (1991)

89) 松浪克文, 飛鳥井望:職業人としての危機. 中年期の心の危機, 飯田眞, 吉松和哉, 町沢静夫 (編), 有斐閣, 東京 (1986)

90) 松浪克文, 山下喜弘:社会変動とうつ病. 社会精神医学14:193-200 (1991)

91) 松浪克文, 小野博行, 丸田伯子:中年の抑うつ. こころの科学50, 日本評論社, 東京 (1993)

92) 松浪克文, 山下喜弘, 丸田伯子:感情障害の経過型から見た成因解明と治療の開発研究, 感情障害における生活リズムの病理とその治療. 平成8年度厚生省精神・神経疾患研究委託費による研究報告集, 平野誠 (編) (1997)

93) Mauz F:Der Prognostik der endogenen Psychosen. Thieme, Stuttgart (1930)

94) Mendelson M:Psychoanalytic Concepts of Depression. Spectrum Publications, New York (1974)

95) Minkowski E:La schizophrenie. Payot, Paris (1927)-村上仁(訳):精神分裂病. みすず書房, 東京(1943)

96) Minkowski E:Le temps vecu. Etudes phenomenologiques et psychopathologiques. Delachaux et Niestle, Neuchatel, Suisse (1968/orig. 1933)-中江育生, 清水誠, 大橋博司 (訳):生きられる時間1, 2. みすず書房, 東京 (1972, 1973)

97) 宮本忠雄:人間学. 躁うつ病, 新福尚武 (編), 医学書院, 東京 (1972)

98) 宮本忠雄:躁うつ病者の妄想的ディスクール. 躁うつ病の精神病理2, 宮本忠雄 (編), 弘文堂, 東京 (1977)

99) 宮本忠雄:躁うつ病における混合状態の意義. 臨床精神医学21:1433-1439 (1992)

100) 森山公夫:躁とうつの内的連関について. 精神経誌67:1163-1186 (1965)

101) 森山公夫:躁うつ病者における性格と発病状況の両極的把握について. 精神医学 10:352-356 (1968)

102) 森山公夫:両極的見地による躁うつ病の人間学的類型学. 精神経誌70:922-943 (1968)

103) Muller-Suur H:Referanteil von "Tellenbach H:Melancholie". Nervenarzt 33:473-474 (1962)

104) The New Harvard Guide to Psychiatry. The Belknap Press of Harvard University Press, Cambridge/Massachusetts/London, England (1988)

105) 西園昌久:うつ病の家族病理と家族療法. 季刊精神療法4:149-157 (1978)

106) 西園昌久:躁うつ病の家族研究から. 臨床精神医学7:1049-1057 (1978)

107) 西園昌久:神経症とうつ病の境界. 神経症の周辺, 清水將之, 高橋徹, 吉松和哉 (編), 医学書院, 東京 (1981)

108) 西園昌久:精神分析理論. 躁うつ病, 飯田眞 (編), 国際医書出版, 東京 (1983)

109) 荻野恒一:精神病理学入門. 誠信書房, 東京 (1964)

110) 岡本進:精神病理学的研究. 躁うつ病の臨床と理論, 大熊輝雄 (編), 医学書院, 東京 (1990)

111) 大橋正和:躁病の発病状況. 躁うつ病の精神病理3, 飯田眞 (編), 弘文堂, 東京 (1979)

112) Pauleikhoff B:Uber die Bedeutung situativer Einflusse bei der Auslosung endogener depressiver Phasen. Arch f Psychiatr u Z f d ges Neurol 197:669-685 (1958)

113) Pauleikhoff B (Hrsg):Situation und Personlichkeit in Diagnostik und Therapie. Kager, Basel (1968)

114) Paykel ES, Prusoff BA, Myers JK:Suicide attempts and recent life events. Arch Gen Psychiatry 32:327-337 (1975)
pubmed

115) Paykel ES, Tenner J:Life events depressive relapse and maintenance treatment. Psychol Med 6:481-485 (1976)

116) Perris C:A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Acta Psychiatr Scand (suppl) 253 (1974)

117) 佐藤哲哉, 坂戸薫, 西岡和郎ほか:メランコリー型性格のための質問紙表 (笠原)の信頼性. 精神医学38:157-162 (1996)

118) 柴田収一:躁鬱病と渇酒症および遁走. 精神経誌60:809-841 (1958)

119) 柴田収一:感情・気分の異常. 現代精神医学大系, 第3巻B 精神症状学II, 大橋博司, 保崎秀夫 (編), 中山書店, 東京 (1976)

120) Schimmelpenning GW:Zur Frage der reaktiven Manie. Hamburger Arztblatt 24 Jg Nr 5:200-204 (1970)

121) Schneider K:Uber reaktive Manie und Angstmanie. Monatschr Psychiatr 46:176-180 (1919)

122) Schneider K:Die Schichtung des emotionalen Lebens und der Aufbau der Depressionszustande. Z ges Neurol Psychiatr 59:281-286 (1921)-赤田豊治 (訳):精神医学18:441-447 (1976)

123) Schneider K:Die Aufdeckung des Daseins durch cyclothyme Depression. Nervenarzt 21:193-194 (1950)

124) Schneider K:Klinische Psychopathologie, 6 Aufl. Thieme, Stuttgart (1962) -平井静也, 鹿子木敏範 (訳):臨床精神病理学. 文光堂, 東京 (1963)

125) Schulte W:Die Entlastungssituation als Wetterwinkel zur Pathogenese und Manifestation neurologischer und psychiatrischer Krankheiten. Nervenarzt 22:140-149 (1951)-佐藤哲哉, 大橋正和 (訳):精神の科学別巻, 諸外国の研究状況と展望. 岩波書店, 東京 (1984)

126) Schulte W:Nichttraurigseinkonnen im Kern melancholischen Erlebens. Nervenarzt 32:314-320 (1961)

127) Schulte W:Psychotherapeutische Bemuhungen bei der Melancholie. Dtsch Med Wochenschr 87:2225-2231 (1962)

128) Schulte W:Studien zur heutigen Psychotherapie. Quelle & Meyer, Heidelberg (1964)-飯田眞, 中井久夫 (訳):精神療法研究. 医学書院, 東京 (1969), 新訳版, 岩崎学術出版社, 東京 (1994)

129) 下田光造:躁うつ病の病前性格に就いて. 精神経誌, 45:101-102 (1941)

130) 下田光造:躁うつ病に就いて. 米子医誌2:1-2 (1950)

131) 新福尚武:仮面デプレッションの問題の輪郭. 仮面デプレッション, 新福尚武 (編), 日本メルク万有, 東京 (1969)

132) Shinfuku N, Ihda S:Uber Pramorbiden Charakter der endogenen Depression. Immodithymie (Spater Immobilithymie) von Shimoda. Fortsch Neurol Psychiatr 37:545-552 (1969)

133) Straus E:Das Zeiterlebnis in der endogenen Depression und in der psychopathischen Verstimmung. Psychologie der menschlichen Welt, pp 126-140, Springer, Berlin (1960)

134) 諏訪尚史:精神分析. 躁うつ病, 新福尚武 (編), 医学書院, 東京 (1972)

135) Tellenbach H:Abbreviatur und Epikritisches zu Ludwig Binswangers Buch "Melancholie und Manie" Psychiatrische Klinik und transzendentale Phanomenologie. Nervenarzt 33:515-520 (1962)

136) Tellenbach H:Zur situationspsychologischen Analyse des Vorfeldes endogener Manien. Jb Psychol Psychothr 12:174-191 (1965)

137) Tellenbach H:Melancholie, 3 Aufl. Springer, Berlin (1978/org. 1961)-木村敏 (訳):メランコリー. みすず書房, 東京 (1985)

138) Tolle R, Fritz H:Zur Auslosung von Manien. Psychiatr Clin 4:12-18 (1971)
pubmed

139) Weitbrecht HJ:Zur Psychopathologie der zyklothymen Depression. Arbeiten zur Psychiatrie, Neurologie und ihren Grenzgebieten, Kranz (ed), pp 139-158, Scherer, Willsbach/Heidelberg (1947)

140) Weitbrecht HJ:Zur Typologie depressiver Psychosen. Fort Neurol Psychiatr 31:247-269 (1952)

141) Wender PH, Klein FD:Mind, Mood and Medicine-A Guide in the New Biopsychiatry. Farra-Straus-Giroux, New York (1981)-松浪克文, 福本修 (訳):現代精神医学への招待 (上・下). 紀伊國屋書店, 東京 (1990)

142) White RB:Current psychoanalytic concepts of depression. Phenomenology and Treatment of Depression, Fann WE, Karaca I, Pokorny AD, et al (ed), Spectrum Pub, New York (1977)

143) Winokur G:Unipolar depression-is it divisible into autonomous subtype? Arch Gen Psychiatry 36:47-52 (1979)
pubmed

144) 山本巌夫:現象学的人間学. 躁うつ病, 飯田眞 (編), 国際医書出版, 東京 (1983)

145) Zerssen Dv, Tauscher R, Possel J:The relationship of premorbid personality to subtypes of an affective illness, J Affect Disord 32:61-72 (1994)

P.105 掲載の参考文献

1) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III). American Psychiatric Association, Washington DC (1980)-高橋三郎, 花田耕一, 藤縄昭 (訳):DSM-III精神障害の分類と診断の手引. 医学書院, 東京 (1983)

2) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Third Edition Revised (DSM-III-R). American Psychiatric Association, Washington DC (1987)-高橋三郎, 花田耕一, 藤縄昭 (訳):DSM-III-R精神障害の分類と診断の手引. 第2版, 医学書院, 東京 (1988)

3) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Forth Edition (DSM-IV). American Psychiatric Association, Washington DC (1994)-高橋三郎, 大野裕, 染矢俊幸:DSM-IV精神疾患の分類と診断の手引. 医学書院, 東京 (1995)

4) Dunner DL:Subtypes of bipolar affective disorder with particular regard to bipolar II. Psychiatry Dev 1:75-86 (1983)

5) Gershon ES, Hamovit J, Guroff JJ, et al:A family study of schizoaffective, bipolar I, bipolar II, unipolar and normal control probands. Arch Gen Psychiatry 39:1157-1167 (1982)
pubmed

6) 花田耕一:ICD-10 (草案)の気分障害. 臨床精神医学19:1057-1066 (1990)

7) 花田耕一:分類と診断基準-ICDとDSMを中心に. 感情障害. 笠原嘉, 松下正明, 岸本英爾 (編), pp 308-314, 朝倉書店, 東京 (1997)

8) 假屋哲彦, 宇田川雅彦:躁うつ病の概念とその変遷. 生物学的精神医学, 中沢恒幸, 小島卓也, 三国雅彦 (編), 第1巻精神医学と生物学の語らい-その源流と現代の視点, pp 81-101, 学会出版センター, 東京 (1992)

9) 笠原嘉, 木村敏:うつ状態についての臨床的分類について. 精神経誌77:715-735 (1975)

10) 加藤正明:DSM I～IIIの変遷の歴史. 精神医学26:114-119 (1984)

11) 木村敏:操作診断の問題点-人間学的精神医学の立場から. 精神経誌99:746-749 (1977)

12) 北村俊則, 栗田広, 藤縄昭:ICD-10を中心とした精神疾患診断基準の動向. 精神医学32:686-694 (1990)

13) 北村俊則:精神疾患診断の問題点と操作診断の必要性. 精神経誌 99:742-746 (1997)

14) 本橋伸高, 假屋哲彦:生化学的診断感情障害, 笠原嘉, 松下正明, 岸本英爾 (編), pp 329-333, 朝倉書店, 東京 (1997)

15) 中根允文:ICD-10からみたDSM-IV. 臨床精神医学25:301-306 (1996)

16) 中安信夫:臨床診断の思想-操作的診断基準に求められるものは何か. 精神経誌 99:736-742 (1997)

17) 太田敏男, 山内俊雄:脳器質疾患, 精神病性障害および気分障害をめぐって. 臨床精神医学25:275-283 (1996)

18) 高橋三郎:ICD-10 (草案)の構造とその特徴臨床精神医学19:1041-1047 (1990)

19) 高橋三郎, 染矢俊幸:DSM-III, DSM-III-R そしてDSM-IV. 臨床精神医学25:269-273 (1996)

20) 高橋三郎, 染矢俊幸, 山田尚登ほか:操作診断学による精神医学の進歩. 精神経誌 99:730-736 (1997)

21) 田中義枝, 中村健二:ICD-10 (草案) 作成の経緯と現状. 臨床精神医学19:1035-1040 (1990)

22) World Health Organization:The ICD-10 Classification of Mental and Behavioural Disorders;Clinical descriptions and diagnostic guidelines. WHO, Geneva (1992)-融道男, 中根允文, 小見山実 (監訳):ICD-10精神および行動の障害-臨床記述と診断ガイドライン. 医学書院, 東京 (1993)

P.123 掲載の参考文献

1) Angst J:How recurrent and predictable is depressive illness? Long-term Treatment of Depression, Montgomery, Rouillon F (ed), pp 1-14, Wiley, Chichester (1992)

2) Brown W, Dornseif B, Wernicke J:Placebo response in depression;A search for predictors. Psychiatry Res 26:259-264 (1988)
pubmed

3) Cooper SF, Dugal R, Elie R:Metabolic interaction between amitriptyline and perphenazine in psychiatric patients. Prog Neuropsychopharmacol 3:369-376 (1979)
pubmed

4) Coppen A, Ghose K, Montgomery SA, et al:Continuation therapy with amitriptyline in depression. Br J Psychiatry 133:28-33 (1978)

5) Dietrich A, Mortensen ME, Wheller J:Cardiac toxicity in an adolescent following chronic lithium and imipramine therapy. J Adolesc Health 14:394-397 (1993)

6) Doogan DP, Caillard V:Sertraline in the prevention of depression. Br J Psychiatry 160:217-222 (1992)
pubmed

7) Downing R, Rickels K:Physicians' prognosis in relationship to drug and placebo response in anxious and depressed psychiatric outpatients. J Nerv Ment Dis 156(2):109-129 (1973)

8) Feinberg SS, Halbreich U:The association between the definition and reported prevalence of treatment-resistant depression. Psychosocial Aspects of Nonresponse to Antidepressant Drugs. Halbreich U, Feinberg SS (ed), pp 5-34, American Psychiatric Press, Washington DC (1986)

9) Frank E, Kupfer DJ, Perel JM, et al:Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47:1093-1099 (1990)
pubmed

10) Glen AIM, Johnson AL, Shepherd M:Continuation therapy with lithium and amitriptyline in unipolar depressive illness;a randomized, double-blind, controlled trial. Psychol Med 14:37-50 (1984)

11) Jacoby R, Lunn MA, Ardern M, et al:How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Br J Psychiatry 162:175-182 (1993)

12) Janicak PG, Davis JM, Preskorn SH, et al:Principles and Practice of Psychopharmacotherapy. Williams & Wilkins, Baltimore (1993)

13) 上島国利, 石福行人:抗うつ薬の循環機能障害. 精神医学32:245-251 (1990)

14) 上島国利:抗うつ薬の知識と使い方. p 42, ライフ・サイエンス, 東京 (1993)

15) 上島国利:抗精神病薬の相互作用. 抗精神病薬の使い方, 大月三郎 (編), pp 225-253, 日本アクセル・シュプリンガー出版, 東京 (1993)

16) Kiloh L, Ball J, Garside R:Prognostic factors in treatment of depressive states with imipramine. Br Med J 1:1225-1227 (1962)
pubmed

17) Klerman GL, Cole JO:Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacol Rev 17:101-141 (1965)
pubmed

18) Klerman GL, Dimascio A, Weissman M, et al:Treatment of depression by drugs and psychotherapy. Am J Psychiatry 131:186-191 (1974)
pubmed

19) Kupfer DJ, Frank E, Perel JM, et al:Five-year outcome for maintenance therapie in recurrent depression. Arch Gen Psychiatry 49:769-773 (1992)

20) Loga S, Curry S, Lander M, et al:Interaction of chlorpromazine and nortriptyline in patients schizophrenia. Clin Pharmacokinet 6:454-462 (1981)

21) Mindham RHS, Howland C, Shepherd M:An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychol Med 3:5-17 (1973)

22) Montgomery SA, Dufour H, Brion S, et al:The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry 153 (suppl):69-76 (1988)

23) Montgomery SA, Doogan DP, Burnside R:The influence of different relapse criteria on the assessnent of long-term efficacy of sertraline. Int Clin Psychopharmacol 6 (suppl 2):37-46 (1991)

24) Montgomery SA, Dunbar GC:Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int Clin Psychopharmacol 6 (suppl 5):65-70 (1993)

25) NIMH/NIH Consensus Development Panel:Mood disorders;pharmacologic prevention of recurrence. Am J Psychiatry 142:469-476 (1985)
pubmed

26) Perry PJ, Zeilmann C, Arndt SV:Tricyclic antidepressant plasma concentrations;an estimate of their sensitivity and specificity as a predictor of response. J Clin Psychopharmacol 14:230-240 (1994)

27) Perry PJ, Alexander B, Liskow BI:Psychotropic Drug Handbook, 7th ed. APA American Psychiatric Press, Washington DC (1997)

28) Prien RF, Klett CJ, Caffey EM Jr:Lithium carbonate and imipramine in prevention of affective episodes;a comparison in recurrent affective illness. Arch Gen Psychiatry 29:420-425 (1973)
pubmed

29) Prien RF, Kupfer DJ, Mansky PA, et al:Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders;a report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 41:1096-1104 (1984)

30) Prien RF, Kupfer DJ:Continuation drug therapy for major depressive episodes; how long should it be maintained? Am J Psychiatry 143:18-23 (1986)
pubmed

31) Rouillon F, Phillips R, Serrurier D, et al:Rechutes, de depression unipolaire et efficacite de la maprotiline. L'Encephale 15:527-534 (1989)

32) 坂井俊之, 上島国利:抗うつ薬の薬物相互作用. 臨床精神医学26:165-177 (1997)

33) Seager CP, Bird RL:Imipramine with electrical treatment in depression;a controlled trial. J Ment Sci 108:704-707 (1962)

34) Simpson HB, Nee JC, Endicott J:First-episode major depression few sex difference in course. Arch Gen Psychiatry 54:633-639 (1997)
pubmed

35) Solomon JG:Seizures during lithium-amitriptyline therapy. Postgrad Med 66:145-148 (1979)
pubmed

36) Spine E, Perucca E:Newer and older antidepressants;a comparative review on drug interactions. CNS Drugs 2:479-497 (1994)

37) Stassen HH, Angst J, Delini-Stula A:Onset of action under antidepressant. Eur Psychiatry 12:163-165 (1997)
pubmed

38) Stein MK, Rickels K, Weise CC:Maintenance therapy with amitriptyline;a controlled trial. Am J Psychiatry 137:370-371 (1980)
pubmed

39) Vandel B, Vandel S, Allers G, et al:Interaction between amitriptyline and phenothiazine in man;effect on plasma concentration of amitriptyline and its metabolite nortriptyline and the correlation with clinical response. Psychopharmacology 65:187-190 (1979)
pubmed

P.137 掲載の参考文献

1) Ahlfors UG, Baastrup PC, Dencker SJ, et al:Flupenthixol decanoate in recurrent manic depressive illness. Acta Psychiatr Scand 64:226-237 (1981)
pubmed

2) Ambelas A:Psychologically stressful events in the precipitation of manic episodes. Br J Psychiatry 135:15-21 (1979)
pubmed

3) Avissar S, Schreiber G:The involvement of guanine nucleotide binding protein in the pathogenesis and treatment of affective disorders. Biol Psychiatry 31:435-459 (1992)
pubmed

4) Avissar S, Danon A, Nechamkin Y, et al:Reduced G protein function and immunoreactive levels of immunonuclear leukocytes of patients with depression. Am J Psychiatry 154:211-217 (1997)

5) 馬場信二, 笹野友寿, 新門弘人ほか:Rapid cycling affective disorderに対するLithium, carbamazepine, clonazepam 併用療法の経験. 精神医学34:399-408 (1992)

6) Bacher MM, Lewis HA:Lithium plus reserpine in refractory manic patients. Am J Psychiatry 136:811-814 (1979)
pubmed

7) Ballenger JC:The clinical use of carbamazepine in affective disorders. J Clin Psychiatry 49 (suppl 1):13-19 (1988)

8) Bradwejn J, Shriqui C, Koszycki D, et al:Double-blind comparison of the effect of clonazepam and lorazepam in acute mania. J Clin Psychopharmacol 10:403-408 (1990)

9) Bunney WE, Goodwin FK, Murphy DL, et al:The "switch process" in manicdepressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Arch Gen Psychiatry 27:304-309 (1972)
pubmed

10) Calabrese JR, Markovitz PJ, Kimmel SE, et al:Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 12 (suppl 1):53s-56s (1992)

11) Calland V:Treatment of mania using a calcium antagonist-preliminary trial. Neuropsychobiology 14:23-26 (1985)

12) Chouinard G, Young SN, Annable L:Antimanic effect of clonazepam. Biol Psychiatry 18:451-466 (1983)
pubmed

13) Dubovsky SL, Franks RD, Lifschitz M, et al:Effectiveness of verapamil in the treatment of a manic patient. Am J Psychiatry 139:502-504 (1982)
pubmed

14) EL-Mallakh RS, Jaziri WA:Calcium channel blockers in affective illness;Role of sodium-calcium exchange. J Clin Psychopharmacol 10:203-206 (1990)
pubmed

15) Emrich HMV, Zerssen D, Kissling W, et al:Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders. Arch Psychiatr Nervenkr 229:1-16 (1980)

16) Frances A, Docherty JP, Kahn DA:Treatment of bipolar disorder. J Clin Psychiatry 57 (suppl 12A):3-80 (1995)

17) Freeman TW, Clothier JL, Pazzaglia P, et al:A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 149:108-111 (1992)
pubmed

18) Goodwin FK, Ebert MH:Lithium in mania;Clinical trials and controlled studies. Lithium, Its Role in Psychiatric Research and Treatment, Gershon S, Shopsin B (ed), Prenum Press, New York (1973)

19) Hischfeld RMA, Clayton RJ, Cohen I, et al:Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 151 (suppl 12):1-36 (1994)

20) 北海道臨床精神薬理研究会:スルトプリドの臨床評価-精神分裂病, 躁病, 非定型精神病について. 臨床精神医学14:381-397 (1985)

21) Hoschl C, Kozeny J:Verapamil in affective disorders;A controlled double-blind study. Biol Psychiatry 25:128-140 (1989)
pubmed

22) Inoue H, Hazama H, Hamazoe K:Antipsychotic and prophylactic effect of acetazolamide (Diamox) on atypical psychosis. Folia Psychiatr Neurol Jpn 38:425-436 (1984)
pubmed

23) Kahn DA, Ross R, Rush AJ, et al:Expert consensus treatment guidelines for bipolar disorder;a guide for patients and families. J Clin Psychiatry 57 (suppl 12A):81-88 (1996)

24) Kanba S, Yagi G, Kamizima K, et al:The first open study of zonisamide, a novel anticonvalsant, shows efficacy in mania. Prog Neuropsychopharmacol Biol Psychiatry 18:707-715 (1994)

25) 岸本朗:気分安定薬. 脳と精神の医学6:273-282 (1995)

26) 岸本朗:躁うつ病に対するカルバマゼピン応用. 臨床精神医学14:269-278 (1985)

27) Kishimoto A:Antiepileptics and lithium in the treatment of mood disorders. Biological Psychiatry Vol 2, Racagni G, et al (ed), Excerpta Medica, Amsterdam (1991)

28) Kishimoto A, Kamata K, Sugihara T, et al:Treatment of depression with clonazepam. Acta Psychiatr Scand 77:88-86 (1988)

29) 小山司, 石金朋人:感情障害の治療-三環抗うつ薬, その他. 精神医学36:17-21 (1994)

30) Kukopulos A, Reginaldi D:Recurrences of manic-depressive episodes during lithium treatment. Handbook of Lithium Therapy, Johnson FN (ed), pp 109-130, MTP Press, Lancaster (1980)

31) Lenzi A, Lazzerini F, Grossi E, et al:Use of carbamazepine in acute psychosis; A controlled study. J Int Med Res 14:78-84 (1986)
pubmed

32) Lerer B, Moore M, Meyendorff E, et al:Carbamazepine versus lithium in mania, a double blind study. J Clin Psychiatry 48:89-93 (1987)

33) Leverich GS, Post RM, Rosoff AS:Factors associated with relapse during maintenance treatment of affective disorders. Int Clin Psychopharmacol 5:135-156 (1990)
pubmed

34) Littlejohn R, Leslie F, Cookson J:Depot antipsychotics in the prophylaxis of bipolar affective disorder. Br J Psychiatry 165:827-829 (1994)
pubmed

35) McElroy SL, Keck PE, Pope HG, et al:Valproate in psychiatric disorders, literature review and clinical guidelines. J Clin Psychiatry 50 (suppl 3):23-29 (1989)

36) Okuma T, Inanaga K, Otsuki S, et al:Comparison of anti-manic efficacy of carbamazepine and chlorpromazine by double-blind controlled study. Clin Eval 7:509-532 (1979)

37) 大熊輝雄, 山下格, 高橋良ほか:カルバマゼピンと炭酸リチウムの躁病に対する薬効の二重盲検法による比較. Clin Eval 16:115-148 (1988)

38) 大月三郎, 原田俊樹:Zotepineの抗躁作用について. 臨床精神医学14:309-321 (1985)

39) Pope HG, McElroy SL, Keck PE, et al:Valproate in the treatment of acute mania;A placebo-controlled study. Arch Gen Psychiatry 48:62-68 (1991)

40) Post RM:Carbamazepine treatment of bipolar affective disorder. Directions in Psychiatry 9, Lesson 3, 1-11 (1989)

41) Post RM, Uhde TW, Roy-Byrne PP, et al:Correlates of antimanic response to carbamazepine. Psychiatry Res 21:71-83 (1987)
pubmed

42) Post RM, Uhde TW, Rubinow DR, et al:Efficacy and mechanisms of action of carbamazepine in affective disorder. Biological Psychiatry, Shagass C, et al (ed), pp 886-888, Elsevier Science Publishing, Amsterdam (1985)

43) Prazzaglia PJ, Post RM, Kener TA, et al:Preliminary controlled trial of nimodipine ultra-rapid cycling affective dysregulation. Psychiatry Res 49:257-272 (1993)

44) Prien RF, Point P, Caffey EM, et al:Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Arch Gen Psychiatry 26:146-153 (1972)

45) Prien RF, Caffey EM Jr, Klett CJ:Relationship between serum lithium level and clinical response in acute mania treated with lithium. Br J Psychiatry 120:409-412 (1972)
pubmed

46) 島薗安雄, 森克己, 宮坂松衛ほか:Timiperon (PP3480) 注射剤の精神分裂病と躁病に対する施設治療経験. 臨床精神医学13:477-491 (1984)

47) Schou M:Fourty years of lithium treatment. Arch Gen Psychiatry 54:9-19 (1997)

48) Schreiber G, Avissar S, Danon A, et al:Hyperfunctional G protein in mononuclear leukocytes of patients with mania. Biol Psychiatry 29:273-280 (1991)
pubmed

49) Shopsin B, Gershon S, Thompson H, et al:Psychoactive drugs in mania;a controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Arch Gen Psychiatry 32:34-42 (1975)

50) Swann AC, Bowden CL, Morris D, et al:Depression during mania, treatment response to lithium or diproex. Arch Gen Psychiatry 54:37-42 (1997)

51) 田島治, 上島国利:リチウムおよびその他の抗躁薬. 精神治療薬大系, 上島国利ほか(編), 第3巻抗うつ薬, 抗躁薬, 抗てんかん薬, 抗パ薬, 漢方薬, pp 112-42, 星和書店, 東京 (1996)

52) Takahashi R, Sakuma A, Itoh K, et al:Comparison of efficacy of lithium carbonate and chlorpromazine in mania;Report of collaborative study group on treatment of mania in Japan. Arch Gen Psychiatry 32:1310-1318 (1975)

53) 竹崎治彦, 花岡正憲:躁うつ病および症候性うつ状態に対するCarbamazepine (Tegretol)の効果. 精神医学13 (2):77-87 (1971)

54) 氏家寛, 堀井茂男, 江原嵩ほか:躁病に対するzotepine治療の有効性. 臨床医学12:1575-1586 (1983)

55) Waldmeier PC:Is there a common domination for the antimanic effect of lithium and anticouval sants? Pharmacopsychiatry 20:37-47 (1987)

56) 渡辺昌祐:躁病の薬物療法. 精神科MOOK, 島薗安雄ほか(編), 躁うつ病の治療と予後, pp 153-164, 金原出版, 東京 (1986)

57) 渡辺昌祐, 石野博:感情障害とリチウムイオン. 精神医学16:1028-1062 (1974)

58) 渡辺昌祐:カルバマゼピンとリチウムの抗躁病効果の比較-2つの二重盲検比較試験資料に基づく分析. 精神医学25:1265-1273 (1983)

59) 渡辺昌祐, 江原嵩:躁病の診断と治療新興医学出版, 東京 (1986)

60) Wehr TA, Sack DA, Rosenthal NE:Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry 144:201-204 (1987)
pubmed

P.152 掲載の参考文献

1) Antonuccio DO, Lewinsohn PM, Steinmetz JL:Identification of therapist differences in a group treatment for depression. J Consult Clin Psychol 50:433-435 (1982)

2) Beck AA, Rush AJ, Shaw BF, et al:Cognitive Therapy of Depression. Guilford Press, New York (1979)

3) Bellack AS, Hersen M, Himmelhoch JM:A comparison of social skills training, pharmacotherapy and psychotherapy for depression. Behev Res Ther 21:101-107 (1983)
pubmed

4) Clinton JJ:Clinical practice guideline. Depression in Primary Care, Vol 2. Treatment of Major Depression, Department of Health and Human Services, Public for Health Service, Agency for Health Care Policy and Research, Rockville, Maryland (1993)

5) Costello CG, Lazarus AA:Depression;loss of reinforcers or loss of reinforcer effectiveness? Behav Ther 3:240-247 (1972)

6) DiMascio A, Weissman MM, Prusoff BA, et al:Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry 35:1450-1456 (1979)

7) Evans MD, Hollon SD, DeRubeis, et al:Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 49:802-808 (1992)
pubmed

8) Fava GA, Grandi S, Zielezny M, et al:Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 151:1295-1299 (1994)
pubmed

9) Frank E, Kupfer DJ, Wagner EF, et al:Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression. Contributing factors [published erratum appears in Arch Gen Psychiatry 1992 May, 49(5):401]. Arch Gen Psychiatry 48:1053-1059 (1991)

10) Gallagher DE, Thompson LW:Effectiveness of psychotherapy for both endogenous and nonendogenous depression in older adult outpatients. J Gerontol 38:707-712 (1983)
pubmed

11) Gallagher DE, Thompson LW:Treatment of major depressive disorder in older adult outpatients with brief psychotherapies. Psychotherapy;theory, research and practice 19:482-490 (1982)

12) Goldstein MJ, Miklowitz DJ:Family intervention for persons with bipolar disorder. Family Interventions in Mental Illness;New Directions for Mental Health Services, Hatfield AB (ed), 62, pp 23-35, Jossey-Bass, San Francisco (1994)

13) Haaga DA, DeRubeis RJ, Stewart BL, et al:Relationship of intelligence with cognitive therapy outcome. Behav Res Ther 29(3):277-281 (1991)
pubmed

14) Haas G:Inpatient family intervention;a randomized clinical trial. Arch Gen Psychiatry 45:217-224 (1988)
pubmed

15) Honig A, Hofman A, Hilwig M, et al:Psychoeducation and expressed emotion in bipolar disorder;preliminary findings. Psychiatry Res 56(3):299-301 (1995)
pubmed

16) 井上和臣:認知療法への招待. 金芳堂, 京都 (1992)

17) Jacobson NS, Fruzzetti AE, Dobson K, et al:Couple therapy as a treatment for depression;II. The effects of relationship quality and therapy on depressive relapse. J Consult Clin Psychol 61(3):516-519 (1993)

18) 笠原嘉:うつ病 (病相期)の小精神療法. 精神療法4(2):118-124 (1978)

19) 北西憲二, 中村敬:遷延性うつ病者に対する精神療法-森田療法を起点として. 精神医学31:255-262 (1989)

20) Klerman GL, Weissman MM, Rounsaville BJ, et al:Interpersonal Psychotherapy of Depression. Basic Books, New York (1984)

21) Lewinsohn PM, MacPhillamy DJ:The relationship between age and engagement in pleasant activities. J Gerontol 29:290-294 (1974)
pubmed

22) 町沢静夫:うつ病の精神療法-最近の動向;支持療法. 精神療法23(1):4-10 (1997)

23) McLean PD, Hakstian AR:Clinical depression;Comparative efficacy of outpatient treatments. J Clin Consult Psychol 47:818-836 (1979)

24) Miller IW, Norman WH, Keitner GI, et al:Cognitive-behavioral treatment of depressed patients. Behav Ther 20:25-47 (1989)

25) 忽滑谷和孝, 高梨葉子, 笠原洋勇ほか:うつ病のサイコエデュケーション. 臨床精神医学26(4):449-455 (1997)

26) Persons JB, Burns DD, Perloff JM:Predictors of dropout and outcome in cognitive therapy for depression in a private practice setting. Cognitive Ther Res 12:557-575 (1988)

27) Prusoff BA, Weissman MM, Klerman GL, et al:Research diagnostic criteria subtypes of depression;Their role as predictors of differential response to psychotherapy and drug treatment. Arch Gen Psychiatry 37:796-803 (1980)
pubmed

28) Reus VI, Weingartner H, Post RM:Clinical implications of state defendant learning. Am J Psychiatry 136:927-931 (1979)

29) Reynolds CR, Frank E, Perel JM, et al:Treatment of consecutive episodes of major depression in the elderly. Am J Psychiatry 151(12):1740-1743 (1994)

30) Reynolds CD, Frank E, Perel JM, et al:Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression;a preliminary report. Am J Psychiatry 149(12):1687-1692 (1992)

31) Rush AJ, Beck AT, Kovacs M, et al:Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cognitive Ther Res 1:17-37 (1977)

32) Schlosser D, Kavanagh DJ, Wilson PH:Intensive cognitive-behaviour therapy for depression;Preliminary findings with four country residents. Behav Change 5(1):28-31 (1988)

33) Schotte C, Maes M, Beuten T, et al:A videotape as introduction for cognitive behavioral therapy with depressed inpatients. Psychol Rep 72(2):440-442 (1993)
pubmed

34) Selmi PM, Klein MH, Greist JH, et al:Computer-administered therapy for depression. MD Comput 8(2):98-102 (1991)
pubmed

35) Shapiro DA, Barkham M, Rees A, et al:Effects of treatment duration and severity of depression on the effectiveness of cognitive-behavioral and psychodynamic-interpersonal psychotherapy. J Consult Clin Psychol 62(3):522-534 (1994)
pubmed

36) Sotsky SM, Glass DR, Shea MT, et al:Patient predictors of response to psychotherapy and pharmacotherapy;findings in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 148(8):997-1008 (1991)
pubmed

37) Thase ME, Bowler K, Harden T:Cognitive behavior therapy of endogenous depression;II. Preliminary findings in 16 unmedicated inpatients. Behav Ther 22 (4):469-477 (1991)

38) Thompson LW, Gallagher D, Breckenridge JS:Comparative effectiveness of psychotherapies for depressed elders. J Consult Clin Psychol 55:385-390 (1987)

39) Thompson LW, Gallagher D, Nies G, et al:Evaluation of the effectiveness of professionals and nonprofessionals an instructors of coping with depression classes for elders. Gerontologist 23:390-396 (1983)
pubmed

40) 牛島定信:初老期うつ病の精神療法. Mod Physician 17(12):1421-1425 (1997)

41) Weissman MM, Klerman GL, Prusoff BA, et al:Depressed outpatients;results one year after treatment with drugs and/or interpersonal psychotherapy. Arch Gen Psychiatry 38:51-55 (1981)
pubmed

42) 矢崎妙子:うつ病の治療;薬物療法と精神療法;うつ病の精神療法. 医学と薬学14 (6):1509-1513 (1985)

P.166 掲載の参考文献

1) Arieti S:Affective disorders. American Handbook of Psychiatry, 2nd ed. Vol III, Arieti S (ed), pp 449-490, Basic Books, New York (1974)

2) Brown GW, Birley JLT, Wing JK:Influence of family life on the course of schizophrenic disorders;A replication. Br J Psychiatry 121:241-258 (1972)

3) Cohen MB, Baker G, Cohen RA, et al:An intensive study of twelve cases of manic depressive psychosis. Psychiatry 17:103-137 (1954)
pubmed

4) Coyne JC:Interpersonal processes in depression. Depression and Families; Impact and Treatment, Keitner GI (ed), pp 33-53, American Psychiatric Press, Washington DC (1990)

5) Goldenberg I, Goldenberg H:Family Therapy "An Overview" 2nd ed. Books/Cole Publishing Company, Pacific Grove, California (1985)

6) Haley J:Strategies of Psychotherapy. Grune & Stratton, Orlando, Florida (1963)-高石昇 (訳):戦略的心理療法. 黎明書房, 名古屋 (1986)

7) 広瀬徹也:感情病の家族へのアプローチ. 精神医学レビュー18, 精神科治療における家族, 下坂幸三 (編), pp 36-43, ライフ・サイエンス, 東京 (1996)

8) Holder D, Anderson CM:Psychoeducational family intervention for depressed patients and their families. Depression and Families;Impact and Treatment, Keitner GI (ed), pp 159-184, American Psychiatric Press, Washington DC (1990)

9) Hooley JM, Orley J, Teasdale D:Levels of expressed emotion and relapse in depressed patients. Br J Psychiatry 148:642-647 (1986)

10) Hooley JM:Expressed emotion and depression. Depression and Families; Impact and Treatment, Keitner GI (ed), pp 57-83, American Psychiatric Press, Washington DC (1990)

11) 市川潤, 小波蔵安勝:慢性および反復性躁うつ病の臨床 (1) -家族的特徴について. 精神医学15:837-844 (1973)

12) 市川潤:躁うつ病と家族. 家族精神医学2, 加藤伸勝, 藤縄昭, 小此木啓吾 (編), pp 171-197, 弘文堂, 東京 (1982)

13) 飯田眞:躁うつ病の状況論の現況と今後の課題. 精神経誌75:274-280 (1973)

14) 飯田眞, 松浪克文, 林直樹:躁うつ病の状況論. 躁うつ病の臨床と理論-大熊輝雄 (編), pp 39-65, 医学書院, 東京 (1990)

15) 石川一郎, 足立博, 懸田克躬:うつ病の予後と配偶者類型. 精神経誌74:359 (1972)

16) 笠原嘉:うつ病の病前性格について. 躁うつ病の精神病理1, 笠原嘉 (編), pp 1-29, 弘文堂, 東京 (1976)

17) Kraus A:Sozialververhakten und Psychose Manisch-Depressiver. Enke, Stuttgart (1977)-岡本進 (訳):躁うつ病と対人行動. みすず書房, 東京 (1983)

18) Kraus A:Rollendynamik Manisch-Depressiver und therapeutische Folgerungen. 精神病理懇話会, 日光 (1986)-長井真理 (訳):躁うつ病者の役割力動. 臨床精神病理8:7-21 (1987)

19) 町沢静夫, 飛鳥井望, 松浪克文ほか:分裂病および躁うつ病の配偶者カウンセリングについて. 季刊精神療法8:126-142 (1982)

20) Madanes C:Strategic Family Therapy. Jossey-Bass, San Francisco (1981)

21) 松浪克文, 山田治, 野島修ほか:うつ病に対する家族療法的アプローチ. 精神療法23:33-42 (1997)

22) Minuchin S:Families and Family Therapy. Harvard Univ Press, Cambridge, Mass (1974)-山根常男 (監訳):家族と家族療法. 誠信書房, 東京 (1984)

23) 西園昌久:躁うつ病の家族研究から. 臨床精神医学7:1049-1057 (1978)

24) 小野博行, 松浪克文, 飯田眞:慢性うつ病の家族療法. 家族療法ケース研究5, うつ病, 下坂幸三, 飯田眞 (編), pp 207-233, 金剛出版, 東京 (1993a)

25) 小野博行, 松浪克文, 遠藤謙二ほか:うつ病と家族療法. 家族療法ケース研究5, うつ病, 下坂幸三, 飯田眞 (編), pp 13-54, 金剛出版, 東京 (1993b)

26) 下坂幸三, 渋沢田鶴子:家族療法の現況-日本とアメリカの場合. 精神医学38:1022-1034 (1996)

27) 武田専, 鈴木寿治, 北見芳雄ほか:躁鬱患者の家族的特徴-特にその両親像について. 精神分析研究13:20-26 (1967)

28) Tellenbach H:Melancholie. Springer, Berlin (1961)-木村敏 (訳):メランコリー. みすず書房, 東京 (1978)

29) Vaughn CE, Leff JP:The Influence of family and social factors on the course of psychiatric illness, a comparison of schizophrenic and depressed neurotic patients. Br J Psychiatry 129:125-137 (1976)
pubmed

P.178 掲載の参考文献

1) A Task Force Report of the American Psychiatric Association:The Practice of Electroconvulsive Therapy. pp 5-48, American Psychiatric Association, Washington DC (1990)

2) Abrams R:Electroconvulsive Therapy, 2nd ed. Oxford Univ Press, New York (1992)

3) 天谷太郎:欧米における電気けいれん療法 (ECT)の臨床研究の成果. 精神科治療学9:1233-1240 (1994)

4) 青葉安里, 山口登, 諸川由実代:高齢患者を対象とした無けいれん電撃療法の有効性と安全性. 精神科治療学9:1219-1224 (1994)

5) Bonne O, Krausz Y, Shapira B, et al:Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. J Nucl Med 37:1075-1080 (1996)
pubmed

6) Coleman EA, Sackeim HA, Prudic J, et al:Subjective memory complaints prior to and following electroconvulsive therapy. Biol Psychiatry 39:346-356 (1996)
pubmed

7) Consensus Conference:Electroconvulsive therapy. JAMA 254:2103-2108 (1985)
pubmed

8) Fink M:Convulsive Therapy. Raven Press, New York (1979)-清水信 (訳):電気けいれん療法. 星和書店, 東京 (1980)

9) Folkerts H:The ictal electroencephalogram as a marker for the efficacy of electroconvulsive therapy. Eur Arch Psychiatry Clin Neurosci 246:155-164 (1996)
pubmed

10) 早川浩, 山脇成人:電気けいれん療法の作用機序. 精神科治療学9:1241-1246 (1994)

11) 樋口久, 菱川泰夫:電気けいれん療法の奏効機序. 精神医学36:69-73 (1994)

12) 星野弘:分裂病治療の経験精神科治療学8:837-844 (1993)

13) 猪川和興, 守屋裕文:適応と手技. 精神科治療学9:1211-1217 (1994)

14) 池沢良郎, 川又大, 村山賢一ほか:bradyphreniaに電撃療法が奏効したパーキンソン病の1例. 精神医学37:303-307 (1995)

15) Jenkusky SM:Public perceptions of electroconvulsive therapy;A historic review. Jefferson J Psychiatry:2-11 (1993)

16) Jha AK, Stein GS, Fenwick P:Negative interaction between lithium and electroconvulsive therapy. Br J Psychiatry 168:241-243 (1996)
pubmed

17) 懸田克躬 (監修):精神科治療ガイドブック. p 4, 金原出版, 東京 (1991)

18) 工藤明, 松本明知:Preoxygenerationを用いた無痙攣性電撃治療の呼吸・循環動態と施行後血清CK値に与える影響日臨麻会誌14(3):71-76 (1994)

19) Lalla FR, Milroy T:The current status of seizure duration in the practice of electroconvulsive therapy. Can J Psychiatry 41:299-304 (1996)
pubmed

20) Lawson JS:Electrode placement in ECT. Psychol Med 20:335-344 (1990)
pubmed

21) Levine SB, Blank K, Schwartz HI, et al:Informed consent in the electroconvulsive treatment of geriatric patients. Bull Am Acad Psychiatry Law 19:395-403 (1991)

22) Major LF:Electroconvulsive therapy in the 1980s. Psychiatr Clin North Am 7:611-623 (1984)
pubmed

23) 松島英介, 太田克也:電気けいれん療法(ECT)の適応と禁忌. 精神科治療学10:491-498 (1995)

24) Mukherjee S:Mechanisms of the antimanic effect of electroconvulsive therapy. Convulsive Therapy 5:227-243 (1989)
pubmed

25) 中井久夫:分裂病の身体症状について. 精神科治療学8:457-470 (1993)

26) 中島一憲, 守屋裕文, 正岡直樹ほか:妊婦の精神病に対する無けいれん電撃治療の有効性と安全性について. 精神医学30:907-914 (1988)

27) 中島一憲, 石井一平, 守屋裕文ほか:精神科治療におけるインフォームド・コンセント-ECTについての試論. 精神経誌94:759-764 (1992)

28) 中島一憲, 山崎久美子, 守屋裕文:「電気けいれん療法(ECT)をめぐる諸問題」についてのアンケート調査. 精神経誌95:537-554 (1993)

29) 中島一憲:インフォームド・コンセントにおける意思決定能力の臨床的分析. 精神科臨床における倫理, 石川義博 (編), pp 163-182, 金剛出版, 東京 (1996)

30) 中嶋保則, 三島博之:電気痙攣療法の麻酔経験. 臨床麻酔20:221-224 (1996)

31) 仲本晴男, 兼島瑞枝, 渡嘉敷史郎ほか:外来における人工呼吸管理下での筋弛緩剤を用いた電気けいれん療法の試み. 精神医学36:1281-1284 (1994)

32) 西尾友三郎:精神科特殊療法の諸問題-ショック療法. 精神経誌69:970-973 (1967)

33) 大林滋, 中島一憲, 松島英介ほか:無痙攣性電撃治療の安全性と有効性について. 精神科治療学5:203-211 (1990)

34) 小木曽洋三, 守屋直樹, 田中孝雄:治療困難なうつ病に対する無けいれん性電撃療法の効果. 臨床精神医学22:1187-1196 (1993)

35) 太田克也, 松島英介:電気けいれん療法-日本臨床52:1232-1238 (1994)

36) 太田共夫:老年期うつ病患者の認知機能に及ぼす電撃療法の影響. 精神科治療学 9:1263-1271 (1994)

37) 折橋洋一郎:頭部通電けいれん療法(ECT) に対する一考察. 医療38:1138-1145 (1984)

38) 尾関祐二, 下田和孝, 染矢俊幸ほか:難治性うつ病に対する修正(無けいれん) 電気けいれん療法について. 精神科治療学9:1225-1232 (1994)

39) Sackeim HA, Decina P, Kanzler M, et al:Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry 144:1449-1455 (1987)
pubmed

40) Sackeim HA, Luber B, Katzman GP, et al:The effects of electroconvulsive therapy on quantitative electroencephalograms. Arch Gen Psychiatry 53:814-824 (1996)
pubmed

41) 斎藤考由:麻酔管理下電気けいれん療法 (無けいれんECT)とその告知同意について. 精神科治療学9:1253-1262 (1994)

42) 佐々木直子:強制水泳テストを用いた電気けいれんショックの神経化学的検討. 日神精薬理誌15:147-156 (1995)

43) Shapira B, Lidsky D, Gorfine M, et al:Electroconvulsive therapy and resistant depression. J Clin Psychiatry 57:32-38 (1996)
pubmed

44) 清水信:改良された電気痙攣療法 (改良ECT)とうつ病. 医学のあゆみ160:776-779 (1992)

45) 塩崎昇吉:電気痙攣療法. 現代精神医学大系, 懸田克躬ほか(編), 第9巻B 躁うつ病II, pp 184-192, 中山書店, 東京 (1979)

46) Sobin C, Prudic J, Devanand DP, et al:Who responds to electroconvulsive therapy? Br J Psychiatry 169:322-328 (1996)
pubmed

47) Suppes T, Webb A, Carmody T, et al:Is postictal electrical silence a predictor of response to electroconvulsive therapy? J Affect Disord 41:55-58 (1996)
pubmed

48) 高柳功, 亀井啓輔, 加藤伸勝ほか:精神科医療における「説明 (告知)と同意」に関するアンケート調査結果について. 厚生省精神保健医療研究 (1991)

49) 高柳強, 西嶋康一, 加藤敏:自治医科大学精神科における電気けいれん療法の実施状況. 臨床精神医学25:317-325 (1996)

50) 山田久美子, 葛城里美, 藤井薫:電気痙攣療法が著効を示したCotard's syndromeの一例. 精神科治療学12:275-287 (1997)

51) 安河内五郎:電気ショック, カルジアゾール・ショック, その他 (痙攣療法). 現代精神医学大系, 懸田克躬ほか (編), 第5巻B 精神科治療学II, pp 11-34, 中山書店, 東京 (1977)

各論

P.207 掲載の参考文献

1) 天野真二:気分障害と形態学的変化. 臨床精神医学25:1313-1322 (1996)

2) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Third Edition. American Psychiatric Press, Washington DC (1981) -高橋三郎, 花田耕一, 藤縄昭 (共訳). DSM-III精神障害の分類と診断の手引. 医学書院, 東京 (1982)

3) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Forth Edition. American Psychiatric Press, Washington DC (1994) -高橋三郎, 大野裕, 染矢俊幸 (共訳). DSM-IV精神疾患の分類と診断の手引. 医学書院, 東京 (1995)

4) Aprison MH, Takahashi R, Tachiki K:Hypersensitive serotonin receptors involved in clinical depression-A theory. Neuropharmacology and Behavior, Haber B, Aprison MH (ed), pp 23-53, Plenum Press, New York (1978)

5) Banerjee SP, Kung LS, Riggi SJ, et al:Development of β-adrenergic receptor subsensitivity by antidepressants. Nature 268:455-456 (1977)

6) Beck AT, Rush AJ, Shaw BF, et al:Cognitive Therapy of Depression. Guilford Press, New York (1979)

7) Bertelsen A, Harvald B, Hauge M:A Danish twin study of manic-depressive disorders. Br J Psychiatry 130:330-351 (1977)
pubmed

8) Bland RC, Newman SC, Orn H:Recurrent and nonrecurrent depression;A family study. Arch Gen Psychiatry 43:1085-1089 (1986)
pubmed

9) Breier A, Charney DS, Ziegelhoffer A:Major depression in patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:1129-1135 (1984)

10) Bunney WE, David J:Norepinephrine in depressive reactions;a review. Arch Gen Psychiatry 13:483-494 (1965)

11) Cadoret RJ, O'Gorman TW, Heywood E, et al:Genetic and environmental factors in major depression. J Affect Disord 9:155-164 (1985)
pubmed

12) Caldecott-Hazard S, Morgan DG, DeLeon-Jones F, et al:Clinical and biochemical aspects of depressive disorders;II. Transmitter/receptor theories. Synapse 9:251-301 (1991)
pubmed

13) Chaney DS, Menkes DB, Heninger GR:Receptor sensitivity and the mechanism of action of antidepressant treatment;implication for the etiology and therapy of depression. Arch Gen Psychiatry 38:1160-1180 (1981)

14) Coppen A:The biochemistry of affective disorders. Br J Psychiatry 113:1237-1264 (1967)
pubmed

15) Coryell W, Winokur G:Course and outcome. Handbook of Affective Disorders, 2nd Edition, Paykel ES (ed), pp 89-108, Churchill Livingstone, Edinburgh (1992)

16) Cotard J:Du delire hypochondriaque dans une forme grave de la melancholie anxieuse. Ann Med-Psychol 38:168 (1880)

17) Duman RS, Heninger GR, Nestler EJ:A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606 (1997)
pubmed

18) Dunner DL, Fleiss JL, Fieve RR:The course of development of mania in patients with recurrent depression. Am J Psychiatry 133:905-908 (1976)
pubmed

19) Egeland JA, Gerhard DS, Pauls DL, et al:Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 325:783-787 (1987)
pubmed

20) Elkins H, Friedman L, Wise A, et al:Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorder;Comparisons with controls or patients with schizophrenia. Arch Gen Psychiatry 52:735-746 (1995)
pubmed

21) Fink M:Convulsive Therapy. Raven Press, New York (1979) 清水信 (訳):電気けいれん療法. 星和書店, 東京 (1980)

22) Frank E, Kupfer DJ, Perel JM, et al:Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47:1093-1099 (1990)
pubmed

23) Gershon ES, Hamovit J, Guroff JJ, et al:A family study of schizo-affective bipolar I, bipolar II, unipolar and control probands. Arch Gen Psychiatry 39:1157-1167 (1982)

24) Gittleson NL:The phenomenology of obsessions in depressive psychosis. Br J Psychiatry 112:261-264 (1996)

25) Goodwin FK, Jamison KR:Childhood and aldolescence. Manic-depressive Illness, pp 186-209, Oxford Univ Press, New York (1990)

26) Howland RH:Thyroid dysfunction in refractory depression;implications for pathophysiology and treatment. J Clin Psychiatry 54:47-54 (1993)
pubmed

27) Joffe RT, Singer W, Levitt AJ, et al:A placebo-controlled comparison of lithium and triiodthyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 50:387-393 (1993)

28) Johnson J, Weissman MM, Kerman GL:Panic disorder, comorbidity and suicide attempts. Arch Gen Psychiatry 47:805-808 (1990)

29) Kaplan HI, Sandock BJ, Grebb JA:Kaplan and Sadock's Synapsis of Psychiatry. Behavioral Sciences/Clinical Psychiatry 7th Edition. Williams & Wilkins Baltimore (1994)-井上令一. 四宮滋子 (監訳):カプラン臨床精神医学テキスト, DSM-IV診断基準の臨床への展開. 医学書院, 東京 (1996)

30) Karno M, Godking JM, Sorenson SB, et al:The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 45:1094-1099 (1988)

31) 笠原嘉, 木村敏:うつ状態の臨床的分類に関する研究. 精神経誌77:715-735 (1975)

32) Keller MB, Lavori PW, Endicott J, et al:Double depression;two year follow-up. Am J Psychiatry 140:689-694 (1983)
pubmed

33) Keller MB, Klerman GL, Lavor PW, et al:Long-term outcome of episode of major depression. JAMA 248:788-792 (1984)

34) Kendler KS, Neale MC, Kessler RC, et al:A population-based twin study of major depression in woman;The impact of varying definitions of illness. Arch Gen Psychiatry 49:257-266 (1992)
pubmed

35) 岸本明:難治性うつ病に対するホルモン剤のaugmentation therapy-適応症例指標. 精神科治療学9:1356-1364 (1994)

36) Kral VA:Masked depression in middle aged men. Can Med Assoc J 79:1-5 (1958)
pubmed

37) Kuroda Y, Mikuni M, Ozawa T, et al:Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors. Psychopharmacology 108:27-32 (1992)

38) Lesser IM, Rubin RT, Recknold JC, et al:Secondary depression in panic disorder and agoraphobia. Arch Gen Psychiatry 45:437-443 (1988)

39) Lindblad K, Nylander P-O, DeBruyn A:Detection of expanded CAG repeats in bipolar affective disorder using the repeat expansion detection (RED) method. Neurobiol Dis 2:55-62 (1995)

40) McGuffin P, Katz R, Rutherford J:Nature, nurture and depression;A twin study. Psychol Med 21:329-335 (1991)
pubmed

41) McInnis MG, McMahon FJ, Chase GA, et al:Anticipation in bipolar affective disorder. Am J Genet 53:385-390 (1993)

42) Mendelwicz J, Fleiss JL:Linkage studies with X-chromosome markers in bipolar (depressive) illness. Biol Psychiatry 9:261-294 (1974)

43) Merikangas KR, Kupfer DJ:Mood disorders;Genetic aspects. Comprehensive Textbook of Psychiatry/VI, Kaplan HJ, Sadock BJ (ed), pp 102-1116, Williams & Wilkins, Baltimore (1995)

44) Merikangas KR, Risch NJ, Weissman MM:Comorbidity and co-transmission of alcoholism, anxiety and depression. Psychol Med 24:69-80 (1994)
pubmed

45) 三国雅彦斉藤和子, 渡辺義文:生育環境ストレスによる神経系の発達に伴う可塑的変化-胎生期ストレスと用いたうつ病態モデル動物の作成を求めて. 脳と精神の医学7:1-10 (1993)

46) Murphy BEP, Dhar V, Ghadirian AM, et al:Response to steroid suppression in major depression resistant to antidepressant therapy. J Psychopharmacol 11:121-126 (1991)

47) 小澤寛樹:G蛋白と躁うつ病の成因機序と治療. 躁うつ病の脳科学-方法論から臨床研究まで, 神庭重信 (編), pp 197-204, 星和書店, 東京 (1995)

48) Penick EC, Powell BJ, Nickel EJ, et al:Comorbidity of lifetime psychiatric disorder among male alcoholic patients. Alcoho Clin Exp Res 18:1289-1293 (1994)

49) Prange AJ Jr, Wilson IC, Rabon AM, et al:Enhancement of imipramine antidepressant activity by thyroid hormone. Am J Psychiatry 126:457-464 (1969)
pubmed

50) Reich T, Clayton PJ, Wenokur G:Family history studies V. The genetics of mania. Am J Psychiatry 125:1358-1369 (1969)

51) Rosenberg CM:Complications of obsessional neurotics. Br J Psychiatry 114:477-478 (1968)

52) Rosenthal NE, Sack DA, Gillin JC, et al:Seasonal affective disorder;a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 41:72-80 (1984)
pubmed

53) Schildkraut JJ:The catecholamine hypothesis of affective disorders;a review of supporting evidence. Am J Psychiatry 122:509-522 (1965)
pubmed

54) 下田光造:躁うつ病の病前性格について. 精神経誌45:101-102 (1941)

55) 杉下真理子, 樋口輝彦, 高橋清久:我が国における季節性感情障害の実態調査と光療法. 精神科治療学5:333-343 (1990)

56) Sulser F, Vetulani J, Mobley P:Mode of action of antidepressant drugs. Biochem Pharmachol 27:257-261 (1978)
pubmed

57) Tellenbach H:Melancholia. Springer, Berlin (1961) 木村敏 (訳):メランコリー. みすず書房, 東京 (1978)

58) 寺尾岳:抗うつ薬とリチウム併用による抗うつ効果増強作用. 精神医学36:122-130 (1994)

59) Vetulani J, Sulser F:Action of various antidepressant treatments reduces reactivity of noradrenergic c-AMP-generating system in limbic forebrain. Nature 257:495-496 (1975)

60) Von Gall M, Becker H:Zur Anwendung der Computer Tomographie (CT) in der klinischen Psychiatrie. Fortschr Neurol Psychiatr 17:381-386 (1978)

61) Wachtel H:Dysfunction of neuronal second messenger function in the aetiology of affective disorders;A pathological concept hypothesing defects beyond first messenger receptors. J Neural Transm 75:21-29 (1989)

62) World Health Organization:ICD 9th Revision;Mental Disorders;Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases. Geneva (1978)

63) World Health Organization:The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines. Geneval (1992)-融道男, 中根允文, 小見山実 (監訳):ICD-10精神および行動の障害-臨床記述と診断ガイドライン. 医学書院, 東京 (1993)

64) 山口隆久, 大工清志, 辻村良太郎ほか:精神疾患の甲状腺ホルモン療法. 精神経誌85:769-776 (1983)

P.223 掲載の参考文献

1) American Psychiatric Association:Practical Guidelines. American Psychiatric Association, Washington DC (1996)

2) Bebbington P, Ramana R:The epidemiology of bipolar affective disorder. Soc Psychiatry Psychiatr Epidemiol 30:279-292 (1995)
pubmed

3) Bland RC:Epidemiology of affective disorders;A review. Can J Psychiatry 42:367-377 (1997)
pubmed

4) Calabrese JR, Fatemi SH, Kujawa M, et al:Predictors of response to mood stabilizers. J Clin Psychopharmacol 16 (Suppl 1):24S-31S (1996)

5) Craddock N, Owen M:Chromosomal aberrations and bipolar affective disorder. Br J Psychiatry 164:507-512 (1994)
pubmed

6) DePaulo JR, McMahon FJ:Recent developments in the genetics of bipolar disorder. Cold Spring Harb Symp Quant Biol 61:783-789 (1996)
pubmed

7) El-Mallakh RS:Lithium;Actions and Mechanisms. American Psychiatric Press, Washington DC (1996)

8) Emamghoreishi M, Shlichter L, Li PP, et al:High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry 154:976-982 (1997)

9) Gershon S, Soares JC:Current therapeutic profiles of lithium. Arch Gen Psychiatry 54:16-20 (1997)
pubmed

10) 樋口輝彦, 本橋伸高:双極性障害の治療ガイドライン. 精神医学39:1161-1168 (1997)

11) 今村明, 岡崎祐士, 林田雅希ほか:精神疾患における表現促進と3塩基繰り返し配列. 脳と精神の医学7:281-294 (1996)

12) 稲山靖弘, 米田博:感情障害の分子生物学的研究. 精神医学38:1147-1153 (1996)

13) Jamison KR:Manic-depressive illness and creativity. Sci Am 272:62-67 (1995)
pubmed

14) 加賀谷有行, 横田則夫, 堀口淳ほか:精神疾患における細胞内カルシウム情報伝達系-神経系モデルとしての血小板の可能性. 神精薬理19:847-853 (1997)

15) 加藤忠史, 塩入俊樹, 高橋三郎:急速交代型双極性障害における心理社会的側面と家族療法. 精神医学36:403-406 (1994)

16) 加藤忠史, 高橋良斉, 高橋三郎:双極性障害における集団療法の試み. 精神科治療学10:165-170 (1995)

17) 加藤忠史, 高橋三郎:緊張病症状を伴う双極性障害 (DSM-IV) について. 精神医学39:593-600 (1997)

18) 加藤忠史:精神疾患の遺伝と分子生物学, 気分障害. 最新精神医学2:423-429 (1997)

19) 加藤忠史:躁うつ病 (双極性障害) における脳画像. 精神医学39:912-922 (1997)

20) Kato T:Investigations of signal transduction systems in affective disorders by magnetic resonance spectroscopy. Signal Transduction in Affective Disorders, Ozawa H, Saito T, Takahata N (ed), pp 133-146, Springer, Tokyo (1998)

21) Kelsoe JR:The genetics of bipolar disorder. Psychiatr Ann 27:285-292 (1997)

22) Manji HK, Potter WZ:Monoaminergic systems. Bipolar Disorder;Biological Models and Their Clinical Application, Young LT, Joffe RT (ed), pp 1-40, Marcel Dekker, New York (1997)

23) Mathews R, Li PP, Young LT, et al:Increased G α q/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder. Biol Psychiatry 41:649-656 (1997)

24) Odagaki Y, Nishi N, Koyama T:Postreceptor signal-transduction systems as potential targets of lithium. Signal Transduction in Affective Disorders, Ozawa H, Saito T, Takahata N (ed), pp 97-119, Springer, Tokyo (1998)

25) Ozawa H, Takahata N:The role of G proteins in the pathophysiology and treatment of affective disorders. Signal Transduction in Affective Disorders, Ozawa H, Saito T, Takahata N (ed), pp 49-67, Springer, Tokyo (1998)

26) 須原哲也, 佐々毅, 須藤康彦:気分障害のin vivo薬理・生化学. 臨床精神医学25:1323-1332 (1996)

27) Srisurapanont M, Yatham LN, Zis AP:Treatment of acute bipolar depression; A review of the literature. Can J Psychiatry 40:533-544 (1995)
pubmed

28) 高橋三郎, 大野裕, 染矢俊幸 (訳):DSM-IV精神疾患の分類と診断の手引. 医学書院, 東京 (1995)-American Psychiatric Association:Quick Reference to the Diagnostic Criteria from DSM-IV. American Psychiatric Press, Washington DC (1994)

29) 高橋三郎, 金井秀子, 三浦悌二ほか:精神障害の頻度と生まれ月-滋賀県患者人口による分析. 精神医学28:1163-1172 (1986)

30) 高橋三郎, 山田尚登, 染矢俊幸ほか:躁とうつ. 新医科学大系, 第10巻脳と行動, pp 129-150, 中山書店, 東京 (1994)

31) Yolken RH, Torrey EF:Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 8:131-145 (1995)
pubmed

P.238 掲載の参考文献

1) Akiskal HS:Subaffective disorders. Dysthymia, cyclothymia, and bipolar II disorders in the 'borderline' realm. Psychiatr Clin North Am 4:25-46 (1981)
pubmed

2) Akiskal HS:Dysthymic and cyclothymic depressions;Therapeutic considerations. J Clin Psychiatry 55 (suppl):46-52 (1994)

3) Akiskal HS:The prevalent clinical spectrum of bipolar disorders;Beyond DSM-IV. J Clin Psychopharmacol 16 (suppl 1):4S-14S (1996)

4) Akiskal HS, Hirschfeld RMA, Yerevanian BI:The relationship of personality to affective disorders. A critical review. Arch Gen Psychiatry 40:801-810 (1983)

5) Akiskal HS, Khani MK, Scott-Strauss A:Cyclothymic temperamental disorders. Psychiatr Clin North Am 2:527-554 (1979)

6) Akiskal HS, Maser J, Zeller PJ, et al:Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 52:114-123 (1995)

7) Akiskal HS, Rosenthal TL, Haykel RF, et al:Characterological depressions; Clinical and sleep EEG findings separating "subaffective dysthymias" from "character spectrum disorders". Arch Gen Psychiatry 37:777-783 (1980)

8) Altshuler LL, Curran JC, Hauser P, et al:T2 heperintensities in bipolar disorder;Magnetic resonance imaging comparison and literature meta-analysis. Am J Psychiatry 152:1139-1144 (1995)

9) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition. APA, Washington DC (1980)
pubmed

10) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition Revised. APA, Washington DC (1987)

11) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorder, 4th Edition. APA, Washington DC (1994)-高橋三郎, 大野裕, 染矢俊幸 (訳):DSM-IV精神疾患の診断・統計マニュアル. 医学書院, 東京 (1996)

12) Andreasen NC, Rice J, Endicott J, et al:Familial rates of affective disorder. A report from the National Institute of Mental Health Collaborative study. Am J Psychiatry 44:461-469 (1987)

13) Angst J:The course of affect disorders;II. Topology of bipolar manic-depressive illness. Arch Psychiatr Nervenkr 226:65-73 (1978)

14) Ansseau M, Kupfer DJ, Reynolds CF:Internight variability of REM latency in major depression;Implications for the use of REM latency as a biological correlate. Biol Psychiatry 20:489-505 (1985)
pubmed

15) Asnis GM, Halbreich U, Nathan RS, et al:The dexamethasone suppression test in depressive illness;Clinical correlates. Psychoneuroendocrinology 7:295-301 (1982)
pubmed

16) Cassano GB, Akiskal HS, Musetti L, et al:Psychopathology, temperament, and past course in primary major depressions. 2. Toward a redefinition of bipolarity with a new semistructured interview for depression. Psychopatholgy 22:278-288 (1989)

17) Cassano GB, Akiskal HS, Savino M, et al:Proposed subtypes of bipolar II and related disorders. With hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J Affect Disord 26:127-140 (1992)
pubmed

18) Coryell W, Endicott J, Andreasen N, et al:Bipolar I, bipolar II, and nonbipolar major depression among the relatives of affective ill probands. Am J Psychiatry 142:817-821 (1985)
pubmed

19) Coryell W, Endicott J, Maser JD, et al:Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry 152:385-390 (1995)
pubmed

20) Coryell W, Endicott J, Reich J, et al:A family study of bipolar II disorder. Br J Psychiatry 145:49-54 (1984)

21) Coryell W, Keller M, Endicott J, et al:Bipolar II illness;Course and outcome over a five year period. Psychol Med 19:129-141 (1989)

22) DePaulo JR, Simpson SG, Gayle JO, et al:Bipolar II disorder in six sisters. J Affect Disord 19:259-264 (1990)

23) Donnelly EF, Goodwin FK, Waldman IN, et al:Prediction of antidepressant response to lithium. Am J Psychiatry 135:552-556 (1978)
pubmed

24) Dunner DL:A review of the diagnostic status of "bipolar II" for the DSM-IV work group on mood disorders. Depression 1:2-10 (1993)

25) Dunner DL, Gershon ES, Goodwin FK:Heritable factors in the severity of affective illness. Am J Psychiatry 123:187 (1970)

26) Dunner DL, Gershon ES, Goodwin FK:Heritable factors in the severity of affective illness. Biol Psychiatry 11:31-42 (1976)
pubmed

27) Dunner DL, Gershon ES, Goodwin FK, et al:Excretion of 17-hydroxycorticosteroids in unipolar and bipolar depressed patients. Arch Gen Psychiatry 26:360-363 (1970)

28) Dunner DL, Stallone F, Fieve RR:Lithium carbonate and affective disorders, part 5;double-blind study of depression in bipolar patients. Arch Gen Psychiatry 33:117-120 (1976)

29) Dunner DL, Stallone F, Fieve RR:Prophylaxis with lithium carbonate; An update. Arch Gen Psychiatry 39:1344-1345 (1982)
pubmed

30) Dunner DL, Tay LK:Abstract of diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression. Compr Psychiatry 34:303-307 (1993)

31) Endicott J, Nee J, Andreasen N, et al:Bipolar II. Combine or keep separate? J Affective Disord 8:17-28 (1985)
pubmed

32) Fieve RR:Bipolar II disorder and its proposed beneficial subtype bipolar IIB; A desirable disorder? Current Psychiatry Therapy II, Dunner DL (ed), pp 261-266, WB Saunders, Philadelphia (1997)

33) Fieve RR, Dunner DL:Unipolar and bipolar affective states. The Nature and Treatment of Depression, Flack F, Dragt S (ed), John Wiley & Sons, New York (1975)

34) Frances A, Docherty JP, Kahn DA:The expert guideline series; Treatment of bipolar disorder. J Clin Psychiatry 57 (suppl 12A) (1996)

35) Gershon ES, Hamovit J, Guroff JJ, et al:A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 39:1157-1167 (1982)
pubmed

36) Giles DE, Rush AJ, Roffwarg HP:Sleep parameters in bipolar I, bipolar II, and unipolar depressions. Biol Psychiatry 21:1340-1343 (1986)
pubmed

37) Halmi KA, Eckert E, Marchi P, et al:Comorbidity of psychiatric diagnoses in patients with anorexia nervosa. Arch Gen Psychiatry 48:712-718 (1991)

38) Heun R, Maier W:The distinction of bipolar II disorder from bipolar I and recurrent unipolar depression; Result of a controlled family study. Acta Psychiatr Scand 87:279-284 (1993)
pubmed

39) 樋口輝彦, 飯田眞, 岩波明ほか:感情障害の薬物療法の新しい指針. 総合病院精神医学9:7-16 (1997)

40) Himmelhoch JM, Thase ME, Mallinger AG, et al:Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 148:910-916 (1991)
pubmed

41) 広瀬徹也:「逃避型抑うつ」につい. 躁うつ病の精神病理2, 宮本忠雄 (編), pp 61-86, 弘文堂, 東京 (1977)

42) 笠原嘉:二十歳台のうつ状態-いわゆる葛藤反応型うつ病をめぐって. 躁うつ病の精神病理5, 笠原嘉 (編), pp 225-248, 弘文堂, 東京 (1987)

43) Kato T, Takahashi S, Shioiri T, et al:Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 31:125-133 (1994)
pubmed

44) Klein DN, Taylor EB, Harding K, et al:Double depression and episodic major depression; Demographic, familial, personality, and socioenvironmental characteristics and short-term outcome. Am J Psychiatry 145:1226-1231 (1988)
pubmed

45) Kupfer DJ, Carpenter LL, Frank E:Is bipolar II a unique disorder? Compr Psychiatry 29:228-236 (1988)

46) Lewinson PM, Klein DN, Seeley J:Bipolar disorders in a community sample of older adolescents;Prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry 34:454-463 (1995)

47) Peselow FD, Dunner DL, Fieve RR, et al:Age of onset of affective illness Psychiatr Clin 5:124-132 (1982)

48) Peselow ED, Dunner DL, Fieve RR, et al:Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients. Am J Psychiatry 139:747-752 (1982)
pubmed

49) Pikonis P, Frank E:Personality pathology in recurrent depression;Nature, prevalence, and relationship to treatment response. Am J Psychiatry 145:435-441 (1988)

50) Possl J, Zerssen Dv:A case history analysis of the 'manic type' and the 'melancholic type' of premorbid personality in affectively ill patients. Eur Arch Psychiatry Neurol Sci 239:347-355 (1990)

51) Quitkin F, Kane J, Rifkin A, et al:Lithium and imipramine in the prophylaxis of unipolar and bipolar II depression-a prospective placebo controlled comparison. Psychopharmacol Bull 17:142-144 (1981)
pubmed

52) Rihmer Z:Dysthymia;A clinical perspective. Dysthymic Disorder, Burton SW, Akiskal HS (ed), pp 112-125, Gaskell, London (1990) 佐藤哲哉, 坂戸薫, 佐藤聡 (訳):気分変調症-軽症慢性うつ病の新しい概念. 金剛出版, 東京 (1992)

53) Rihmer Z, Barsi J, Arato M, et al:Suicide in subtypes of primary major depression. J Affect Disord 18:221-225 (1990)
pubmed

54) Sakado K, Sato T, Uehara T, et al:Evaluating the diagnostic specificity of the Munich Personality Test in major depression. J Affect Disord 43:187-194 (1997)
pubmed

55) Samson JA, Gudeman JE, Schatzberg AF, et al:Toward a biochemical classification of depressive disorders-VIII;Platelet monoamine oxidase activity in subtypes of depressions. J Psychiatry Res 19:547-555 (1985)

56) Sato T, Sakado K, Uehara T, et al:Age distribution of the melancholic type of personality (Typus melancholicus) in outpatients with major depression;A comparison with a population without a history of depression. Psychopathology 27:43-47 (1974)

57) Simpson SG, Al-mufti R, Andersen AE, et al:Bipolar II affective disorder in eating disorder inpatients. J Nerv Ment Dis 180:719-722 (1992)
pubmed

58) Simpson SG, DePaulo JR:Fluoxetine treatment of bipolar II depression. J Clin Psychopharmacol 11:52-54 (1991)
pubmed

59) Simpson SG, Folstein SE, Meyers DA, et al:Bipolar II;The most common bipolar phenotype? Am J Psychiatry 150:901-903 (1993)
pubmed

60) Spitzer RL, Endicott J, Robins E:Research diagnostic criteria. Ratinale and reliability. Arch Gen Psychiatry 35:773-782 (1978)

61) Tsuang MT, Woolson RF, Winokur G, et al:Stability of psychiatric diagnosis. Schizophrenia and affective disorders. Arch Gen Psychiatry 38:535-539 (1981)
pubmed

62) Tellenbach H:Melancholie. Springer, Berlin (1961)

63) Weiss MK, Tohen M, Zarate C, et al:Diagnosis and management of bipolar II disorder. Compr Ther 20:121-124 (1994)
pubmed

64) Weissman MM, Myers JK:Affective disorders in a US urban community. The use of Research Diagnostic Criteria in an epidemiological survey. Arch Gen Psychiatry 35:1304-1311 (1978)

65) Wicki W, Angst J:The Zurich study. X. Hypomania in a 28-to 30-year old cohort. Eur Arch Psychiatry Clin Neurosci 240:339-348 (1991)

66) Winokur G, Morrison J:The Iowa 500; Follow-up of 225 depressives. Br J Psychiatry 123:543-548 (1978)

67) Zerssen Dv, Possl J:The premorbid personality of patients with different subtypes of an affective illness;Statistical analysis of blind assignment of case history data to clinical diagnoses. J Affect Disord 18:39-50 (1990)

68) Zerssen Dv, Tauscher R, Poessl J:The relationship of premorbid personality to subtype by means of an operationalized procedure for the diagnosis of personality structures. J Affect Disord 32:61-72 (1994)

69) Zisook S, Janowsky DS, Overall JE, et al:The dexamethasone suppression test and unipolar/bipolar distinctions. J Clin Psychiatry 46:461-465 (1985)
pubmed

P.254 掲載の参考文献

1) 阿部隆明, 大塚公一郎, 永野満ほか:「未熟型うつ病」の臨床精神病理学的検討-構造力動論 (W. Janzarik)からみたうつ病の病前性格と臨床像. 臨床精神病理 16:239-248 (1995)

2) Angst J:Manie. Lexikon der Psychiatrie, 2. Aufl. Muller C(ed), Spger, Heidelberg(1986)

3) APA(高橋三郎, 大野裕, 染矢俊幸訳):DSM-IV精神疾患の分類と診断の手引. 医学書院, 東京(1995)

4) Bauer MS, Whybrow PC, Gyulai L:Testing definitions of dysphoric mania and hypomania;prevalence, clinical characteristics and inter-episode stability. J Affect Disord 32:201-211(1994)

5) Berner P:Psychiatrische Systematik. dritte, uberarbeitete und erganzte Aufl. Verlag Hans Huber, Bern, Stuttgart, Wien(1982)

6) Binswanger L:Melancholie und Manie. G. Neske, Pfullingen(1960)

7) Bourgeois M, Verdoux H, Henry-demotes Mainard C:Manies dysphoriques et etats mixtes. L'Encephale SP VI:21-32(1995)

8) Court J:The continuum model as a resolution of paradoxes in manic-depressive psychosis. Br J Psychiatry 120:133-141 (1972)

9) Dell'osso L, Placidi GF, Nassi R, et al:The manic-depressive mixed state; familial, temperamental and psychopathologic characteristics in 108 female inpatients. Eur Arch Psychiatr Clin Neurosci 240:234-239(1991)

10) Guislain J:Lecons orales sur les phrenopathies. Gand (1852)

11) Haustgen T:Aspects historiques des troubles bipolaires dans la psychiatrie frangaise. L'Encephale SP VI:13-20(1995)

12) 樋口輝彦, 町山幸輝:混合状態の生物学的側面. 臨床精神医学21:1423-1432 (1992)

13) Himmelhoch JM, Mulla D, Neil JF, et al:Incidence and significance of mixed affective states in a bipolar population. Arch Gen Psychiatry 33:1062-1066 (1976)

14) Himmelhoch JM, Garfinkel ME:Mixed mania;diagnosis and treatment. Psychopharmacol Bull 22:613-620 (1986)
pubmed

15) Hole G:Mischzustand. Lexikon der Psychiatrie, Muller C (ed), Springer, Heidelberg (1973)

16) Hole G, et al:Melancholie. Lexikon der Psychiatrie, 2. Aufl. Muller C (ed), Springer, Heidelberg (1986)

17) Jaspers K:Allgemeine Psychopathologie, 8. Aufl. Springer-Verlag, Berlin (1965)

18) Keller MB, Lavori PW, Coryell W, et al:Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 255:3138-3142(1986)

19) Koukopoulos A, Pani L, Serra G, et al:La depression anxieuse-excitee;un syndrome affectif mixte. L'Encephale SP VI:33-36(1995)

20) Kraepelin E:Psychiatrie, 5. Aufl. A. Abel, Leipzig (1896), 6. Aufl. (1899), 7. Aufl. (1904), 8. Aufl. (1913)

21) Leonhard K:Die atypischen Psychosen und Kleists Lehre von den endogenen Psychosen. Psychiatrie der Gegenwart, II. Springer, Berlin (1960)

22) McElroy SL, Keck PE, Pope HG, et al:Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 149:1633-1644 (1992)

23) 宮本忠雄:躁うつ病における混合状態の意義-臨床精神病理学的検討. 臨床精神医学21:1433-1439(1992)

24) 迎豊, 市川潤:混合状態. 現代精神医学大系, 懸田克躬ほか(編), 第9巻B 躁うつ病II, 中山書店, 東京(1979)

25) Post RM, Rubinow DR, Uhde TW, et al:Dysphoric mania. Clinical and biological correlates. Arch Gen Psychiatry 46:353-358(1989)

26) Schneider K:Klinische Psychopathologie, 9. Aufl. G. Thieme, Stuttgart(1971)

27) Secunda SK, Swann AC, Katz NM, et al:Diagnosis and treatment of mixed mania. Am J Psychiatry 144:96-98(1987)

28) 茂野良一, 大橋正和, 飯田真:混合状態の概念とその変遷. 臨床精神医学21:1407-1415 (1992)

29) Specht G:Uber die Struktur und klinische Stellung der Melancholia agitata. Zbl Nervenheilk Psychiat 31:449-469(1908)

30) Swann AC, et al:Specificity of mixed affective states;clinical comparison of dysphoric mania and agitated depression. J Affect Disord 28:81-89(1993)

31) Swann AC:Mixed or dysphoric manic states;psychopathology and treatment. J Clin Psychiatry 56 (supple 3):6-10 (1995)

32) Westphal A, Kolpin O:Bemerkungen zu dem Aufsatz von Prof. Dr. G. Specht; Uber den Angstaffekt im manisch-depressiven Irresein. Zbl Nervenheilk Psychiat 30:729-731 (1907)

33) Weygandt W:Uber die Mischzustande des manisch-depressiven Irreseins. J. F. Lehmann, Munchen(1899)

34) Whybrow PC, Mendels J:Toward a biology of depression;some suggestions from neurophysiology. Am J Psychiatry 125:1491-1500(1969)

35) Winokur G, Clayton P, Reich T:Manic-depressive Illness. C. V. Mosby, St Louis (1969)

P.269 掲載の参考文献

1) Akiskal HS:Dysthymic disorder;psychopathology of proposed chronic depressive subtypes. Am J Psychiatry 140:11-20 (1983)
pubmed

2) Akiskal HS, Rosenthal TL, Haykal RF, et al:Characterological depressions; clinical and sleep EEG findings separating "subaffective dysthymias" from "character-spectrum disorders". Arch Gen Psychiatry 37:777-783(1980)

3) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disordres. American Psychiatric Association, Washington DC (1980)

4) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington DC (1987)
pubmed

5) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Press, Washington DC (1994)

6) Angst J, Wicki W:The Zurich Study;XI. Is dysthymia a separate form of depression? Results of the Zurich Cohort Study. Eur Arch Psychiatry Neurol Sci 240:349-354 (1991)

7) Barrett JE:Naturalistic change after 2 years in neurotic depressive disorders (RDC categories). Compr Psychiatry 25:404-418 (1984)
pubmed

8) Barrett JE, Barrett JA, Oxman TE, et al:The prevalence of psychiatric disorders in a primary care practice. Arch Gen Psychiatry 45:1100-1106 (1988)

9) Bland RC, Orn H, Newma SC:Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand Suppl 338:24-32 (1988)

10) Brambilla F, Catalano M, Genazzani AR, et al:Neuroendocrine aspects of dysthymic disorders. Anxious Depression;Assessment and Treatment, Racagni G, Smeraldi E(ed), Raven Press, New York (1987)

11) Cassano GB, Perugi G, Maremmani I, et al:Social adjustment in dysthymia. Dysthymic Disorder, Burton SW, Akiskal HS (ed), pp 78-85, Gaskell, London (1990)

12) Costello EJ, Costello AJ, Edelbrock C, et al:Psychiatric disorders in pediatric primary care. Arch Gen Psychiatry 45:1107-1116 (1988)
pubmed

13) Devanand DP, Nobler MS, Singer T, et al:Is dysthymia a different disorder in the elderly? Am J Psychiatry 151:1592-1599 (1994)
pubmed

14) Evans S, Cloitre M, Kocsis JH, et al:Social-vocational adjustment in unipolar mood disorders;results of the DSM-IV field trial. J Affect Disord 38:73-80 (1996)

15) Faravelli C, Incerpi G:Epidemiology of affective disorders in Florence;preliminary results. Acta Psychiatr Scand 72:331-333 (1985)
pubmed

16) Frances A, Kocsis J, Marin D, et al:Diagnostic criteria for dysthymic disorder. Psychopharmacol Bull 25:325-329 (1989)
pubmed

17) Freeman HL:Historical and nosological aspects of dysthymia. Acta Psychiatr Scand Suppl 383:7-11 (1994)
pubmed

18) 古川壽亮:気分変調症. 精神科治療指針, 大原健士郎, 広瀬徹也(編), 星和書店, 東京(in press)

19) Gonzales LR, Lewinsohn PM, Clarke GN:Longitudinal follow-up of unipolar depressives;an investigation of predictors of relapse. J Consult Clin Psychol 153:461-469 (1985)

20) Hellerstein DJ, Yanowitch P, Rosenthal J, et al:A randomized doubleblind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 150:1169-1175 (1993)

21) Hirschfeld RMA:Personality and dysthymia. Dysthymic Disorder, Burton SW, Akiskal HS (ed), pp 69-77, Gaskell, London (1990)

22) Howland RH:General health, health care utilization, and medical comorbidity in dysthymia. Int J Psychiatry Med 23:211-238 (1993)
pubmed

23) Howland RH, Thase ME:Biological studies of dysthymia. Biol Psychiatry 30:283-304 (1991)
pubmed

24) Kashani J, Carlson GA, Beck NC, et al:Depression, depressive symptoms, and depressed mood among a community sample of adolescents. Am J psychiatry 144:931-934 (1987)
pubmed

25) Katon W, von Korff M, Lin E, et al:Distressed high utilizes of medical care. Gen Hosp Psychiatry 12:355-362 (1990)
pubmed

26) Keller MB, Lavori PW, Endicott J, et al:"Double depression"; two-year follow up. Am J Psychiatry 140:689-694 (1983)
pubmed

27) Keller MB, Shapiro RW:"Double depression"; superimposition of acute depressive episodes on chronic depressive disorders. Am J Psychiatry 139:438-442 (1982)
pubmed

28) Kessler RC, McGonagle KA, Zhao S, et al:Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States;results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19 (1994)
pubmed

29) Khan AU:Sensitivity and specificity of TRH stimulation test in depressed and nondepressed adolescents. Psychiatry Res 25:11-17 (1988)
pubmed

30) Kivelae SL, Pahkala K, Laippala P:Prevalence of depression in an elderly population in Finland. Acta Psychiatr Scand 78:401-413 (1988)

31) Klein DN, Taylor EB, Dickstein S, et al:The early-late onset distinction in DSM-III-R dysthymia. J Affect Disord 14:25-33 (1988)
pubmed

32) Klein DN, Taylor EB, Dickstein S, et al:Primary early-onset dysthymia; comparison with primary nonbipolar nonchronic major depression on demographic, clinical, familial, personality, and socioenvironmental characteristics and short-term outcome. J Abnorm Psychol 97:387-398 (1988)
pubmed

33) Klein DN, Taylor EB, Harding K, et al:Double depression and episodic major depression;Demographic, clinical, familial, personality, and socioenvironmental characteristics and short-term outcome. Am J Psychiatry 145:1226-1231 (1988)
pubmed

34) Kocsis JH, Frances AJ:A critical discussion of DSM-III dysthymic disorder. Am J Psychiatry 144:1534-1542 (1987)
pubmed

35) Kocsis JH, Friedman RA, Markowitz JC, et al:Maintenance therapy for chronic depression;a controlled clinical trial of desipramine. Arch Gen Psychiatry 53:769-774 (1996)
pubmed

36) Koenigsberg HW, Kaplan RD, Gilmore MM, et al:The relationship between syndrome and personality disorder in DSM-III;experience with 2, 462 patients. Am J Psychiatry 142:207-212 (1985)
pubmed

37) Kovacs M, Akiskal HS, Gatsonis C, et al:Childhood-onset dysthymic disorder; clinical features and prospective naturalistic outcome. Arch Gen Psychiatry 51:365-374 (1994)
pubmed

38) Leader JB, Klein DN:Social adjustment in dysthymia, double depression and episodic major depression. J Affect Disord 37:91-101 (1996)
pubmed

39) Markowitz JC, Moran ME, Kocsis JH, et al:Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients. J Affect Disord 24:63-71 (1992)
pubmed

40) McCullough JP, Kasnetz MD, Braith JA, et al:A longitudinal study of an untreated sample of predominantly late onset characterological dysthymia. J Nerv Ment Dis 176:658-667 (1988)
pubmed

41) McCullough JP, Roberts WC, McCune KJ, et al:Social adjustment, coping style and clinical course among DSM-III-R community unipolar depressives. Depression 2:36-42 (1994)

42) Pepper CM, Klein DN, Anderson RL, et al:DSM-III-R axis II comorbidity in dysthymia and major depression. Am J Psychiatry 152:239-247 (1995)
pubmed

43) Perez-Stable EJ, Miranda J, Munoz RF, et al:Depression in medical outpatients. Arch Intern Med 150:1083-1088 (1990)

44) Ravindran AV, Chudzik J, Bialik RJ, et al:Platelet serotonin measures in primary dysthymia. Am J Psychiatry 151:1369-1371 (1994)
pubmed

45) Rosenthal TL, Akiskal HS, Scott-Strauss A, et al:Familial and developmental factors in characterological depressions. J Affect Disord 3:183-192 (1981)
pubmed

46) Roy A, Sutton M, Pickar D:Neuroendocrine and personality variables in dysthymic disorder. Am J Psychiatry 142:94-97 (1985)
pubmed

47) Sanderson WC, Beck AT, Beck J:Syndrome comorbidity in patients with major depression or dysthymia;prevalence and temporal relationships. Am J Psychiatry 147:1025-1028 (1990)
pubmed

48) Spitzer RL, Endicott J, Robins E:Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders. New York State Psychiatric Institute, New York (1978)

49) Thase ME, Fava M, Halbreich U, et al:A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry 53:777-784 (1996)
pubmed

50) Versiani M:Pharmacotherapy of dysthymia;a controlled study with imipramine, moclobemide or placebo. Neuropsychopharmacology 10:298S (1994)

51) von Korff M, Shapiro S, Burke JD, et al:Anxiety and depression in a primary care clinic;comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments. Arch Gen Psychiatry 44:152-156 (1987)

52) Weissman MM, Leaf PJ, Bruce ML, et al:The epidemiology of dysthymia in five communities;rates, risks, comorbidity, and treatment. Am J Psychiatry 145:815-819 (1988)
pubmed

53) Weissman MM, Leaf PJ, Tischler GL, et al:Affective disorders in five United States communities. Psychol Med 18:141-153 (1988)
pubmed

54) Weissman MM, Myers JK:Affective disorders in a US urban community;the use of Research Diagnostic Criteria in an epidemiological survey. Arch Gen Psychiatry 35:1304-1311 (1978)

55) Wells KB, Burnam MA, Rogers W, et al:The course of depression in adult outpatients;results from the Medical Outcomes Study. Arch Gen Psychiatry 49:788-794 (1992)
pubmed

56) Wittchen HU, von Zerssen D:Verlaufe behandelter und unbehandelter Depressionen und Angststorungen;Eine klinisch-psychiatrische und epidemiologische Verlaufsuntersuchung. Springer, Berlin (1987)

57) World Health Organization:The ICD-10 Classification of Mental and Behavioural Disorders;Diagnostic Criteria for Research. World Health Organization, Geneva (1993)

58) WPA Dysthymia Working Group:Dysthymia in clinical practice. Br J Psychiatry 166:174-183 (1995)

59) Zich JM, Attkisson CC, Greenfield TK:Screening for depression in primary care clinics;the CES-D and the BDI. Int J Psychiatry Med 20:259-277 (1990)
pubmed

P.287 掲載の参考文献

1) Akiskal HS, Djenderdijan AH, Rosenthal RH, et al:Cyclothymic disorder; validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 134:1227-1233 (1977)

2) Akiskal HS, Khani M, Scott-Strauss A:Cyclothymic temperamental disorders. Psychiatr Clin North Am 2:527-554 (1979)

3) Akiskal HS:Subaffective disorders;dysthymic, cyclothymic and bipolar II disorders in the "borderline" realm. Psychiatr Clin North Am 4:25-46 (1981)
pubmed

4) Akiskal HS, Mallya G:Criteria for the "soft" bipolar spectrum;Treatment implications. Psychopharmacol Bull 23:68-73 (1987)
pubmed

5) Alanes R, Torgersen S:The relationship between DSM-III symptom disorders (Axis I) and personality disorders (Axis II) in an outpatient population. Acta Psychiatr Scand 78:485-492 (1988)

6) American Psychiatric Association (APA):Diagnostic and Statistical Manual of Mental Disoders, 3rd ed. American Psychiatric Press, Washington DC (1980)

7) American Psychiatric Association (APA):Diagnostic and Statistical Manual of Mental Disoders, 3rd ed. rev. American Psychiatric Press, Washington DC (1987)

8) American Psychiatric Association (APA):Diagnostic and Statistical Manual of Mental Disoders, 4th ed. American Psychiatric Press, Washington DC (1994)

9) Depue RA, Slater JF, Wolfstrtter-Kausch H, et al:A behavioral paradigm for identifying persons at risk for bipolar depressive disorders;A conceptual framework and five validation studies. J Abnorm Psychol 90:381-437 (1981)

10) Dunner DL, Gershon ES, Goodwill FK:Heritable factors in the severity of affective illness. Biol Psychiatry 11:31-42 (1976)

11) Dunner DL, Russek FD, Russek B, et al:Classification of bipolar affective disorder subtypes. Compr Psychiatry 23:186-189 (1982)
pubmed

12) Frances A, Docherty JP, Kahn DA:Treatment of bipolar disorder. The expert consensus guideline series. J Clin Psychiatry 57 (suppl 12A):15 (1996)

13) Goodwin FK, Jamison KR:Manic-Depressive Illness. Oxford Univ Press, New York (1990)

14) 広瀬徹也:Dysthymia(気分変調症). 臨床精神医学23:1595-1601 (1994)

15) 広瀬徹也:気分循環症. 精神科治療学10(臨):128-129 (1995)

16) Howland RH, Thase ME:A comprehensive review of cyclothymic disorder. J Nerv Ment Dis 181:485-493 (1993)
pubmed

17) Jacobson FM:Low-dose valproate;a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. J Clin Psychiatry 54:229-234 (1993)

18) Kaplan HI, Sadock BJ, Grebb JA:Kaplan and Sadock's Synopsis of Psychiatry; Behavioral Science/Clinical Psychiatry, 7th ed. Williams & Wilkins, Baltimore (1994)

19) Kahlbaum KL:Die Katatonie oder das Spannungsirresein. Ein klinische Form psychischer Krankheit. Hirschwald, Berlin (1874)

20) Keller MB, Shapiro RW:"double depression"; superimposition of acute depressive episodes in chronic depressive disorders. Am J psychiatry 139:438-442 (1982)
pubmed

21) Klein DN, Depue RA, Slater JF:Cyclothymia in the adolescent offspring of parents with bipolar affective disorder. J Abnorm Psychol 94:115-127 (1985)
pubmed

22) Klein DN, Depue RA, Slater JF:Inventory identification of cyclothymia IX. Validation in offspring of bipolar I patients. Arch Gen Psychiatry 43:441-445 (1986)
pubmed

23) Klein DN, Taylor EB, Harding K, et al:The unipolar-bipolar distinction in the characterological mood disorders. J Nerv Ment Dis 178:318-323 (1990)
pubmed

24) Kraepelin E:Das manisch-depressive Irresein. Psychiatrie. III Band, 8 Aufl. , pp 1181-1395, Barth, Leipzig (1913)

25) Kretscmer E:Korberbau und Charakter. Springer, Berlin (1936)

26) Levitt JA, Joffe RT, Ennis J, et al:The prevalence of cyclothymia in borderline personality disorder. J Clin Psychiatry 51:335-339 (1990)

27) Mallon JC, Klein DN, Bornsten RF, et al:Discriminant validity of the General Behavior Inventory;an outpatients study. J Pers Assess 50:568-577 (1986)

28) Peselow ED, Dunner DL, Fieve RR, et al:Prophylactic effect of lithium against depression in cyclothymic patients;a life-table analysis. Compr Psychiatry 22:257-264 (1981)
pubmed

29) Peselow ED, Dunner DL, Fieve RR, et al:Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients. Am J Psychiatry 139:747-752 (1982)
pubmed

30) 坂元薫, 中平進:Rapid cyclerの治療. 抗うつ薬の科学, 中山和彦(編), pp 139-165, 星和書店, 東京 (1995)

31) 坂元薫:臨床精神病理学的観点から見たComorbidity概念の意義と問題点. 精神科治療学12:751-759 (1997)

32) 斎藤環:Cyclothymia(気分循環症)と考えられる一例. 精神科臨床における症例からの学び方, 藤縄昭(編), pp 163-196, 日本評論社, 東京 (1994)

33) Sass H, Herpertz S, Houben I, et al(西村勝治訳):準感情病性人格障害 (Subaffective personality disorders). 精神医学38:885-894 (1996)

34) Schneider K:Klinische Psychopathologie, 6 Aufl. , Thieme, Stuttgart (1962)

35) Spitzer RL, Endicott J, Robins E:Research diagnostic criteria-rationale and reliability. Arch Gen Psychiatry 351773-782 (1978)

36) Waters BGH:Early symptoms of bipolar affective psychosis. Can Psychiatr Assoc J 2:55-60(1979)

37) Wehr TA, Sack DA, Rosenthal MD, et al:Rapid cycling affective disorder; Contributing factors and treatment responses in 51 patients. Am J psychiatry 145:179-184 (1988)

38) Weissman MM, Myers JK:Affective disorders in a US urban community. Arch Gen Psychiatry 35:1304-1311 (1978)

39) World Health Organization (WHO):Mental Disorders;Glossary and guide to their classification in accordance with the ninth revision of the International Classification of Diseases (ICD-9). WHO, Geneva (1978)

40) World Health Organization:The ICD-10 Classification of Mental and Behavioural Disorders-Clinical descriptions and diagnostic guidelines. WHO, Geneva (1992)

P.301 掲載の参考文献

1) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Third edition (DSM-III). American Psychiatric Association, Washington DC (1980)

2) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Forth edition (DSM-IV)-高橋三郎ほか(訳):DSM-IV精神疾患の診断・統計マニュアル. 医学書院, 東京 (1996)

3) Davidson JR, Miller RD, Turnbull CD, et al:Atypical depression. Arch Gen Psychiatry 39:527 (1982)
pubmed

4) Davidson JR, Giller E, Zisook S, et al:An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology. Arch Gen Psychiatry 45:120 (1988)
pubmed

5) Derecho CN, Wetzler S, Mcginn LK:Atypical depression among psychiatric inpatients;clinical features and personality traits. J Affect Disord 39:55 (1996)
pubmed

6) Frederic M, Jonathan W, Stewart J, et al:Columbia atypical depression. Br J Psychiatry 163:30 (1993)

7) Harrison WM, Cooper TB, Stewart JW, et al:The tyramine challenge test as a marker for melancholia. Arch Gen Psychiatry 41:681 (1984)
pubmed

8) Himmelhoch J, Thase Mallinger A, et al:Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 148:910 (1991)
pubmed

9) Horwath E, Johnson J, Weissman MM, et al:The validity of major depression with atypical features based on a community study. J Affect Disord 26:117 (1992)
pubmed

10) Huston PE, Locker LM:Manic-depressive psychosis. Arch Neurol Psychiatry 60:37 (1948)

11) Klein DF:Differential diagnosis and treatment of the dysphorias. Depression, Gallan DM (ed), Spectrum, New York (1976)

12) Klein DF:The pharmacological validation of psychiatric diagnosis. Validity of Psychiatric Diagnosis, Robins L, Barrett J (ed), Raven Press, New York (1989)

13) Kupfer D, Thase M:Validity of major depression. Diagnosis and Classication in Psychiatry-A critical appraisal of DSM-III, Tischler (ed), Cambridge Univ Press, New York (1987)

14) Liebowitz M, Quitkin F, Stewart J, et al:Antidepressant specificity in atypical depression. Arch Gen Psychiatry 45:129 (1988)
pubmed

15) Lonnqvist J, Sihvo S, Syvalahti E, et al:Moclobemide and fluoxetine in atypical depression. J Affect Disord 31:169 (1994)

16) McGilm LK, Asnis GM, Robinson E:Biological and clinical validation of atypical depression. Psychiatry Res 60:191 (1996)

17) McGrath PJ, Stewart JW, Harrison WN, et al:Predictive value of symptoms of atypical depression for differential drug treatment outcome. J Clin Psychopharmacol 12:197 (1992)

18) McGrath PJ, Stewart JW, Nunes EN, et al:A double blind crossover trial of imipramine and phenelzine for out patients with treatment refractory depression. Am J Psychiatry 150:118 (1993)

19) McGrath PJ, Stewart JW, NuNes EN, et al:Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant. J Clin Psychiatry 55:336 (1994)

20) Pare C, Mack J:Differentiation of two genetically specific types of depression by the response to antidepressant drug. J Med Genetics 8:306 (1971)

21) Paykel E, Rowan P, Rao B, et al:Atypical depression-Nosology and response to antidepressants. Treatment of Depression;Old controversies and new approaches. Clayton P, Barrett J (ed), Raven Press, New York (1983)

22) Pollitt J, Young J:Anxiety state or masked depression? A study based on the action of monoamine oxidase inhibitors. Br J Psychiatry 119:143 (1971)
pubmed

23) Person B, Quitkin FM, McGrath PJ, et al:Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression. Psychopharmacol Bull 25:524 (1989)

24) Quitkin FM, Rabkin JG, Stewart JW, et al:Sleep of atypical depressives. J Affect Disord 8:61 (1985)
pubmed

25) Quitkin FM, Stewart J, McGrath P, et al:Phenelzine vs imipramine in the treatment of probable atypical depression-Defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 145:306 (1988)

26) Quitkin FM, McGrath P, Stewart J, et al:Phenelzine and imipramine in mood reactive depressives-Further delineation of the syndrome of atypical depression. Arch Gen Psychiatry 46:1068 (1989)

27) Quitkin FM, McGrath PJ, Stewart JW, et al:Atypical depression, panic attacks, and response to imipramine and phenelzine;A replication. Arch Gen Psychiatry 47:935 (1990)
pubmed

28) Quitkin FM, Stewart JW, McGrath PJ:Columbia atypical depression;A subgroup of depressives with better response to MAOI than tricyclic antidepressants of placebo. Br J Psychiatry 163:30, 491 (1993)

29) Ram RW, Stewart JN:The validity of atypical depression in DSM-IV. Compr Psychiatry 37:375 (1996)

30) Ravaris C, Robinson D, Ives J:Phenelzine and amitriptyline in the treatment of depression. Arch Gen Psychiatry 37:1075 (1980)
pubmed

31) Robertson HA, Lam RW, Stewart JN, et al:Atypical depressive symptoms and cluster in unipolar and bipolar depression. Acta Psychiatr Scand 94:421 (1996)
pubmed

32) Robinson D, Nies A, Ravaris C, et al:The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive-anxiety state. Arch Gen Psychiatry 29:407 (1973)
pubmed

33) Rothschild R, Quitkin H, Quitkin FM, et al:A double blind placebo controlled comparison of phenelzine and imipramine in treatment of bulimia in atypical depressives. Int J Eat Disord 15:1(1994)
pubmed

34) Rowan P, Paykel E, Parker R:Phenelzine and amitriptyline;Effects on symptoms of neurotic depression. Br J Psychiatry 140:475 (1982)
pubmed

35) Sargant W:Some newer drugs in the treatment of depression and their relation to other somatic treatments. Psychosomatics 1:14 (1960)

36) Soloff P, Cornelius J, George A, et al:Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 50:377 (1993)
pubmed

37) Sovner R:The clinical characteristics and treatment of atypical depression. J Clin Psychiatry 42:285 (1981)
pubmed

38) Spitzer RL, Williams JB:Hysteroid dysphoria;an unsuccessful attempt to demonstrate its syndromal validity. Am J Psychiatry 139:1286 (1982)
pubmed

39) Stewart JW, McGrath PJ, Quitkin FM:Can mildly depressed outpatients with atypical depression benefit from antidepressants? Am J Psychiatry 149:615 (1992)
pubmed

40) Stewart J, McGrath P, Rabkin J, et al:Atypical depression;A valid clinical entity? Psychiatr Clin North Am 16:479 (1993)
pubmed

41) Stewart JW, Tricamo E, McGrath PJ, et al:Prophylactic eflicacy of phenelzine and imipramine inchronic atypical depression;likelihood of recurrence on descontinuation after 6 months' remission. Am J Psychiatry 154:31(1997)

42) Tam EM, Lam RW, Robertson HA, et al:Atypical depressive symptom in seasonal and non-seasonal mood disorders. J Affect Disord 44:39 (1997)
pubmed

43) Thase ME, Carpenter L, Kupfer DJ, et al:Clinical significance of reversed vegetative subtypes of recurrent major depression. Psychopharmacol Bull 27:17 (1991)
pubmed

44) Terman M, Terman J, Quitkin F, et al:Light therapy for seasonal affective disorder-A review of efficacy. Neuropsychopharmacology 2:1 (1989)
pubmed

45) West E, Dally P:Effects of iproniazid in depressive syndromes. Br Med J 2:1491 (1959)

46) 横山知行, 多田利光, 飯田眞:著しい不安焦燥状態にMAO阻害薬が奏効した一例. 精神医学35:307(1993)

47) 横山知行, 多田利光, 飯田眞:MAO阻害薬が奏効した非定型うつ病像を伴う双極性障害の一例. 精神医学35:1321(1993)

P.319 掲載の参考文献

1) Akil H, Haskett RF, Young EA, et al:Multiple HPA profiles in endogenous depression;effect of age and sex on cortisol and beta-endorphin. Biol Psychiatry 33:73-85 (1993)
pubmed

2) Allen JJ, Iacono WG, Depue RA, et al:Regional electroencephalographic asymmetries in bipolar seasonal affective disorder before and after exposure to bright light. Biol Psychiatry 33:642-646 (1993)
pubmed

3) Arbisi PA, Depue RA, Krauss S, et al:Heat-loss response to a thermal challenge in seasonal affective disorder. Psychiatry Res 52:199-214 (1994)
pubmed

4) Bauer MS, Kurtz J, Winokur A, et al:Thyroid function before and after four-week light treatment in winter depressives and controls. Psychoneuroendocrinology 18:437-443 (1993)
pubmed

5) Booker JM, Hellekson CJ:Prevalence of seasonal affective disorders in Alaska. Am J Psychiatry 149:1176-1182 (1992)
pubmed

6) Carlsson A, Svennerholm L, Winblad B:Seasonal and circadian monoamine variation in human brain examined postmortem. Acta Psychiatr Scand 61 (suppl 280):75-78 (1980)

7) Checkly SA, Murphy DG, Abbas M, et al:Melatonin rhythms in seasonal affective disorder. Br J Psychiatry 163:332-337 (1993)

8) Childs PA, Rodin I, Martin NJ, et al:Effect of fluoxetine on melatonin in patients with seasonal affective disorder and matched controls. Br J Psychiatry 166:196-198 (1995)
pubmed

9) Cohen RM, Gross M, Nordahl TE, et al:Preliminary data on the metabolic brain pattern of patients with winter seasonal affective disorder. Arch Gen Psychiatry 49:545-552 (1992)
pubmed

10) Coiro V, Volpi R, Marchesi C, et al:Abnormal serotonergic control of prolactin and cortisol secretion inpatients with seasonal affective disorder. Psychoneuroendocrinology 18:551-556 (1993)

11) Coiro V, Volpi R, Marchesi C, et al:Lack of seasonal variation in abnormal TSH secretion in patients with seasonal affective disorder. Biol Psychiatry 35:36-41 (1994)
pubmed

12) Dahl K, Avery DH, Lewy AJ, et al:Dim light melatonin onset and circadian temperature during a constant routine in hypersomnic winter depression. Acta Psychiatr Scand 88:60-66 (1993)
pubmed

13) Depue RA:Effects of light on the biology of seasonal affective disorder. Annual Meeting of the Society for Light Treatment and Biological Rhythms, Bethesda Md. June 21(1989)

14) Dilsaver SC, Qamar AB, Del Medico VJ:The efficacy of bupropion in winter depression;results of an open trial. J Clin Psychiatry 53:252-255 (1992)

15) Eastman CI, Gallo LC, Lahmeyer HW, et al:The circadian rhythm of temperature during light treatment for winter depression. Biol Psychiatry 34:210-220 (1993)
pubmed

16) Eastman CI, Isahmeyer HW, Watell LG, et al:A placebo-controlled trial of light treatmant for winter depression. J Affective Disord 26:211-221 (1992)

17) Garia-Borrenguero D, Jacobsen FM, Murphy DL, et al:Hormonal response to the administration of chlorophenylpiperazine in patients with seasonal affective disorder and control. Biol Psychiatry 37:740-749 (1995)

18) Hellekson C:Phenomenology of seasonal affective disorder;an Alaska perspective. Seasonal Affective Disorders and Phototherapy, Rosenthal NE, Blehar MC (ed), Guilford Press, New York (1989)

19) Jacobson FM, Wehr TA, Skwerer RA, et al:Morning versus midday phototherapy of seasonal affective disorder. Am J Psychiatry 144:1301-1305 (1987)

20) James S, Wehr TA, Sack DA, et al:Treatment of seasonal affective disorder with evening light. Br J Psychiatry 147:424-428 (1985)
pubmed

21) Kasper S, Wehr TA, Bartko JJ, et al:Epidemiological endings of seasonal changes in mood and behavior-A telephone survey of Montgomery county, Maryland. Arch Gen Psychiatry 46:823-833 (1986)

22) Kripke DF, Mullaney DJ, Klauber MR, et al:Controlled trial of bright light for nonseasonal major depressive disorders. Biol Psychiatry 31:119-134 (1992)
pubmed

23) Lam RW:Morning light therapy for winter depression;predictors of response. Acta Psychiatr Scand 89:97-101 (1994)

24) Lam RW, Gorman CP, Michalon M, et al:Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. Am J Psychiatry 152:1765-1770 (1995)
pubmed

25) Leonhardt G, Wirz-Justice A, Krauchi K, et al:Longterm follow-up of depression in seasonal affective disorder. Compr Psychiatry 35:457-464 (1994)
pubmed

26) Levitt AJ, Joffe RT, Moul DE, et al:Side effects of light therapy in seasonal affective disorder. Am J Psychiatry 150:650-652 (1993)
pubmed

27) Lewy AJ, Kern HA, Rosenthal NE:Bright light treatment of a manic-depressive patient with a seasonal mood cycle. Am J Psychiatry 139:1496-1498 (1982)
pubmed

28) Lewy AL, Sack RL, Singer CM, et al:The phase shift hypothesis for bright light's therapeutic mechanism of action;Theoretical considerations and experimental evidence. Psychopharmacol Bull 23:349-353 (1987)

29) Lewy AJ, Sack RL, Singer CM, et al:Winter depression and the phase-shift hypothesis for bright light's therapeutic effects;History, theory and experimental evidence. J Biol Rhythm 3:121-134 (1988)

30) Lewy AJ, Wehr TA, Goodwin E, et al:Light suppresses melatonin secretion in humans. Science 210:1257-1269 (1980)

31) Lingjaerde O, Reichborn-Kjennerud T, Haggag A, et al:Treatment of winter depression in Norway. II. A comparison of the selective monoamine oxidase inhibitor moclobemide and placebo. Acta Psychiatr Scand 88:372-380 (1993)

32) Lingjaerde O, Reichborn-Kjennerud T, Hau E:Thyroid function in seasonal disorder. J Affective Disord 33:39-45 (1995)

33) Mackert A, Volz HP, Stieglitz RD, et al:Phototherapy in non-seasonal depression. Biol Psychiatry 30:257-268 (1991)

34) Magnusson A, Stefansson JG:Prevalence of seasonal affective disorder in Iceland. Arch Gen Psychiatry 50:941-946 (1993)
pubmed

35) McGrath RE, Buckwald B, Resnick EV:The effect of L-tryptophan on seasonal affective disorder. J Clin Psychiatry 51:162-163 (1990)
pubmed

36) Meesters Y, Jansen JH, Lambers PA, et al:Morning and evening light treatment of seasonal affective disorder;Response, relapse and prediction. J Affective Disord 28:165-177 (1993)
pubmed

37) Mellerup ET, Errebo I, Molin J, et al:Platelet paroxetine binding and light therapy in winter depression. J Affective Disord 29:11-15 (1993)
pubmed

38) Murase S, Murase S, Kitabatake M, et al:Seasonal mood variation among Japanese residents of Stockholm. Acta Psychiatr Scand 92:51-55 (1995)
pubmed

39) Nagayama H, Sasaki M, Ichii S, et al:Atypical depressive symptoms possibly predict responsiveness to phototherapy in seasonal affective disorder. J Affective Disord 23:185-189 (1991)
pubmed

40) Niijima A, Nagai K, Nagai N, et al:Effects of light stimulation on the activity of the autonomic nerves in anesthetized rats. Physiol Behav 54:555-561 (1993)
pubmed

41) O'Brien JT, Sahakian BJ, Checkley SA:Cognitive impairments in patients with seasonal affective disorder. Br J Psychiatry 163:338-343 (1993)
pubmed

42) Okawa M, Shirakawa S, Uchiyama M, et al:Seasonal variation of mood and behaviour in a healthy middle-aged population in Japan. Acta Psychiatr Scand 94:211-216 (1996)

43) Oren DA, Jacobsen FM, Wehr TA, et al:Predictors of response to phototherapy in seasonal affective disorder. Compr Psychiatry 33:111-114 (1992)
pubmed

44) Oren DA, Levedosky AA, Kasper S, et al:Circadian profiles of cortisol, prolactine. Biol Psychiatry 39:157-170 (1996)

45) Ozaki K, Ono Y, Ito A, et al:Prevalence of seasonal difficulties in mood and behavior among Japanese civil servants. Am J psychiatry 152:1225-1227 (1995)

46) Ozaki N, Rosenthal NE, Mazzola P, et al:Platelet 3H-paroxetine binding, 5-HT-stimulated Ca++ response, and 5-HT content in winter seasonal affective disorder. Biol Psychiatry 36:458-466 (1994)

47) Ozaki K, Rosenthal NE, Myers F, et al:Effect of season on electro-oculographic ratio in winter affective disorder. Psychiatry Res 59:151-155(1995)

48) Palinkas LA, Houseal M, Rosenthal NE:Subsyndromal seasonal affective disorder in Antarctica. J Nerv Ment Dis 1841530-534 (1996)

49) Papatheodorou G, Kutcher S:The effect of adjunctive therapy on ameliorating breakthrough depressive symptoms in adolescent-onset bipolar disorder. J Psychiatry Neurosci 20:226-232(1991)

50) Partonen T, Lonnqvist J:Moclobemide and fluoxetine in treatment of seasonal affective disorder. J Affective Disord 41:93-99 (1996)
pubmed

51) Potokin S, Zetin M, Stamenkovic V, et al:Seasonal affective disorder;prevalence varies with latitude and climate. Clin Neuropharmacol 9(suppl 4):181-183 (1986)

52) Rosenthal NE, Jacobsen FM, Sack DA, et al:Atenolol in seasonal affective disorder;A test of the melatonin hypothesis. Am J Psychiatry 145:52-56 (1988)
pubmed

53) Rosenthal NE, Sack DA, Gillin JC, et al:Seasonal affective disorder;A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 41:72-80 (1984)
pubmed

54) Rybakowski J, Plocka M:Seasonal variations of the dexamethasone suppresion test in depression compared with schizophrenia;a gender effect. J Affective Disord 24:87-91 (1992)

55) Saadoczky E, Falus A, Nemeth A, et al:Effect of phototherapy on 3H-imipramine binding sites in patients with SAD, non-SAD and in healthy controls. J Affective Disord 22:179-184 (1991)

56) Sakamoto K, Nakadaira S, et al:A longitudinal follow-up study of seasonal affective disorder. Am J Psychiatry 152:862-868 (1995)
pubmed

57) Schlager DS:Early-morning administration of short-acting beta blockers for treatment of winter depression. Am J Psychiatry 151:1383-1385 (1994)
pubmed

58) Schwartz PJ, Brown C, Wehr TA, et al:Winter seasonal affective disorder;a follow-up study of the first 59 patients of the National Institute of Mental Health Studies Program. Am J Psychiatry 153:1028-1036 (1996)
pubmed

59) 高橋清久:うつ病の時間生物学-特に季節性感情障害をめぐって. 精神科診断学1:255-268 (1990)

60) Takahashi K, Asano Y, Kohsaka M, et al:Multi-center study of seasonal affective disorders in Japan. A preliminary report. J Affective Disord 21:57-65 (1991)
pubmed

61) 高橋清久, 坂元薫:季節性感情障害の多施設共同研究報告-長期経過の検討. 厚生省精神・神経疾患委託費, 感情障害の臨床像・長期経過および予後に関する研究, 平成5年度研究報告書, pp 5-11 (1994)

62) Teicher MH, Glod CA:Seasonal affective disorder;rapid resolution by low-dose alplazolam. Psychopharmacol Bull 26:197-202 (1990)
pubmed

63) Teicher MH, Magnus E, Harper D, et al:Circadian rest-activity disturbances in seasonal affective disorder. Arch Gen Psychiatry 54:124-130 (1997)
pubmed

64) Terman M, Amira M, Terman JS, et al:Predictors of response and nonresponse to light treatment for winter depression. Am J Psychiatry 153:1423-1429 (1996)

65) Terman M, Terman JS, Quitkin PJ, et al:Light therapy for seasonal affective disorder;a review of efficacy. Neuropsychopharmacology 2:1-22 (1989)

66) Thalen BE, Kjellman BF, Morkirid L, et al:Seasonal and non-seasonal depression. A comparison of clinical characteristics in Swedish patients. Eur Arch Psychiatry Clin Neurosci 245:101-108 (1995)

67) Thompson C, Isaacs C:Seasonal affective disorder-a British samples; symptomatology in relation to mode of referral and diagnostic subtype. J Affective Dis 14:1-11 (1988)

68) Thompson C, Raheja SK, King EA:A follow-up study of seasonal affective disorder. Br J Psychiatry 167:380-384 (1996)

69) 渡邊慶一郎, 高橋清久:季節性感情障害の症例. 治療学31:746-749 (1997)

70) Wirz-Justice A, Bucheli C, Graw P, et al:Light treatment of seasonal affective disorder in Switzerland. Acta Psychiatr Scand 74:193-204 (1986)
pubmed

71) Wirz-Justice A, Gra P, Krauchi K, et al:Light therapy in seasonal affective disorder is independent of time of day or circadian phase. Arch Gen Psychiatry 50:929-937 (1993)
pubmed

72) Wirz-Justice A, van der Velde P, Bucher A, et al:Comparison of light treatment with citalopram in winter depression;a longitudinal single case study. Int Clin Psychopharmacol 7:109-116 (1992)
pubmed

73) Wurtman RJ, O'Rouke D, Wurtman JJ:Nutrient imbalances in depressive disorders. Possible brain mechanisms. Ann NY Acad Sci 575:75-82 (1989)

74) Yamada N, Martin-Iverson MT, Daimon K, et al:Clinical and chronobiological effects of light therapy on nonseasonal affective disorders. Biol Psychiatry 37:866-873 (1995)
pubmed

75) Yathan LN:Hormonal responses to dl-fenfluramine challenge are not blunted in seasonal affective disorder. Psychoneuroendocrinology 20:433-438 (1995)

P.342 掲載の参考文献

1) Akiskal HS:External validating criteria for psychiatric diagnosis;Their application in affective disorders. J Clin Psychiatry 41:6-15 (1980)
pubmed

2) Alarcon RD:Rapid cycling affective disorders. Clin Rev Compr Psychiatry 25:522-540 (1985)

3) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders (4th ed);DSM-IV. APA, Washington DC (1994)-高橋三郎, 大野裕, 染矢俊幸(訳):DSM-IV精神疾患の分類と診断の手引. pp 138-139, 医学書院, 東京 (1995)

4) 馬場信二, 笹野友寿, 新門弘人ほか:Rapid cycling affective disorderに対するlithium, carbamazepine, clonazepam併用療法の効果. 精神医学34:399-408 (1992)

5) Ballenger JC, Post RM:Therapeutic effects of carbamazepine in affective illness;a preliminary report. Commun Psychopharmacol 2:159-175 (1978)
pubmed

6) Ballenger JC:The clinical use of carbamazepine in affective disorders. J Clin Psychiatry 49 (suppl):13 (1988)

7) Bartalena L, Pellegrini L, Meschi M, et al:Evaluation of thyroid function in patients with rapidcycling and non-rapidcycling bipolar disorders. Psychiatry Res 34:13-17 (1990)
pubmed

8) Bauer MS, Whybrow PC, Winokur A:Rapid cycling bipolar affective disorder. I. Association with grade I hypotyroidism. Arch Gen Psychiatry 47:427-432 (1990)

9) Bauer MS, Whybrow PC:Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine;A preliminary study. Arch Gen Psychiatry 47:435-440(1990)

10) Berman E, Wolpert EA:Intractable manic-depressive psychosis with rapid cycling an 18 year-old woman successfully treated with electro-convulsive therapy. J Nerv Ment Dis 175:236-239 (1987)

11) Brown R:U. S. experience with valproate in manic depressive illness;A multi center trial. J Clin Psychiatry 50 (suppl 3):13-16 (1989)

12) Bunney WB Jr, Hartmann EL:Study of a patient with 48-hour manic-depressive cycles. Arch Gen Psychiatry 12:611-618(1965)

13) Calabrese JR, Delucchi GA:Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 147:431-434 (1990)
pubmed

14) Calabrese JR, Markovits PJ, Kimmel SH, et al:Spectrum of eflicacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol 12:53-56 (1992)

15) Cho JT, Bone S, Dunner DI, et al:The effect of lithium treatment on thyroid function in patients with primary affective disorder. Am J Psychiatry 136:115-116 (1979)

16) Chouinard G, Young SN, Annable L:Anti-manic effect of clonazepam. Biol Psychiatry 18:451-466 (1983)

17) Chouinard G:Use of clonazepam in the maintenance treatment of manic-depressive illness. Biological Psychiatry, Shagass C, Josiesser C, Bridge WH, et al(ed), Elsevier, New York (1986)

18) Chouinard G:Clonazepam in acute and maintenance treatment of bipolar affective disorders. J Clin Psychiatry 48 (Oct suppl):26-36 (1987)

19) Chouinard G:The use of benzodiazepines in the treatment of manic-depressive illness. J Clin Psychiatry 49:15-19 (1988)
pubmed

20) Chouinard G, Beaulair L, Geisa R, et al:A piolt study of magnesium aspartate hydrochloride (Magnesiocard(R))as a mood stabilizer for rapid cycling affective disorder patients. Prog Neuropsychopharmacol Biol Psychiatry 14:171-180 (1990)

21) Corywell W, Endicott J, Keller M:Rapidly cycling affective disorder;demographics, diagnosis, family history, and course. Arch Gen Psychiatry 49:126-131 (1992)

22) Cowdry RW, Wehr TA, Zis AP, et al:Thyroid abnormalities associated with rapid cycling bipolar illness. Arch Gen Psychiatry 40:414-420 (1983)
pubmed

23) Crane GE:The psychiatric side-effects of iproniazid. Am J Psychiatry 112:494 501 (1956)

24) Di Costanzo E, Schifano F:Lithium alone or in combination with carbamazepine for the treatment of rapid cycling bipolar affective disorder. Acta Psychiatr Scand 83:456-459 (1991)
pubmed

25) Dubovski SL, Francs RD, Lifshitz ML, et al:Effectiveness of verapamil in the treatment of a manic patient. Am J Psychiatry 139:502-504 (1982)

26) Dubovski SL, Francs RD, Schrier D:Phenelzine-induced hypomania;Effect of verapamil. Biol Psychiatry 20:1009-1014 (1985)

27) Dunner DL, Fieve RR:Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 30:229-233 (1974)
pubmed

28) Dunner DL, Patric V, Fieve RR:Rapid Cycling manic depressive patients. Compr Psychiatry 18:561-566 (1977)

29) Dunner DL:Rapid cycling bipolar manic depressive illness. Psychiatr Clin North Am 2:461-467 (1979)

30) Emrich HM, Dose M, von Zerssen D:The use of sodium-valproate and of oxycarbamazepine in patients with affective disorders. J Affect Disord 8:243-250 (1985)

31) Extein I, Potasch ALC, Gold MS:Does subclinical hypothyroidism predispose to tricyclic-induced rapid mood cycles? J Clin Psychiatry 43:290-291 (1982)

32) Forrest D:Bipolar illness following right hemispherectomy. Arch Gen Psychiatry 39:817-823 (1982)

33) 藤川徳美, 中原俊夫, 更井啓介:三環系抗うつ薬によりrapid cyclingを呈した双極性うつ病の1例. 広島医学40:406-408 (1987)

34) 二木文明, 谷口宏:Rapid cyclerの1症例. 臨床精神医学26:1595-1601 (1997)

35) Gelenberg AJ, Klerman GL, Hartmann EJ:Recurrent unipolar depression with a 48-hour cycle. Br J Psychiatry 133:123-129 (1978)

36) Gianniani AJ, Loiselle RH, Price WA, et al:Comparison of antimanic efficacy of clonidine and verapamil. J Clin Pharmacol 25:307-308 (1989)

37) Gold PW, Extein I, Ballenger JC, et al:Rapid mood cycling and concomitant cortisol changes produced by cyproheptadine. Am J Psychiatry 137:378-379 (1980)
pubmed

38) Goldstein JA:Danazol and the rapid cycling Patient. J Clin Psychiatry 47:153-154 (1986)

39) Goodwin FK, Jamison KR:Manic Depressive Illness. pp 185-195, Oxford Univ Press, New York(1990)

40) 後藤健一, 三木和平, 山田和夫ほか:難治性双極性感情障害の薬物療法におけるStep Care Approach. 第5回臨床精神神経薬理学会抄録p 78(1995)

41) Hanna SM, Jenner FA, Pearson IB, et al:The therapeutic effect of lithium carbonate on a patient with a forty-eight hour periodic psychosis. Br J Psychiatry 121:271-280 (1972)
pubmed

42) 挾間秀文:Rapid Cyclerの治療. 精神科治療学7:3-13(1992)

43) 樋口輝彦, 関口定, 朝倉幹雄ほか:難治性うつ病の実態に関する多施設共同調査研究. 脳と精神の医学4:135-146(1993)

44) Himmelhoch JM:Mixed states, manic-depressive illness and the nature of mood. Psychiatr Clin North Am 2:449-459 (1979)

45) 広瀬徹也:ラピッドサイクラー. 臨床精神医学20:1307-1308(1991)

46) 乾正, 東均, 西村健:炭酸脱水素酵素阻害剤の抗精神病作用 Acetazolamideによる感情精神病の治療. 臨床精神医学14:279-285(1985)

47) Joyce PR:Carbamazepine in rapid cycling bipolar affective disorder. Int Clin Psychopharmacol 3:123-129 (1988)
pubmed

48) 神庭重信:リチウム非反応者に期待される気分安定薬. 神精薬理11:781-792 (1989)

49) 神庭重信, 木下徳久, 中村中:Rapid Cycler;抗うつ薬療法の弊害的側面としての考察. 精神科治療学6:149-158(1991)

50) 神庭重信:抗うつ薬による躁転あるいは病相の頻発化の問題. 精神科治療学7:911-917 (1992)

51) Kanba S, Yagi G, Kamijima K, et al:The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania. Prog Neuropsychopharmacol Biol Psychiatry 18:707-715 (1994)
pubmed

52) 神庭重信:再発予防の観点からみた難治性気分障害とその薬物療法. 臨床精神医学 23:1617-1630 (1994)

53) 仮屋哲彦, 佐藤佳夫:rapid cyclerの薬物療法. 精神医学36:37-41(1994)

54) 岸本朗, 井上雄一, 小村文明ほか:長期観察からみたカルバマゼピンの躁うつ病相予防効果-リチウム剤との比較およびresponderに関する検討. 精神医学25:1255-1264 (1983)

55) 岸本朗, 国元憲文, 挾間秀文:Clonazepam(リボトリール)の抗うつ作用. 精神医学29:183-197(1987)

56) 岸本朗, 長田泉美, 挾間秀文ほか:女性ホルモンと躁うつ病予防薬併用による双極病の予防. 精神経誌92:762(1990)

57) 岸本朗:頻発性気分障害(rapid cycler)の治療. 臨床精神医学22:1117-1127 (1993)

58) Ko GN, Leckman JF, Heninger GR:Induction of rapid mood cycling during L-DOPA treatment in a bipolar patient. Am J Psychiatry 138:1624-1625 (1981)

59) Kukopulos A, Reginaldi D, Landdomada P, et al:Course of the manic-depressive cycle and changes caused by treatments. Pharmachopsychiatry 13:156-167 (1980)

60) Kukopulos A, Caliari B, Tundo A, et al:Rapid cyclers, temperament and antidepressants. Compr Psychiatry 24:249-258 (1983)
pubmed

61) Leibow D:L-thyroxine for rapid cycling bipolar illness. Am J Psychiatry 140:1255 (1983)
pubmed

62) Lerer B:48-Hour depressive cycling induced by antidepressant. Br J Psychiatry 137:183-185 (1980)
pubmed

63) Levy AB, Drake ME, Shy KE:EEG, evidence of epileptiform paroxysms in rapid-cycling bipolar patients. J Clin Psychiatry 49:232-234 (1988)
pubmed

64) 松崎太志, 岸本朗, 井上雄一ほか:治療抵抗性のRapid cyclerに対するバルプロ酸の予防効果. 精神経誌94:1361(1992)

65) Mattson A, Seltzer RL:MAOI-induced rapid cycling bipolar affecitve disorder in an adolescent. Am J Psychiatry 138:677-679 (1981)

66) McElroy SL, Keck PE, Pope HG, et al:Valproate in the treatment of rapid-cycling bipolar disorder. J Clin Psychopharmacol 8:275-279 (1988)
pubmed

67) 水間日香里, 中村純, 中沢洋一:晩発性rapid cyclerの一例. 精神科治療学6:1405-1412 (1991)

68) 本橋伸高, 南海昌弘, 小山恵子ほか:リチウムとバルプロ酸の併用が有効と思われる病相頻発型双極性障害の2例. 精神医学35:87(1993)

69) 中村中, 木下徳久, 神庭重信ほか:病相頻発型気分障害の10例の臨床的特徴. 精神医学34:427-430(1992)

70) 中村純:抗てんかん薬ゾニサミドと炭酸リチウムの併用が効果を示したrapid cyclerの一例. 精神医学35:1003(1993)

71) 丹羽政信, 久保田正春, 跡部勝ほか:家族の強い感情表出(High-EE)が遷延化因子となったと思われるラピッドサイクラーの1症例. 臨床精神医学26:1503-1510 (1997)

72) 野村総一郎, 山岡功一, 藤田潔史ほか:難治性うつ病の治療-自験20症例の経験から. 精神経誌93:870-876(1991)

73) Nurnberger J, Guroff JJ, Hamovit J, et al:A family study of rapid-cycling bipolar illness. J Affect Disord 15:87-91 (1988)
pubmed

74) 太田垣洋子, 井上武司, 谷山純子ほか:炭酸リチウム, カルバマゼピン, バルプロ酸の併用が有効と思われた"rapid cycler"の1例. 広島医学47:1108-1110 (1994)

75) Oppenheim G:Drug-induced rapid cycling;Possible outcome and management. Am J Psychiatry 139:939-941 (1982)
pubmed

76) Oppenheim G:A case of rapid mood cycling with estrogen;Implications for therapy, J Clin Psychiatry 45:34-45 (1984)
pubmed

77) Post RM, Rubinnow DR, Ballenger JC:Conditioning and sensitization in the longitudinal course of affective illness. Br J Psychiatry 149:191-201 (1986)

78) Post RM, Kramlinger KG, Altshuler LL, et al:Treatment of rapid cycling bipolar illness. Psychopharmacol Bull 26:37(1990)
pubmed

79) Post RM:Sensitization and kindling perspectives for the course of affective illness;Toward a new treatment with the anticonvulsant carbamazepine. Pharmacopsychiatry 23:3-17(1990)

80) Potter WZ, Murphy DL, Wehr TA, et al:Clorgyline;A new treatment for patients with refractory rapid cycling disorder. Arch Gen Psychiatry 33:505-510 (1982)

81) Price WA, DiMarzio L:Premenstral tension syndrome in rapid-cycling bipolar affective disorder. J Clin Psychiatry 47:415-417 (1986)

82) Roy-Byrne PP, Joffe RT, Uhde TW, et al:Approaches to the evaluation and treatment of rapid-cycling affective illness. Br J Psychiatry 145:543-550(1984)

83) 笹野友寿, 渡辺昌祐:Haloperidolによって誘発されたrapid cyclerの一症例. 精神医学35:663-666(1993)

84) 笹野友寿, 渡辺昌祐:難治性うつ病(rapid cycler). 精神科症例集, 木村敏ほか (編), 3. 躁うつ病I, pp 273-288, 中山書店, 東京(1995)

85) Senba J, Nankai M, Maruyama Y, et al:Increase in urinary β-phenylethylamine preceding the switch from mania to depression;A rapid cycler. J Nerv Ment Dis 176:116-119 (1988)

86) Siris SG, Chertoff HR, Perel JM:Rapid cycling affective disorder during imipramine treatment;A case report. Am J Psychiatry 136:341-342 (1979)
pubmed

87) Stancer HC, Persad E:Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Arch Gen Psychiatry 39:311-312 (1982)
pubmed

88) 春原善治, 三木和平, 山田和夫ほか:18年間にわたり病相を繰り返したRapid Cyclerの一治療例. 第7回神奈川県精神薬理学会抄録, p 5(1996)

89) 田島治, 上島国利:抗うつ薬による躁転とrapid cycling. 精神科治療学4:149-154 (1988)

90) Tay L, Dunner DL:A report on three patients with rapid cycling unipolar depression. Compr Psychiatry 33:253-255(1992)

91) 冨高辰一郎, 中平進, 加茂康二ほか:ラピッドサイクラーの臨床的特徴と治療抵抗性. 精神医学36:353-357(1994)

92) 渡辺昌祐:感情障害における診断と治療の問題点. 第1回横浜感情障害研究会抄録 (1997)

93) Wehr TA, Goodwin FK:Rapid cycling in manic-depressive induced by tricyclic antidepressants. Arch Gen Psychiatry 36:555-559 (1979)
pubmed

94) Wehr TA, Goodwin FK:Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 144:1403-1411 (1987)
pubmed

95) Wehr TA, Sack DA, Rosenthal NE, et al:Rapid cycling affective disorders; contributing factors and treatment responses in 51 patients. Am J Psychiatry 145:179-184 (1988)
pubmed

96) Wehr TA, Sack DA, Rothenthal NE, et al:Rapid cycling affective disorder. Am J Psychiatry 147:725 (1990)

97) 田村宏, 田中朱美:月経前緊張症の治療が奏効したrapid cyclerの1症例. 臨床精神医学26:1587-1594 (1997)

98) Wolpert EA, Goldberg JF, Harrow M:Rapid cycling in unipolar and bipolar affective disorders. Am J Psychiatry 147:725-728(1990)

99) 山田和夫, 三木和平, 桜井向陽ほか:難治性感情障害の臨床類型と長期経過. 厚生省精神・神経疾患研究委託費感情障害の臨床像・長期経過及び予後に関する研究班, 平成5年研究報告書, pp 57-64(1994)

100) 山田和夫, 三木和平, 桜井向陽ほか:病相頻発型うつ病性障害の臨床経過と治療法について. 平成6年度厚生省精神・神経疾患研究委託費による研究報告書, p 510 (1995)

101) 山田和夫, 後藤健一, 三木和平ほか:難治性感情障害の経過類型と治療法の開発研究(2)病相頻発型感情障害と遷延性うつ病の治療的工夫. 平成7年度厚生省精神・神経疾患研究委託費による研究報告書, p 57(1996)

102) 山田和夫, 伊藤導智, 後藤健一ほか:難治性感情障害の経過類型と治療法の開発研究. 平成8年度厚生省精神・神経疾患研究委託費による研究報告書(1997)

103) 山田和夫:ラピッド・サイクラー. KEY WORD 1997-98精神, 松下正明ほか (編), pp 250-251, 先端医学社, 東京(1997)

104) 山田和夫, 神庭重信:双極性感情障害の抗てんかん薬augmentation therapy. 精神科治療学9:134-1348(1994)

105) 山口登, 青葉安里, 常泉智弘ほか:Rapid cycling affective disorder発症に関する諸因子と治療について. 精神医学34:63-68 (1992)

106) Zis AP, Cowdry RW, Wehr TA, et al:Tricyclic-induced mania and MHPG excretion. Psychiatry Res 1:93-99 (1979)
pubmed

P.357 掲載の参考文献

1) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. American Psychiatric Association, Washington DC (1994)

2) Ananth J:Side effects in the neonate from psychotropic agents excreted through breast feeding. Am J Psychiatry 135:801-805 (1978)
pubmed

3) Beck CT:A meta-analysis of the relationship between postpartum depression and infant temperament. Nurs Res 45:225-230 (1996)
pubmed

4) Brockington IF, Cox-Roper A:The nosology of puerperal mental illness. Motherhood and Mental Illness 2. Causes and Consequences, Kumar R, Brockington IF (ed), pp 1-16, Wright, London(1988)

5) Butler J, Leonard BE:Post-partum depression and the effect of nomifensine treatment. Int Clin Psychopharmacol 1:244-252 (1986)
pubmed

6) Chen CH:Postpartum depression among adolescent mothers and adult mothers. Kaohsiung J Med Sci 12:104-113 (1996)
pubmed

7) Cooper PJ, Campbell EA, Day A, et al:Non-psychotic psychiatric disorder after childbirth;a prospective study of prevalence, incidence, course and nature. Br J Psychiatry 152:799-806 (1988)
pubmed

8) Dalton K:Prospective study into puerperal depression. Br J Psychiatry 118:689-692 (1971)
pubmed

9) Davidson J, Robertson E:A follow up study of post partum illness 1946-1978. Acta Psychiatr Scand 71:451-457 (1985)

10) Dean C, Kendell RE:The symptomatology of puerperal illness. Br J Psychiatry 139:128-133 (1981)
pubmed

11) Dowlatshahi D, Paykel ES:Life events and social stress in puerperal psychosis; Absence of effect. Psychol Med 20:655-662 (1990)
pubmed

12) Goldberg HL, DiMascio A:Psychotropic drugs in pregnancy. Psychopharmacology. A Generation of Progress, Lipton MA, DiMascio A, Killam KF (ed), pp 1047-1055 (1978)

13) Hamilton JA, Harberger PN, Parry B:The problem of terminology. Postpartum Psychiatric Illness, Hamilton JA, Harberger PN (ed), pp 33-40, Univ Pennsylvania Press, Philadelphia (1992)

14) Hannah P, Adams D, Glover V, et al:Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria. J Psychiatr Res 26:69-75 (1992)
pubmed

15) Harris B, Lovett L, Smith J, et al:Cardiff puerperal mood and hormone study. III. Postnatal depression at 5 to 6 weeks postpartum, and its hormonal correlates across the peripartum period. Br J Psychiatry 168:739-744 (1996)
pubmed

16) 畑田けい子, 岡崎祐士:産褥期の精神障害. Perinatal Care 13:36-42(1994)

17) Hobfoll SE, Lavin J, Hulsizer MR, et al:Depression prevalence and incidence among inner-city pregnant and postpartum women. J Consult Clin Psychol 63:445-453 (1995)
pubmed

18) Horowitz JA, Damato RN, Solon L, et al:Postpartum depression;Issues in clinical assessment. J perinatol 15:268-278 (1995)

19) 藤川徳美, 山脇成人, 東方田芳邦:女性ホルモン投与が奏効した無月経を伴い遷延した産褥期うつ病の1例. 精神科治療学8:819-823(1993)

20) Illes S, Gath D, Kennerley H:Maternity blues. 2. A comparison between postoperative women and post-natal women. Br J Psychiatry 155:363-366 (1989)

21) Kennerley H, Gath D:Maternity blues. 3. Associations with obtetric psychological and psychiatric factor. Br J Psychiatry 155:367-373 (1989)

22) 北村俊則:産後のうつ病とその援助. 母子保健情報33:15-18 (1996)

23) Kumar R, Robson KM:A prospective study of emotional disorders in childbearing women. Br J Psychiatry 144:35-47 (1984)
pubmed

24) Main TF:Mothers with children in psychiatric hospital. Lancet ii:845-847 (1958)

25) Mallet P, Andrew M, Hunter C, et al:Cognitive function, thyroid status and ostpartum depression. Acta Psychiatr Scand 91:243-246 (1995)

26) McGorry P, Colmell S:The nosology and prognosis of puerperal psychosis. A review. Compr Psychiatry 31:519-534 (1990)

27) Melzer ES, Kumar R:Puerperal mental illness, clinical features and classification;a study of 142 mother-and-baby admissions. Br J Psychiatry 147:647-654 (1985)

28) Metastasio P, Verdecchia P, D'Urzo E, et al:Postpartum depression. Minerva Ginecol 47:43-45 (1995)
pubmed

29) Murray L, Stein A:The effect of postnatal depression on the infant. Psychological Aspect of Obstetric and Gynecology. Vol 3, No4, pp 921-934, Bailliere, London (1989)

30) Nomura J, Okano T:Endocrine function and hormonal treatment of postpartum psychosis. Postpartum Psychiatric Illness. A Picture Puzzle, Hamilton JA, Harberger PN (ed), pp 176-190, Univ Pennsylvania Press, Philadelphia (1992)

31) 野村純一:産後精神障害の分類と診断. 精神科診断学5:285-292(1994)

32) 岡野禎治, 野村純一:甲状腺ホルモン療法が奏効した産後うつ病の1症例. 臨床精医学19:1674-1680(1990)

33) 岡野禎治, 野村純一, 越川法子ほか:Maternity Bluesと産後うつ病の比較文化的研究. 精神医学33:1051-1058(1991)

34) 岡野禎治, 野村純一:産褥精神病-その概念と今日的意義について. 精神科治療学9:148-156(1994)

35) O'Hara MW, Schlechte J, Lewis D, et al:Controlled prospective study of postpartum mood disorders;Psychological, environmental, and hormonal variables. J Abnorm Psychol 100:63-73 (1991)
pubmed

36) Paykel ES, Emms EM, Fletcher J, et al:Life events and social support in puerperal depression. Br J Psychiatry 136:339-346 (1980)
pubmed

37) Prettyman RJ, Friedman T:Care of women with puerperal psychotic disorders in England and Wales. Br Med J 302:1245-1246 (1991)

38) 佐野信也, 土居通哉:うつ病の特殊型-産後うつ病. 日本臨床52:151-156 (1994)

39) 島悟:マタニティ・ブルーズと産後うつ病の診断学. 季刊精神科診断学5:321-330 (1994)

40) Stewart S, Jambunathan J:Hmong women and postpartum depression. Health Care Women Int 17:319-330 (1996)
pubmed

41) Stowe ZN, Nemeroff CB:Women at risk for postpartum-onset major depression. Am J Obstet Gynecol 173:639-645 (1995)
pubmed

42) 高橋三郎, 井野恵三:産後の精神障害, その疾病学的位置付け. 精神経誌85:787-793 (1983)

43) 高橋三郎:産褥期に関連した適応障害(マタニティ・ブルー)と精神障害. 臨婦産47:635-637 (1993)

44) 高橋修三, 田中俊誠:マタニティ・ブルーと産褥うつ病. Perinatal Care 12:31-37 (1993)

45) Trad PV:Using maternal representational patterns to evaluate postpartum epression. Am J Psychotherapy 49:128-148 (1995)

46) 渡辺勉:産褥期感情障害に関する心理統計学的研究II, 性格特性と産後抑うつ状との関連について. 聖マリアンナ医大誌21:679-686 (1993)

47) Whiffen VE:The comparison of postpartum depression;a rose by any other name. J Psychiatr Neurosci 16:160-165 (1991)

48) Wieck A, Kumar R, Kirst AD, et al:Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. Br Med J 303:613-616 (1991)

49) World Health Organization:The ICD-10 Classification of Mental and Behavioural Disorders;Clinical descriptions and diagnostic guidelines. WHO (1992)-融道男, 中根允文, 小見山実(監訳):ICD-10精神および行動の障害-臨床記述と診断ガイドライン. 医学書院, 東京 (1993)

P.370 掲載の参考文献

1) Akiskal HS, Biter AH, Puzantin VR, et al:The nosological status of neurotic depression. Arch Gen Psychiatry 35:756-766 (1978)

2) 秋山剛, 五味渕隆志:分裂病質・分裂病型人格障害の抑うつ症状について. 臨床精神病理18:13-21 (1997)

3) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. APA, Washington DC (1994)

4) 荒井稔:非定型うつ病. 精神科ケースライブラリー, 広瀬徹也ほか(編), 中山書店, 東京(1998)

5) Hertrich O:Beitrag zur Diagnostik und Differentialdiagnostik der leichteren depressiven Zustandsbilder. Fortschr Neurol Psychiatr 30:237-272 (1962)

6) 平沢一:軽症うつ病の臨床と予後. 医学書院, 東京 (1966)

7) 広瀬徹也:「逃避型抑うつ」について. 躁うつ病の精神病理2, 宮本忠雄(編), 弘文堂, 東京 (1977)

8) 広瀬徹也:軽症うつ病をめぐって-軽症化との関連において. 臨床精神医学 22:261-267 (1993)

9) 伊藤彰紀, 笠原嘉:勤労者にみられる頻回欠勤について. 精神医学35:627-634 (1993)

10) 上島国利:躁うつ病の臨床. 金剛出版, 東京(1983)

11) Kaplan IH, Sadock BJ, et al:Mood disorder. Kaplan and Sadock's Synopsis of Psychiatry, 7th Edition. Williams & Wilkins, Baltimore (1994)-井上令一, 四宮滋子(編訳):カプラン臨床精神医学テキスト. 医学書院NYW, 東京 (1996)

12) 笠原嘉, 木村敏:うつ状態の臨床的分類に関する研究. 精神経誌10:715-735 (1975)

13) 笠原嘉:軽症うつ病の臨床から. 外来精神医学, みすず書房, 東京(1991)所収

14) 笠原嘉:軽症うつ病. 講談社, 東京(1996)

15) Kennedy F, Wiesel B:The clinical nature of "manic-depressive equivalents and their treatment. Trans Am Neurol Assoc 109:96-101 (1946)

16) Kielholz P:Diagnostik und Therapie der depressiven Zustandsbilder. Schweiz Med Wochenschr 87:87-90 (1957)

17) Kral VA:Masked depression in middle aged men. Can Med Assoc 79:1-5 (1958)
pubmed

18) 宮本忠雄:現代社会とうつ病. 臨床医4:1771(1978)

19) 斉藤環:Cyclothymia(気分循環症)と考えられる一例. 精神科臨床における症例からの学び方, 藤縄昭(編著), 日本評論社, 東京(1994)

20) 新福尚武:仮面デプレッション. 日本万有, 東京(1969)

21) Stanly L:Masked Depression. Aronson, New York (1996)

22) Schulte W:Nichttraurigseinkonnen im Kern melancholsches Erlebens. Nervenarzt 32:314 (1961)

23) Tellenbach H:Melancholie. Springer, Berlin (1961)木村敏(訳):メランコリー. みすず書房東京(1978)

24) 筒井末春:仮面デプレッションのすべて. 新興医学出版社, 東京(1982)

25) Weitbrecht HJ:Psychiatrie im Grundriss. Springer, Berlin (1973)-切替辰哉 (訳):臨床精神医学. 医学書院, 東京 (1974)

26) West ED, Dally PJ:Effect of iproniazid in depressive syndrome. Br Med J 1:1491-1492 (1959)
pubmed

27) World Health Organization:The ICD-10 Classification of Mental and Behavioural Disorders. WHO, Geneva (1992)

P.383 掲載の参考文献

1) Akiskal HS:The prevalent clinical spectrum of bipolar disorders;beyond DSM-IV. J Clin Psychopharmacol (suppl) 16 (2):4S-14S (1996)

2) Altamura AC, Carta MG:Lifetime prevalence of brief recurrent depression (results from a community survey). Eur Neuropsychopharmacol (suppl):99-102 (1995)

3) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. APA, Washington DC (1994)

4) Angst J, Dobler-Mikola MA:The Zurich Study-a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. IV. Recurrent and nonrecurrent brief depression. Eur Arch Psychiatry Neurol Sci 234:408-416 (1985)

5) Angst J:Recurrent brief depression. A new concept of depression. Pharmacopsychiatry 23:63-66 (1990)
pubmed

6) Angst J, Merikangas K, Scheidegger P, et al:Recurrent brief depression;a new subtype of affective disorder. J Affective Disord 19:87-98 (1990)

7) Angst J, Wicki W:The Zurich Study. XIII. Recurrent brief anxiety. Eur Arch Psychiatry Clin Neurosci 241:296-300 (1992)
pubmed

8) Angst J:The history and concept of recurrent brief depression. Eur Arch Psychiatry Clin Neurosci 244:171-173 (1994)
pubmed

9) Angst J, Hochstrasser B:Recurrent brief depression;the Zurich Study. J Clin Psychiatry (suppl) 55 (4):3-9 (1994)

10) Angst J:Comorbidity of mood disorders;a longitudinal prospective study. Br J Psychiatry (suppl) 168:31-37 (1996)

11) Clayton PJ, Marten S, Davis MA, et al:Mood disorder in woman professionals. J Affective Disord 2:37-46 (1980)
pubmed

12) Dunner DL, Fieve RR:Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 30:229-233 (1974)
pubmed

13) Dunner DL, Patrick V, Fieve RR:Rapid cycling manic depressive patients. Compr Psychiatry 18:561-566 (1977)
pubmed

14) Gregory MS:Transient attacks of manic-depressive insanity. Med Record 88:1040-1044 (1915)

15) 広瀬徹也:逃避型抑うつについて. 躁うつ病の精神病理2, 宮本忠雄(編), pp 61-86, 弘文堂, 東京(1977)

16) Hochstrasser B, Angst J:The Zurich Study. XXII. Epidemiology of gastrointestinal complaints and comorbidity with anxiety and depression. Eur Arch Psychiatry Clin Neurosci 246:261-272 (1996)
pubmed

17) 伊藤彰紀, 笠原嘉:勤労者にみられる短期反復型頻回欠勤について. 精神医学 35:627-634 (1993)

18) Judd LL:What is subsyndromal symptomatic depression (SSD)? Past, Present and Future of Psychiatry, Beigel A, Lopez-Ibor JJ, Costa e Silba (ed), pp 295-299, World Scientific Publishing (1994)

19) Judd LL, Rapaport MH, Paulus MP, et al:Subsyndromal symptomatic depression; a new mood disorder? J Clin Psychiatry 55 (suppl):18-28 (1994)

20) Kasper S, Ruhrmann S, Hasse T, et al:Recurrent brief depression and its relationship to seasonal affective disorder. Eur Arch Psychiatry Clin Neurosci 242:20-26 (1992)

21) Kasper S, Ruhrmann S, Hasse T, et al:Evidence for a seasonal form of recurrent brief depression (RBD-seasonal). Eur Arch Psychiatry Clin Neurosci 244:205-210 (1994)

22) Keller MB, Hanks DL, Klein DN:Summary of the DSM-IV mood disorders field trial and issue overview. Psychiatr Clin North Am 19:1-28 (1996)

23) Kessler RC, McGonagle KA, Swartz M, et al:Sex and depression in the National Comorbidity Survey I. Lifetime prevalence, chronicity and recurrence. J Affective Disord 29:85-96(1993)

24) Kraepelin E:Psychiatrie. Verlag von Johann Ambrosius Barth, Leipzig (1913)

25) Maier W, Herr R, Lichtermann D, et al:Brief depression among patients in general practice. Prevalence and variation by recurrence and severity. Eur Arch Psychiatry Clin Neurosci 244:190-195 (1994)
pubmed

26) Merikangas KR, Wicki W, Angst J:Heterogeneity of depression. Classification of depressive subtypes by longitudinal course. Br J Psychiatry 164:342-348 (1994)
pubmed

27) Montgomery SA, Montgomery D, Baldwin D, et al:Intermittent 3-day depressions and suicidal behavior. Neuropsychobiology 22:128-134 (1989)
pubmed

28) Montgomery SA, Montgomery D, Baldwin D, et al:The duration, nature and recurrence rate of brief depressions. Prog Neuropsychopharmacol Biol Psychiatry 14:729-735 (1990)
pubmed

29) Montgomery SA, Montgomery D:Features of recurrent brief depression. L' Encephale:521-523 (1992)

30) Montgomery SA, et al:Brief unipolar depressions;is there a bipolar component? L'Encephale:41-43 (1992)

31) Montgomery DB, Roberts A, Green M, et al:Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. Eur Arch Psychiatry Clin Neurosci 244:211-215 (1994)
pubmed

32) Paskind HA:Brief attacks of manic-depressive depression. Arch Neurol Psychiatry 22:123-134 (1929)

33) Pretorius HW, Bodemer W, Roos JL, et al:Personality traits, brief recurrent depression and attempted suicide. S Afr Med J 84:690-694 (1994)
pubmed

34) Read CF:Discussion. Arch Neurol 22:133 (1929)

35) 仙波純一:反復性短期うつ病性障害 (recurrent brief depressive disorder, ICD-10)の一例. 精神医学36:291-295(1994)

36) Shibayama M, Seki N:Oflice refusal in Japan. Past, Present and Future of Psychiatry, Beigel A, Lopez-Ibor JJ, Costa e Silba (ed), pp 1253-1256, World Scientific Publishing (1994)

37) Spitzer RL, Endicott J, Robins E:Research Diagnostic Criteria;rationale and reliability. Arch Gen Psychiatry 35:773-782 (1978)
pubmed

38) Staner L, Dela Fuente JM, Kerkhofs M, et al:Biological and clinical features of recurrent brief depression;a comparison with major depressed and healthy subjects. J Affective Disord 26:241-245 (1992)

39) Tay LK, Dunner DL:A report on three patients with "rapid cycling" unipolar depression. Compr Psychiatry 33:253-255 (1992)
pubmed

40) Vollrath M, Wicki W, Angst J:The Zurich Study. VIII. Insomnia;association with depression, anxiety, somatic syndromes, and course of insomnia. Eur Arch Psychiatry Neurol Sci 239:113-124 (1989)
pubmed

41) Vollrath M, Koch R, Angst J:The Zurich Study. IX. Panic disorder and sporadic panic;symptoms, diagnosis, prevalence, and overlap with depression. Eur Arch Psychiatry Neurol Sci 239:221-230 (1990)
pubmed

42) Weiller E, Lecrubier Y, Maier W, et al:The relevance of recurrent brief depression in primary care. A report from the WHO project on Psychological Problems in General Health Care conducted in 14 countries. Eur Arch Psychiatry Clin Neurosci 244:182-189 (1994)
pubmed

43) World Health Organization:The ICD-10. Classification of Mental and Behavioural Disorders;Diagnostic criteria for research. WHO, Geneva (1993)-中根允文, 岡崎祐士, 藤原妙子(訳):ICD-10精神および行動の障害-DCR研究用診断基準. 医学書院, 東京 (1994)

P.395 掲載の参考文献

1) Abrams R:Electroconvulsive Therapy, 3rd ed. Oxford Univ Press, New York (1997)

2) Alexopoulos GS, Meyers BS, Young RC, et al:Recovery in geriatric depression. Arch Gen Psychiatry 53:305-312 (1996)
pubmed

3) American Psychiatric Association:Quick Reference to the Diagnostic Criteria from DSM-IV. American Psychiatric Association, Washington DC (1994)-高橋三郎, 大野裕, 染矢俊幸(訳):DSM-IV精神疾患の分類と診断の手引. 医学書院, 東京 (1995)

4) Amsterdam JD, Hornig-Rohan M:Treatment algorithms in treatment-resistant depression. Psychiatr Clin North Am 19:371-386 (1996)

5) Angst J:Verlauf unipolar depressiver, bipolar manisch-depressiver und schizoaffectiver Erkrankungen und Psychosen Ergebnisse einer prospectiven Studie. Fortschr Neurol Psychiatr 48:3-30 (1980)

6) Aronson R, Offman HJ, Joffe RT, et al:Triiodothyronine augmentation in the treatment of refractory depression. Arch Gen Psychiatry 53:842-848 (1996)
pubmed

7) Baxter LR Jr, Schwartz JM, Bergman KS, et al:Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 49:681-689(1992)

8) Berner P, Kryspin-Exner K, Poeldinger W:Therapy possibilities for therapy-resistant depression. Pharmacopsychiatry 7:189-193 (1974)

9) Birkenhager TK, Vegt M, Nolen WA:An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression. Pharmacopsychiatry 30:23-26(1997)

10) Blankenburg W:Zur Leistungsstruktur bei chronischen endogenen psychosen. Nervenarzt 41:577-587(1970)-岡本進(訳):慢性内因性精神病者における仕事の構造について. 分裂病の人間学, 木村敏(編訳), pp 187-221, 医学書院, 東京 (1981)

11) Burger-Prinz H:Ein Psychiater berichtet. Hoffmann und Campe Verlag, Hamburg (1971)福田哲雄(監訳):ある精神科医の回想. 佑学社, 東京(1981)

12) Corrigan FM:Sodium valproate augmentation of fluoxetine or fluvoxamine effects. Biol Psychiatry 31:1178-1179 (1992)
pubmed

13) Coryell W, Scheftner W, Keller M, et al:The enduring psychosocial consequences of mania and depression. Am J Psychiatry 150:720-727 (1993)
pubmed

14) Cullen M, Mitchell P, Brodaty H, et al:Carbamazepine for treatment-resistant melancholia. J Clin Psychiatry 52:472-476 (1991)
pubmed

15) de Montigny C:Lithium addition in refractory depression. Refractory Depression, Current Strategies and Future Directions, Nolen W, Zohar J, Roose SP, et al (ed), pp 47-57, John Wiley & Sons, Chichester (1994)

16) 藤山直樹, 広瀬徹也:難治性うつ病の概念. 精神医学レビュー, 上島国利(編), No2, 難治性うつ病, pp 5-16, ライフ・サイエンス, 東京(1991)

17) Gitlin MJ, Swendsen J, Heller TL, et al:Relapse and impairment in bipolar disorder. Am J Psychiatry 152:1635-1640 (1995)
pubmed

18) Goldberg JF, Harrow M, Grossman LS:Course and outcome in bipolar affective disorder;A longitudinal follow-up study. Am J Psychiatry 152:379-384 (1995)
pubmed

19) Guscott R, Grof P:The clinical meaning of refractory depression;a review for the clinician. Am J Psychiatry 148:695-704 (1991)
pubmed

20) 樋口輝彦:抗うつ薬治療抵抗性うつ病. 臨床精神医学23:1609-1616(1994)

21) 樋口輝彦, 関口定, 朝倉幹雄ほか:難治性うつ病の実態に関する多施設共同調査研究. 脳と精神の医学4:135-146(1993)

22) 平山壮一郎, 藤川徳美, 本橋伸高ほか:Bromocriptine投与が有効であった遷延性うつ病の1例. 精神科治療学11:1071-1074(1996)

23) 広瀬徹也:躁うつ病の慢性化と遷延化. 精神経誌81:797-802(1979)

24) 広瀬徹也:経過類型, 残遺状態と人格変化. 現代精神医学大系, 懸田克躬ほか (編), 第9巻B 躁うつ病II, pp 79-98, 中山書店, 東京(1979)

25) 飯田真, 阿部輝夫, 石川一郎:躁うつ病の慢性化-その要因の多元的研究. 宮本忠雄(編), 躁うつ病の精神病理2, pp 87-127, 弘文堂, 東京(1977)

26) 井上猛, 泉剛, 本間裕士ほか:抗うつ薬に治療抵抗性のうつ病の実態とその治療戦略-自験例における調査結果と治療抵抗性うつ病の段階的治療に関する試案. 精神経誌98:329-342(1996)

27) Inoue T, Tsuchiya K, Miura J, et al:Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression. Biol Psychiatry 40:151-153 (1996)
pubmed

28) 石谷直子:精神科作業療法. 星和書店, 東京(1984)

29) Kiloh LG, Andrews G, Neilson M:The long-term outcome of depressive illness. Br J Psychiatry 153:752-757 (1988)

30) 木村敏:非うつ病性抑うつ症状について. 日医新報3586:21-25(1993)

31) 岸本朗:難治性うつ病の実態と新しい薬物療法の試み. 脳と精神の医学4:147-154 (1993)

32) 岸本朗:難治性うつ病に対するホルモン剤のaugmentation therapy. 精神科治療学9:1356-1364 (1994)

33) Klein RG:The role of methylphenidate in psychiatry. Arch Gen Psychiatry 52:429-433 (1995)
pubmed

34) Kraepelin E:Psychiatrie. Verlag von Johann Ambrosius Barth, Leipzig (1913)-西丸四方, 西丸甫夫(訳):躁うつ病とてんかん. みすず書房, 東京(1986)

35) Kusumi I, Ohmori T, Kohsaka M, et al:Chronobiological approach for treatment-resistant rapid cycling affective disorders. Biol Psychiatry 37:553-559 (1995)
pubmed

36) Lee AS, Murray RM:The long-term outcome of Maudsley depressives. Br J Psychiatry 153:741-751 (1988)

37) Leibenluft E, Wehr TA:Is sleep deprivation useful in the treatment of depression? Am J Psychiatry 149:159-168 (1992)
pubmed

38) Leonard BE:Biochemical aspects of therapy-resistant depression. Br J Psychiatry 152:453-459 (1988)
pubmed

39) Martinsen EW:Benefits of exercise for the treatment of depression. Sport Med 9:380-389 (1990)
pubmed

40) Meltzer HY, Maes M, Elkis H:The biological basis of refractory depression. Refractory Depression, Current Strategies and Future Directions, Nolen W Zohar J, Roose SP, et al(ed), pp 177-198, John Wiley & Sons, Chichester (1994)

41) 三国雅彦, 黒田安計, 宗岡克政ほか:抗うつ薬の作用機序からみたうつ病の難治化と新しい薬物療法の可能性. 脳と精神の医学4:155-160(1993)

42) Moller H-J:Therapieresistenz auf Antidepressiva;Riskfaktoren und Behandlungsmoglichkeiten. Nervenarzt 62:658-669 (1991)
pubmed

43) 森温理:難治性うつ病の治療. 臨床精神医学8:303-319(1979)

44) 本橋伸高:失敗例から学ぶ日常医薬品の上手な使い方(1)抗うつ薬. JIM 4:52-53 (1994)

45) 本橋伸高:難治性うつ病の治療. 治療学31:683-685 (1997)

46) 本橋伸高, 高橋清久:抗うつ薬. 生体の科学42:529-531(1991)

47) Mueller TI, Keller MB, Leon AC, et al:Recovery after 5 years of unremitting major depressive disorder. Arch Gen Psychiatry 53:794-799 (1996)
pubmed

48) Murphy BEP, Dhar V, Ghadirian AM, et al:Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol 11:121-126 (1991)

49) 鍋田恭孝:遷延化したうつ病の精神療法. 精神医学レビュー, 上島国利(編), No 2, 難治性うつ病, pp 66-78, ライフ・サイエンス, 東京(1991)

50) Nemeroff CB:Augmentation strategies in patients with refractory depression. Depress Anxiety 4:169-181 (1996)
pubmed

51) Nierenberg AA, White K:What next? A review of pharmacologic strategies for treatment resistant depression. Psychopharmacol Bull 26:429-460 (1990)
pubmed

52) 野村靖幸:抗うつ薬の薬理. 治療学31:671-674 (1997)

53) 太田恵理子, 藤原豊, 久保信介ほか:メチルフェニデートの短期投与が有効であった抑制型うつ状態の5例. 精神科治療学10:1163-1169(1995)

54) Okamoto Y, Motohashi N, Hayakawa H, et al:Addition of lithium to chronic antidepressant treatment potenciates presynaptic serotonergic function without changes in serotonergic receptors on the rat cerebral cortex. Neuropsychobiology 33:17-20 (1996)

55) 岡本泰昌, 藤川徳美, 石田百合ほか:抗うつ薬抵抗性うつ病に対するリチウム追加投与の影響. 精神医学38:405-409(1996)

56) Paykel ES:Epidemiology of refractory depression. Refractory Depression, Current Strategies and Future Directions, Nolen W, Zohar J, Roose SP, et al (ed), pp 3-17, John Wiley & Sons, Chichester (1994)

57) Potter WZ, Manji HK:Dopaminergic drugs and systems in refractory depression. Refractory Depression, Current Strategies and Future Directions, Nolen W, Zohar J, Roose SP, et al (ed), pp 211-227, John Wiley&Sons, Chichester (1994)

58) Sackeim HA, Prudic J, Devanand DP, et al:The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 10:96-104 (1990)
pubmed

59) 斎藤巌:日本における認知, 認知行動療法. 認知療法ハンドブック, 大野裕, 小屋津孝明(編), 上巻, pp 1-22, 星和書店, 東京(1996)

60) 坂本暢典, 岩橋正人:うつ病の長期化・慢性化に対する治療上の工夫. 精神科治療学7:15-25(1992)

61) Scott J:Chronic depression. Br J Psychiatry 153:287-297 (1988)
pubmed

62) Scott J:Predictors of non-response to antidepressants. Refractory Depression, Current Strategies and Future Directions, Nolen W, Zohar J, Roose SP, et al (ed), pp 19-28, John Wiley&Sons, Chichester (1994)

63) Scott J:Psychological treatment for depression. An update. Br J psychiatry 167:289-292 (1995)
pubmed

64) Seth R, Jennings AL, Bindman J, et al:Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression. Br J Psychiatry 161:562-565 (1992)
pubmed

65) Sitland-Marken PA, Wells BG, Froemming JH, et al:Psychiatric applications of bromocriptine therapy. J Clin Psychiatry 51:68-82 (1990)
pubmed

66) Sobin C, Prudic J, Devanand DP, et al:Who responds to electroconvulsive therapy? A comparison of effective and ineffective forms of treatment. Br J Psychiatry 169:322-328 (1996)
pubmed

67) 鈴木克治, 久住一郎, 井上猛ほか:治療抵抗性感情障害に対するサイロキシンの治療効果. 精神医学37:477-484(1995)

68) 竹中秀夫, 小島卓也:遷延性うつ病. 臨床精神医学23:1587-1593(1994)

69) 谷向弘:遷延うつ病の治療. 臨床精神医学2:67-76(1973)

70) Targum SD, Greenberg RD, Harmon RL, et al:Thyroid hormone and the TRH stimulation test in refractory depression. J Clin Psychiatry 45:345-346(1984)

71) Taylor D:Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination;Interaction and therapeutic uses. Br J Psychiatry 167:575-580 (1995)
pubmed

72) Thase, ME, Rush AJ:Treatment-resistant depression. Psychopharmacology; Fourth Generation of Progress, Bloom FE, Kupfer DJ (ed), pp 1081-1097, Raven Press, New York (1995)

73) Winokur G, Coryell W, Keller M, et al:A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry 50:457-465 (1993)

74) 山口隆久:遷延性うつ病の治療への新しい試み. 精神科治療学2:27-36(1987)

P.409 掲載の参考文献

1) Akiskal HS, Bitar AH, Puzantian VR, et al:The nosological status of neurotic depression. Arch Gen Psychiatry 35:756-766 (1978)
pubmed

2) Akiskal HS:Dysthymic disorder;Psychopathology of proposed chronic depressive subtypes. Am J Psychiatry 140:11-20 (1983)
pubmed

3) Botte L, Gilles C, Evrard JL, et al:Moclobemide versus placebo in the treatment of depression;a multicentre study in Belgium. Acta Psychiatr Scand 82 (suppl 360):42 (1990)

4) Evans S, Cloitre M, Kocsis JH, et al:Social-vocational adjustment in unipolar mood disorders;results of the DSM-IV field trial. J Affect Disord 38:73-80 (1996)

5) Hellerstein DJ, Yanowitch P, Rosenthal J, et al:A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia. Am J Psychiatry 150:1169-1175 (1993)

6) 広瀬徹也:Dysthymia(気分変調症). 臨床精神医学23:1595-1601(1994)

7) 古川壽亮:Dysthymiaとmajor depressionのcomorbidity(Double depression) について. 精神科治療学12:891-897(1997)

8) Keller MB, Shapiro RW:"Double depression"; Superimposition of acute depressive episodes on chronic depressive disorders. Am J Psychiatry 139:438-442 (1982)
pubmed

9) Keller MB, Lavori PW, Endicott J, et al:"Double depression"; Two-year follow-up. Am J Psychiatry 140:689-694 (1983)
pubmed

10) Keller MB:Course, outcome and impact on the community. Acta Psychiatr Scand 89 (suppl 383):24-34 (1994)

11) Keller MB, Klein DN, Hirschfeld RMA, et al:Results of the DSM-IV mood disorders field trial Am J Psychiatry 152:843-849(1995)

12) Klein DN, Taylor EB, Harding K, et al:Double depression and episodic major depression;Demographic, clinical, familial, personality, and socioenvironmental characteristics and short-term outcome. Am J Psychiatry 145:1226-1231 (1988)
pubmed

13) Klein DN, Taylor EB, Dickstein S, et al:Primary early-onset dysthymia; comparison with primary nonbipolar nonchronic major depression on demographic, clinical, familial, personality and socioenvironmental characteristics and short-term outcome. J Abnorm Psychol 97:387-398 (1988)
pubmed

14) Kocsis JH, Frances HA, Voss C, et al:Imipramine treatment for chronic depression. Arch Gen Psychiatry 45:253-257 (1988)

15) Kocsis JH, Friedman RA, Markowitz JC, et al:Maintenance therapy for chronic depression. A controlled clinical trial of desipramine. Arch Gen Psychiatry 53:769-774 (1996)
pubmed

16) Kovacs M, Feinberg TL, Crouse-Novak MA, et al:Depressive disorders in childhood; I. A longitudinal prospective study of characteristics and recovery. Arch Gen Psychiatry 41:229-237 (1984)

17) Lapierre YD:Pharmacological therapy of dysthymia. Acta Psychiatr Scand 89 (suppl 383):42-48 (1994)

18) Leader JB, Klein DN:Social adjustment in dysthymia, double depression and episodic major depression. J Affect Disord 37:91-101 (1996)
pubmed

19) Levitt AJ, Joffe RT, MacDonald C:Life course of depressive illness and characteristics of current episode in patients with double depression. J Nerv Ment Dis 179:678-682 (1991)
pubmed

20) Miller IW, Norman WH, Dow MG:Psychosocial characteristics of "double depression". Am J Psychiatry 143:1042-1044 (1986)
pubmed

21) Regier DA, Boyd JH, Burce ML, et al:One-month prevalence of mental disorders on the United States. Based on five epidemiological catchment area sites. Arch Gen Psychiatry 45:977-986 (1988)

22) Rosenthal TL, Akiskal HS, Scott-Straus A, et al:Familial developmental factors in characterological depressions. J Affect Disord 3:183-192 (1981)

23) Sotsky SM, Glass DR, Shea MT, et al:Patient predictors of response to psychotherapy and pharmacotherapy;Findings in NIMH treatment of depression collaborative research program. Am J Psychiatry 148:997-1008 (1991)
pubmed

24) Wells KB, Burnam MA, Rogers W, et al:The course of depression in adult outpatients. Results from the Medical Outcome Study. Arch Gen Psychiatry 49:788-794 (1992)

25) The WPA Dysthymia Working Group:Dysthymia in clinical practice. Br J Psychiatry 166:174-183 (1995)

P.421 掲載の参考文献

1) Caroll BJ, Feiberg M, Grenden JF, et al:A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry 38:15-22 (1981)

2) Coryell W, Winokur G, Keller M, et al:Alcoholism and primary depression;A family study approach to coexisting disorders. J Affect Disord 24:93-99 (1992)
pubmed

3) Goodwin FK, Jamison KR:Alcohol and drug abuse in manic-depressive illness. Manic Depressive Illness, pp 210-226, Oxford Univ Press (1990)

4) Grant BF, Harford TC:Comorbidity between DSM-IV alcohol use disorders and major depression;results of a national survey. Drug Alcohol Depend 39:197-206 (1995)
pubmed

5) Hasegawa K, Mukasa H, Nakazawa Y, et al:Primary and secondary depression in alcoholism-clinical features and family history. Drug Alcohol Depend 27:275-281 (1991)
pubmed

6) 広瀬徹也:躁うつ病とアルコール. 日ア精医誌1:35-41(1994)

7) Holsboer F, von Bardelben U, Buller R, et al:Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression;alcoholsm and panic disorder. Horm Metab Res 16(suppl):80-88(1987)

8) Imatoh N, Nakazawa Y, Ohshima H, et al:Circadian rhythm of REM sleep of chronic alcoholics during alcohol withdrawal. Drug Alcohol Depend 18:77-85 (1986)
pubmed

9) 上島国利:抗うつ薬の未来. 抗うつ薬の過去・現在・未来, 上島国利(編), pp 85-98, 星和書店, 東京(1992)

10) 加藤伸勝:アルコール依存症と感情障害. 日本臨床52(5):222-226(1994)

11) Kendler KS, Heath AC, Neale MC, et al:Alcoholism and major depression in women. A twin study of the causes of comorbidity. Arch Gen Psychiatry 50:690-698 (1993)
pubmed

12) Kodama H, Nakazawa Y, Kotorii T, et al:Biorhythm of core temperature in depressive and non-depressive alcoholics. Drug Alcohol Depend 21:1-6 (1988)
pubmed

13) Kripke DF, Mullaney DJ, Atkinson M, et al:Circadian rhythm disorders manic depressives. Biol Psychiatry 13:335-351 (1978)
pubmed

14) Kroll P, Palmer C, Greden J:The dexamethasone suppression test in patients with alcoholism. Biol Psychiatry 18:441-450 (1983)
pubmed

15) Kupfer DJ:REM latency;a psychobiologic marker for primary depressive disease. Biol Psychiatry 11:159-174 (1976)
pubmed

16) Merikangas KR, Leckman JF, Prusoff BA, et al:Familial transmission of depression and alcoholism. Arch Gen Psychiatry 42:367-372 (1985)
pubmed

17) 中村純, 内村直尚, 河村直樹ほか:アルコール症に引き続いて起こる二次性躁病は存在するか? 日ア精医誌2:99-104(1995)

18) 中沢洋一, 野中健作, 小鳥居湛ほか:二次性うつ病を発症した慢性アルコール症の1例. 臨精医17:485-493(1988)

19) Petty F:The depressed alcoholic-clinical features and medical management. Gen Hosp Psychiatry 14:258-264 (1992)
pubmed

20) Proto G, Barberi M, Bertilissi F:Pseudo-Cushing's syndrome;an example of alcohol-induced central disorder in corticotropin-releasing factor-ACTH release? Drug Alcohol Depend 16:111-115 (1985)

21) Rado S:The psychoanalysis of pharmacothymia (drug addiction). Psychoanal Quart 2:1-23 (1933)

22) Reich CH, Davis RK, Himmelhoch JM:Exessive alcohol use in manic-depressive illness. Am J Psychiatry 131:83-86 (1974)

23) Rounsaville BJ, Dolinsky ZS, Babor TF, et al:Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry 44:505-513 (1987)
pubmed

24) Schuckit MA, Pitts FN, Reich T, et al:Alcoholism;two types of alcoholism in women. Arch Gen Psychiatry 20:509-514 (1971)

25) 鈴木健二:アルコール性感情障害. アルコール臨床ハンドブック, 斎藤学, 高木敏(編), pp 292-299, 金剛出版, 東京(1982)

26) 高橋三郎, 大野裕, 染矢俊幸(訳):DSM-IV精神疾患の分類と診断の手引. pp85-96, 医学書院, 東京(1995)

27) 融道男, 中根允文, 小見山実(監訳):ICD-10精神および行動の障害. pp 81-91, 医学書院, 東京(1993)

28) 内村直尚, 中村純, 土山祐一郎ほか:振戦せん妄に対するmianserin高用量の治療および予防効果. 日ア精医誌1:85-93(1994)

29) Vogel GW, Vogel F, McAbee RS, et al:Improvement of depression by REM sleep deprivation. New findings and a theory. Arch Gen Psychiatry 37:247-253 (1980)

30) Winokur G:The division of depressive illness into depression spectrum disease and pure depressive disease. Int Pharmacopsychiatry 9:5-13 (1974)
pubmed

31) Winokur G, Coryell W:Familial alcoholism in primary unipolar major depressive disorder. Am J Psychiatry 148:184-188 (1991)
pubmed

P.436 掲載の参考文献

1) 藍沢鎮雄, 星野良一, 竹内龍雄ほか:不安神経症者の性格特徴について. 精神医学 27:287-293 (1985)

2) Albus M, Scheibe G:Outcome of panic disorder with or without concomitant depression;a 2-year prospective follow-up study. Am J Psychiatry 150:1878-1880 (1993)

3) Albus M, Scheibe G, Scherer J:Panic disorder with or without concomitant depression 5 years after treatment;a prospective follow-up. J Affect Disord 34:109-115 (1995)

4) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, 4th ed. ;DSM-IV. APA, Washington DC (1994)-高橋三郎, 大野裕, 染矢俊幸(訳):DSM-IV精神疾患の診断・統計マニュアル. 医学書院, 東京(1996)

5) Andrade L, Eaton WW, Chilcoat H:Lifetime comorbidity of panic attacks and major depression in a population-based study. Symptom profiles. Br J Psychiatry 165:363-369 (1994)

6) Angst J, Dobler-Mikola A:The Zurich Study. V. Anxiety and phobia in young adults. Eur Arch Psychiatr Neurol Sci 235:171-178 (1985)

7) Angst J, Vollrath M, Merikangas KR, et al:Comorbidity of anxiety and depression in the Zurich Cohort Study of young adults. Comorbidity of Mood and Anxiety Disorders, Maser JD, Cloninger CR(ed), pp 123-137, American Psychiatric Press, Washington DC (1990)

8) Ball SG, Buchwald AM, Waddell MT, et al:Depression and generalized anxiety symptoms in panic disorder;implications for comorbidity. J Nerv Ment Dis 183:304-308 (1995)
pubmed

9) Barrett JE, Barrett JA, Oxman TE, et al:The prevalence of psychiatric disorders in a primary care practice. Arch Gen Psychiatry 45:1100-1106 (1988)

10) Blazer D, Swartz M, Woodbury M, et al:Depressive symptoms and depressive diagnoses in a community population;use of a new procedure for analysis of psychiatric classification. Arch Gen Psychiatry 45:1078-1084 (1988)

11) Boulenger J-P, Lavallee Y-J:Mixed anxiety and depression;diagnostic issues. J Clin Psychiatry 54 (suppl):3-8 (1993)

12) Bowen RC, Kohout J:The relationship between agoraphobia and primary affective disorders. Can J Psychiatry 24:317-322 (1979)

13) Brawman-Mintzer O, Lydiard RB:Generalized anxiety disorder;issues in epidemiology. J Clin Psychiatry 57 (suppl 7):3-8 (1996)

14) Breier A, Charney DS, Heninger GR:Major depression in patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:1129-1135 (1984)
pubmed

15) Breier A, Charney DS, Heninger GR:The diagnostic validity of anxiety disorders and thier relationship to depressive illness. Am J Psychiatry 142:787-797 (1985)

16) Brown GW, Bifulco A, Harris TO:Life stress, chronic subclinical symptoms and vulnerability to clinical depression. J Affect Disord 11:1-9 (1986)

17) Buller R, Marier W, Benkert O:Clinical subtypes in panic disorder;their descriptive and prospective validity. J Affect Disord 11:105-114 (1986)

18) Cassano GB, Perugi G, Musetti L, et al:The nature of depression presenting concomitantly with panic disorder. Compr Psychiatry 30:473-482 (1989)
pubmed

19) Chen YW, Dilsaver SC:Comorbidity of panic disorder in bipolar illness;evidence from the Epidemiologic Catchment Area Survey. Am J Psychiatry 152:280-282 (1995)
pubmed

20) 千谷七郎:うつ病像の構造分析. 精神医学3:253-266(1961)

21) Clancy J, Noyes R Jr, Hoenk PR, et al:Secondary depression in anxiety neurosis. J Nerv Ment Dis 166:846-850 (1978)
pubmed

22) Clark DA, Beck AT, Beck JS:Symptom differences in major depression, dysthymia, panic disorder, and generalized anxiety disorder. Am J Psychiatry 151:205-209 (1994)
pubmed

23) Clark LA, Watson D:Tripartite model of allxiety and depression; psychometric evidence and taxonomic implications. J Abnorm Psychol 100:316-336 (1991)
pubmed

24) Clayton PJ:Anxious depression;A reemerging subtype of depression. Anxious Depression;Assessment and Treatment, Racagni G, Smeraldi E (ed), pp 1-5, Raven Press, New York (1987)

25) Clayton PJ, Grove WM, Coryell W, et al:Follow-up and family study of anxious depression. Am J Psychiatry 148:1512-1517 (1991)
pubmed

26) Coryell W, Noyes R, Clancy J:Excess mortality in panic disorder;a comparison with primary unipolar depression. Arch Gen Psychiatry 39:701-703 (1982)
pubmed

27) Coryell W, Endicott J, Andreasen NC, et al:Depression and panic attacks;the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry 145:293-300 (1988)
pubmed

28) Cox BJ, Direnfeld DM, Swinson RP, et al:Suicidal ideation and suicide attempts in panic disorder and social phobia. Am J Psychiatry 151:882-887 (1994)
pubmed

29) Crowe RR, Noyes R, Pauls DL, et al:A family study of panic disorder. Arch Gen Psychiatry 40:1065-1069 (1983)
pubmed

30) Dally PJ, Rohde P:Comparison of antidepressant drugs in depressive illnesses. Lancet i:18-20 (1961)
pubmed

31) Dealy RS, Ishiki DM, Avery DH, et al:Secondary depression in anxiety disorders. Compr Psychiatry 22:612-618 (1981)
pubmed

32) 傳田健三, 北川信樹, 嶋中昭二ほか:抑うつ状態を伴うpanic disorderの臨床的研究. 精神医学38:709-717(1996)

33) Dick CL, Bland RC, Newman SC:Panic disorder. Acta Psychiatr Scand Suppl 376:45-53 (1994)
pubmed

34) Donnelly EF, Murphy DL, Goodwin FK:Primary affective disorder;Anxiety in unipolar and bipolar depressed groups. J Clin Psychol 34:621-623 (1978)
pubmed

35) Downing RW, Rickels K:Mixed anxiety-depression;fact or myth? Arch Gen Psychiatry 30:312-317 (1974)
pubmed

36) Eaton WW, Dryman A, Sorenson A, et al:DSM-III major depressive disorder in the community;a latent class analysis of data from the NIMH Epidemiologic Catchment Area Programme. Br J Psychiatry 155:48-54 (1989)
pubmed

37) Fawcett J, Kravitz HM:Anxiety syndromes and their relationship to depressive illness. J Clin Psychiatry 44 (8, sec 2):8-11 (1983)

38) Freud S(加藤正明訳):「不安神経症」という特定症状群を神経衰弱から分離する由について. フロイト選集10, 改訂版, pp 1-32, 日本教文社, 東京(1969)

39) Friedman S, Jones JC, Chernen L, et al:Suicide ideation and suicide attempts among patients with panic disorder;a survey of two outpatient clinics. Am J Psychiatry 149:680-685 (1992)
pubmed

40) 藤井薫:Panic Disorderの薬物療法. 精神医学33:798-809(1991)

41) 古川壽亮:不安と抑うつ-測定と定義の問題. 不安の臨床, 清水將之(編), pp 63-81, 金剛出版, 東京(1994)

42) Garvey MJ, Tollefson GD, Tuason VB:Comparison of major depressions with and without panic attacks. Compr Psychiatry 28:65-67 (1987)
pubmed

43) Goldstein RB, Weissman MM, Adams PB, et al:Psychiatric disorders in relatives of probands with panic disorder and/or major depression. Arch Geii Psychiatry 51:383-394 (1994)
pubmed

44) Grunhaus L:Simultaneous panic and depressive disorders. Am J Psychiatry 142:1230-1231 (1985)
pubmed

45) Grunhaus L, Rabin D, Harel Y, et al:Simultaneous panic and depressive disorders;clinical and sleep EEG correlates. Psychiatr Res 17:251-259 (1986)

46) Grunhaus L, Harel Y, Krugler T, et al:Major depressive disorder and panic disorder;Effects of comorbidity on treatment outcome with antidepressant medications. Clin Neuropharmacol 11:454-461 (1988)
pubmed

47) Grunhaus L, Panda AC, Brown MB, et al:Clinical characteristics of patients with concurrent major depressive disorder and panic disorder. Am J Psychiatry 151:541-546 (1994)

48) Gurney C, Roth M, Garside RF, et al:Studies in the classification of affective disorders;the relationship between anxiety states and depressive illnesses, II. Br J Psychiatry 121:162-166 (1972)
pubmed

49) Hagnell O, Grasbeck A:Comorbidity of anxiety and depression in the Lundby 25-year prospective study;The pattern of subsequent episodes. Comorbidity of Mood and Anxiety Disorders, Maser JD, Cloninger CR (ed), pp 139-152 American Psychiatric Press, Washington DC (1990)

50) Halle MT, Dilsaver SC:Comorbid panic disorder in patients depression. Am J Psychiatry 150:1108-1110 (1993)
pubmed

51) Hamilton M:Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry 154:201-206 (1989)
pubmed

52) Henriksson MM, Isometsa ET, Kuoppasalmi KI, et al:Panic disorder in completed suicide. J Clin Psychiatry 57:275-281 (1996)
pubmed

53) Hiller W, Zaudig M, v Bose M:The overlap between depression and anxiety on different levels of psychopathology. J Affect Disord 16:223-231 (1989)

54) 広瀬徹也:不安と抑うつ-"不安発作・抑制型"うつ病をめぐって. 躁うつ病の精神病理3, 飯田眞(編), pp 79-105, 弘文堂, 東京(1979)

55) 堀川直史, 山崎友子, 小川雅美ほか:うつ病と神経症症状. 精神科治療学5:523-531 (1990)

56) Hornig CD, McNally RJ:Panic disorder and suicide attempt;a reanalysis of data from the Epidemiologic Cathment Area study. Br J Psychiatric 167:76-79 (1995)

57) 市川潤, 迎豊:うつ病, 精神病理学的側面. 現代精神医学大系, 懸田克躬ほか(編), 第9巻A躁うつ病I, pp 199-232, 中山書店, 東京(1979)

58) Johnson J, Weissman MM, Klerman GL:Panic disorder, comorbidity, and suicide attempts. Arch Gen Psychiatry 47:805-808 (1990)
pubmed

59) Judd FK, Burrows GD:Anxiety disorders and their relationship to depression. Handbook of Affective Disorders, 2nd ed. Paykel ES (ed), pp 77-87, Churchill Livingstone, Edinburgh (1992)

60) 笠原嘉, 木村敏:うつ状態の臨床的分類に関する研究. 精神経誌77:715-735 (1975)

61) 笠原嘉:軽症うつ病-「ゆううつ」の精神病理. 講談社, 東京(1996)

62) Keller MB, Lavori PW, Goldenberg IM, et al:Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord 28127-38 (1993)

63) Kendell RE:The stability of psychiatric diagnoses. Br J Psychiatry 124:352-356 (1974)
pubmed

64) Kerr TA, Roth M, Schapira K, et al:The assessment and prediction of outcome in affective disorders. Br J Psychiatry 121:167-174 (1972)
pubmed

65) Kessler RC, McGonagle KA, Zhao S, et al:Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19 (1994)
pubmed

66) Kessler RC, Nelson CB, McGonagle KA, et al:Comorbidity of DSM-III-R major depressive disorder in the general population;results from the US National Comorbidity Survey. Br J Psychiatry 168 (suppl 30):17-30 (1996)

67) Leckman JF, Weissman MM, Merikangas KR, et al:Panic disorder and major depression;Increased risk of depression, alcoholism, panic, and phobic disorders in families of depressed probands with panic disorder. Arch Gen Psychiatry 40:1055-1060 (1983)
pubmed

68) Lesser IM, Rubin RT, Pecknold JC, et al:Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment. Arch Gen Psychiatry 45:437-443 (1988)
pubmed

69) Liebowitz MR:Depression with anxiety and atypical depression. J Clin Psychia-try 54 (suppl):10-14 (1993)

70) Lydiard RB:Coexisting depression and anxiety;special diagnostic and treatment issues. J Clin Psychiatry 51 (suppl):48-54 (1991)

71) Mapother E:Discussion on manic-depressive psychosis. Br Med J ii:872-879 (1926)

72) Markowitz JS, Weissman MM, Ouellette R, et al:Quality of life in panic disorder. Arch Gen Psychiatry 46:984-992 (1989)
pubmed

73) Marriott PF, Greenwood KM, Armstrong SM:Seasonality in panic disorder. J Affect Disord 31:75-80 (1994)
pubmed

74) Mendels J, Weinstein N, Cochrane C, et al:The relationship between depression and anxiety. Arch Gen Psychiatry 27:649-653 (1972)
pubmed

75) 宮前文彦, 横山茂生, 渡辺昌祐:「不安発作-抑制型」うつ病の2例. 川崎医学会誌10:238-243(1984)

76) Mountjoy CQ, Roth M:Studies in the relationship between depressive disorders and anxiety states. Part 1. Rating scales. J Affect Disord 4:127-147 (1982)

77) Mountjoy CQ, Roth M:Studies in the relationship between depressive disorders and anxiety states. Part 2. Clinical items. J Affect Disord 4:149-161 (1982)
pubmed

78) Munjack DJ, Moss HB:Affective disorder and alcoholism in families of agoraphobics. Arch Gen Psychiatry 38:869-871 (1981)
pubmed

79) Murphy JM, Sobol AM, Olivier DC, et al:Prodromes of depression and anxiety; The Stirling County Study. Br J Psychiatry 155:490-495 (1989)
pubmed

80) Nagy LM, Krystal JH, Charney DS, et al:Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment;2. 9-year naturalistic follow-up study. J Clin Psychopharmacol 13:16-24 (1993)
pubmed

81) 中村勇二郎:不安とうつの精神病理学-メランコリー親和型性格にみられる不安とうつ. 精神医学29:137-145(1987)

82) 二宮英彰, 佐藤栄剛, 鬼塚俊明ほか:恐慌性障害患者における不安と抑うつの併存と薬物に対する反応. 九州神精医42:194-201(1996)

83) Noyes R Jr, Clancy J, Hoenk PR, et al:The prognosis of anxiety neurosis. Arch Gen Psychiatry 37:173-178 (1980)
pubmed

84) Noyes R Jr, Crowe RR, Harris EL, et al:Relationship between panic disorder and agoraphobia;a family study. Arch Gen Psychiatry 43:227-232 (1986)
pubmed

85) Noyes R Jr, Reich J, Christiansen J, et al:Outcome of panic disorder;relationship to diagnostic subtypes and comorbidity. Arch Gen Psychiatry 47:809-818 (1990)
pubmed

86) Noyes R, Clancy J, Woodman C, et al:Environmental factors related to the outcome of panic disorder;A seven-year follow-up study. J Nerv Ment Dis 181:529-538 (1993)

87) Nutzinger DO, Zapotoczky HG:The influence of depression on the outcome of cardiac phobia (panic disorder). Psychopathology 18:155-162 (1985)
pubmed

88) Paykel ES:Classification of depressed patients;a cluster analysis derived grouping. Br J Psychiatry 118:275-288 (1971)
pubmed

89) Rabkin JD, Stewart JW, Quitkin FM, et al:Should atypical depression be included in DSM-IV? DSM-IV Sourcebook, Vol 2, Widiber TA, et al(ed), pp 239-260, APA, Washington DC (1996)

90) Raskin M, Peeke HVS, Dickman W, et al:Panic and generalized anxiety disorders. Developmental antecedents and precipitants. Arch Gen Psychiatry 39:687-689 (1982)

91) Raskin A:Role of depression in the antipanic effects of antidepressant drugs. Clinical Aspects of Panic Disorder, Ballenger JC (ed), pp 169-180, Wiley-Liss, New York (1990)

92) Reich J:Distinguishing mixed anxiety/depression from anxiety and depressive groups using the family history method. Compr Psychiatry 34:285-290 (1993)
pubmed

93) Roth M, Gurney C, Garside RF, et al:Studies in the classification of affective disorders;the relationship between anxiety states and depressive illnesses, I. Br J Psychiatry 121:147-161 (1972)
pubmed

94) Roth M, Mountjoy CQ:The distinction between anxiety states and depressive disorders. Handbook of Affective Disorders, Paykel ES (ed), pp 70-92, Chur-chill Livingstone, Edinburgh (1982)

95) Rudd MD, Dahm PF, Rajab MH:Diagnostic comorbidity in persons with suicidal ideation and behavior. Am J Psychiatry 150:928-934 (1993)
pubmed

96) 坂本暢典:Panic disorderとうつ病のco-morbidity(合併)に対する治療的反応について. 精神科治療学8:649-656(1993)

97) 坂上紀幸, 八島章太郎, 鑑江真二郎ほか:双極性障害に合併するパニック発作. 第93回日本精神神経学会総会プログラム・抄録集, pp 99(1997)

98) Sanderson WC, DiNardo PA, Rapee RM, et al:Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. J Abnorm Psychol 99:308-312 (1990)
pubmed

99) Sanderson WC, Beck AT, Beck J:Syndrome comorbidity in patients with major depression or dysthymia;prevalence and temporal relationships. Am J Psychiatry 147:1025-1028 (1990)
pubmed

100) Sartorius N, Ustun TB, Lecrubier Y, et al:Depression comorbid with anxiety; results from the WHO study on psychological disorders in primary health care. Br J Psychiatry 168 (suppl 30):38-43 (1996)

101) Savino M, Perugi G, Simonini E, et al:Affective comorbidity in panic disorder; Is there a bipolar colmection? J Affect Disord 28:155-163(1993)

102) Schapira K, Roth M, Kerr TA, et al:The prognosis of affective disorders;The differentiation of anxiety states from depressive illness. Br J Psychiatry 121:175-181 (1972)

103) Schneider K:Klinische Psychopathologie. Thieme, Stuttgart (1962)-平井静也, 鹿子木敏範(訳):臨床精神病理学. 文光堂, 東京(1975)

104) Spaner D, Bland RC, Newman SC:Major depressive disorder. Acta Psychiatr Scand (suppl 376):7-15 (1994)
pubmed

105) Stahl SM:Mixed anxiety and depression;clinical implications. J Clin Psychia try 54 (suppl):33-38 (1993)

106) Stavrakaki C, Vargo B:The relationship of anxiety and depression;a review of the literature. Br J Psychiatry 149:7-16 (1986)
pubmed

107) Stein MB, Shea CA, Uhde TW:Social phobic symptoms in patients with panic disorder;practical and theoretical implications. Am J Psychiatry 146:235-238 (1989)
pubmed

108) Stein MB, Tancer ME, Uhde TW:Major depression in patients with panic disorder;factors associated with course and recurrence. J Affect Disord 19:287 296 (1990)

109) 杉原徳郎, 岸本朗, 水川六郎ほか:恐慌発作を有するうつ病の臨床的検討. 精神医学30:507-516(1988)

110) 高橋徹:不安神経症-パニック障害とその周辺. 改訂第2版, 金原出版, 東京(1992)

111) 竹内龍雄, 林竜介, 冨山學人ほか:不安神経症の慢性期病像について. 精神医学30:105-107 (1988)

112) 竹内龍雄, 林竜介, 冨山學人ほか:Panic disorder-4類型化の試み. 精神医学32:957-962 (1990)

113) 竹内龍雄, 池田政俊, 林竜介ほか:Panic Disorderの薬物療法の検討-抗うつ薬と抗不安薬療法の特徴を中心に. 心身医療3:241-247(1991)

114) Torgersen S:Genetic aspects of mixed anxiety-depressive disorders. Anxious Depression;Assessment and Treatment, Racagni G, Smeraldi E (ed), pp 89-93, Raven Press, New York (1987)

115) Torgersen S:A twin-study perspective of the comorbidity of anxiety and depression. Comorbidity of Mood and Anxiety Disorders, Maser JD, Cloninger CR (ed), pp 367-378, American Psychiatric Press, Washington DC (1990)

116) Uhde TW, Boulenger J-P, Roy-Byrne PP, et al:Longitudinal course of panic disorder;clinical and biological considerations. Prog Neuro-Psychopharmacol Biol Psychiatry 9:39-51 (1985)

117) Van Valkenburg C, Akiskal HS, Puzantian V, et al:Anxious depressions; clinical, family history, and naturalistic outcome-comparisons with panic and major depressive disorders. J Affect Disord 6:67-82 (1984)
pubmed

118) Voll Korff M, Shapiro S, Burke JD, et al:Anxiety and depression in a primary care clinic;comparison of diagnostic interview schedule, general health questionnaire, and practitioner assessments. Arch Gen Psychiatry 44:152-156 (1987)

119) Weissman MM, Klerman GL, Markowitz JS, et al:Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med 321:1209-1214 (1989)
pubmed

120) Weissman MM, Wickramaratne P, Adams PB, et al:The relationship between panic disorder and major depression;a new family study. Arch Gen Psychiatry 50:767-780 (1993)
pubmed

121) West ED, Dally PJ:Effect of iproniazid in depressive syndromes. Br Med J 1:1491-1494 (1959)
pubmed

122) Wittchen H-U, Essau CA, Krieg JC:Anxiety disorders;similarities and differences of comorbidity in treated and untreated groups. Br J Psychiatry 159 (suppl 12):23-33 (1991)

123) Wittchen HU, Essau CA:Comorbidity and mixed anxiety-depressive disorders; is there epidemiologic evidence? J Clin Psychiatry 54 (suppl):9-15 (1993)

124) Wittchen H-U:Critical issues in the evaluation of comorbidity of psychiatric disorders. Br J Psychiatry 168 (suppl 30):9-16 (1996)

125) Woodruff RA, Guze SB, Clayton PJ:Anxiety neurosis among Psychiatric outpatients. Compr Psychiatry 13:165-170 (1972)
pubmed

126) World Health Organization:The ICD-10 Classification of Mental and Behavioural Disorders;Clinical descriptions and diagnostic guidelines. WHO, Geneva (1992)-融道男, 中根允文, 小見山実(監訳):ICD-10精神および行動の障害-臨床記述と診断ガイドライン. 医学書院, 東京(1993)

127) Wu LH, Dunner DL:Suicide attempts in rapid cycling bipolar disorder patients. J Affect Disord 29:57-61 (1993)
pubmed

128) 山田久美子, 児島克博, 藤井薫:Panic disorderと二次性うつ病. 九州神精医 37:38-42 (1991)

129) 横山知行, 佐藤新, 飯田眞:不安の臨床遺伝学. 臨床精神医学21:519-526 (1992)

130) Zinbarg RE, Barlow DH, Liebowitz M, et al:The DSM-IV field trial for mixed anxiety-depression. Am J Psychiatry 151:1153-1162 (1994)
pubmed

P.454 掲載の参考文献

1) Akiskal HS:Subaffective disorders;Dysthymic, cyclothymic and bipolar II disorders in the"Borderline"realm. Psychiatr Clin North Am 4:25-46(1981)

2) Akiskal HS, Walker P, Puzantian VR, et al:Bipolar outcome in the course of depressive illness;Phenomenologic, familial, and pharmacologic predictors. J Affect Disord 5:115-128 (1983)
pubmed

3) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders(4th ed). APA, Washington DC(1994)-高橋三郎ほか(訳):DSM-IV 精神疾患の分類と診断の手引. 医学書院, 東京(1995)

4) Black DW, Bell S, Hulbert I, et al:The importance of axis II in patients with major depression;A controlled study. J Affect Disord 14:115-122(1988)

5) Bolton S, Gunders on JG:Distinguishing borderline personality disorder from bipolar disorder;Differential diagnosis and implications. Am J Psychiatry 153:1202-1207 (1996)

6) Corbitt EM, Malone EM, Haas GL, et al:Suicidal behavior in patients with major depression and comorbid personality disorders. J Affect Disord 39:61-72 (1996)

7) Fava M, Alpert JE, Borus JS, et al:Patterns of personality disorder comorbidity in early-onset versus late-onset major depression. Am J Psychiatry 153:1308-1312 (1996)
pubmed

8) Figueroa EF, Silk KR, Huth A, et al:History of childhood sexual abuse and general psychopathology. Compr Psychiatry 38(1):23-30(1997)

9) Friedman RC, Aronoff MS, Clarkin JF, et al:History of suicidal behavior in depressed borderline inpatients. Am J Psychiatry 140:1023-1026(

10) Grinker RR, Werble B:The Borderline Patient. Jason Aronson, New York (1967)

11) Gunderson JG, Kolb JE, Austin V:The diagnostic interview for borderline patients. Am J Psychiatry 138:896-903(1981)

12) Gunderson JG, Kolb JE:Discriminating features of borderline patients. Am J Psychiatry 135:792-796 (1978)
pubmed

13) Gunderson JG, Elliott GR:The interface between borderline personality disorder and affective disorder. Am J Psychiatry 142:277-288(1985)

14) Gunderson JG, Phillips KA:A current view of the interface between borderline personality disorder and depression. Am J Psychiatry 148:967-975(1991)

15) Gunderson JG, Sabo AN:The phenomenological and conceptual interface between borderline personality disorder and PTSD. Am J Psychiatry 150:19-27 (1993)

16) Herman JL, Perry JC, van der Kolk B:Childhood trauma in borderline personality disorder. Am J Psychiatry 148:490-495(1989)

17) Herman JL:Trauma and Recovery. Basic Books, New York(1992)-中井久夫(訳):心的外傷と回復. みすず書房, 東京(1996)

18) 生田憲正:摂食障害入院治療の諸原則;境界パーソナリティ障害合併症例の長期入院治療. 精神科治療学8(3):285-291(1993)

19) Kutcher SP, Marton P, Korenblum M:Adolescent bipolar illness and personality disorder. J Am Acad Child Adolesc Psychiatry 29(3):355-358(1990)

20) Links PS, Hesiegrave RJ, Mitton JE:Borderline psychopathology and recurrence of clinical features. J Nerv Ment Dis 183(9):582-586(1995)

21) Masterson JF:Treatment of the Borderline Adolescent;A developmental approach. Wiley&Sons, New York(1972)-成田善弘, 笠原嘉(訳):青年期境界例の治療. 金剛出版, 東京(1979)

22) McGlashan TH:Borderline personality disorder and unipolar affective disorder; Longterm effects of comorbidity. J Nerv Ment Dis 175(8):467-473 (1987)
pubmed

23) 皆川邦直, 三宅由子(編):境界例. 医学書院, 東京(1993)

24) 守屋直樹:境界パーソナリティ障害と抑うつ. 精神科治療学2(3):389-400(1987)

25) 守屋直樹:感情障害と境界パーソナリティに関する臨床的研究. 慶応医学67(2):407-419 (1990)

26) 守屋直樹, 生田憲正, 村上健ほか:青年期境界例の長期経過. 思春期青年期精神医学7(2):155-161(1997)

27) Moriya N, Miyake Y, Minakawa K, et al:Diagnosis and clinical features of borderline personality disorder in the East and West;A preliminary report. Compr Psychiatry 34(6):418-423 (1993)

28) 中尾和久, 頼藤和寛:境界性人格障害の薬物療法と精神療法的対応. 思春期青年期精神医学6(2):107-125(1996)

29) Nishizonomaher A, Ikuta N, Ogiso Y, et al:Psychotic symptom in depression and borderline personality disorder. J Affect Disord 28:279-285(1993)

30) Pinto A, Grapentine WL, Francis G, et al:Borderline personality disorder in adolescents;Affective and cognitive features. J Am Acad Child Adolesc Psychiatry 34(10):1338-1343 (1996)

31) Pope HG, Jonas JM, Hudson JI, et al:The validity of DSM-III borderline personality disorder;A phenomenologic, family history, treatment response, and long-term follo-up study. Arch Gen Psychiatry 40:23-30(1983)

32) Rogers JH, Widiger TA, Krupp A:Aspects of depression associated with borderline personality disorder. Am J Psychiatry 152:268-270(1995)

33) Shea MT, Glass DR, Pilkonis PA, et al:Frequency and implication of personality disorders in a sample of depressed out-patients. J Pers Disord 1:27-42 (1987)

34) Soloff PH, George A, Nathan S, et al:Progress in pharmacotherapy of borderline disorders;A double-blind study of amitriptyline, haloperidol, and placebo. Arch Gen Psychiatry 43:691-697(1986)

35) Southwick SM, Yehuda R, Giller EL:Psychological dimensions of depression in borderline personality disorder. Am J Psychiatry 152:789-791(1995)

36) Torgersen S:Genetic and nosological aspects of schizotypal and borderline personality disorders;A twin study. Arch Gen Psychiatry 41:546-554(1984)

37) Westen D, Moses MJ, Silk KR, et al:Quality of depressive experience in borderline personality disorder and major depression;When depression is not just depression. J Pers Disord 6:382-393(1992

P.466 掲載の参考文献

1) Buckman MT, Kellner R:Reduction of distress in hyperprolactinemia with bromocriptine. Am J Psychiatry 142:242-244 (1985)
pubmed

2) Cleare AJ, McGregor A, Chambers SM:Thyroxine replacement increases central 5-hydroxytryptamine activity and reduces depressive symptoms in hypothyroidism. Neuroendocrinology 64:65-69 (1996)
pubmed

3) Cohen S, Herbert TB:Health psychology;Psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annu Rev Psychol 113-142 (1996)
pubmed

4) Dietch JT, Zetin M:Diagnosis of organic depressive disorders. Psychosomatics 24:971-979 (1983)
pubmed

5) Dowson DM, Sabin TD:Chronic Fatigue Syndrome. pp 1-218, Little Brown, Boston (1993)

6) Fava GA, Sonino N, Morphy MA:Major depression associated with endocrine disease. Psychiatr Dev 4:321-348 (1987)
pubmed

7) Filley CM, Kleinschmidt-DeMasters BK:Neurobehavioral presentation of brain neoplasms. West J Med 163:19-25 (1995)

8) Fitzgera M, Malone KM, Li SH, et al:Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. Am J Psychiatry 154:556-558 (1997)

9) Franco-Bronson K:The management of treatment-resistant depression in the medical ill. Psychiatr Clin North Am 19:329-350 (1996)

10) Goodnick PJ, Henry JH, Buki VMV:Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 56:128-136 (1995)

11) Haggerty JJ, Prange AJ Jr:Borderline hypothyroidism and depression. Ann Rev Med 46:37-46 (1995)
pubmed

12) Hamilton JA, Harberger PN (ed):Postpartum Psychiatric Illness. pp 1-361, Univ Pennsylvania Press, Philadelphia (1992)

13) Joffe RT, Rubinow DR, Denicoff KD, et al:Depression and carcinoma of the pancreas. Gen Hosp Psychiatry 8:241-245 (1986)
pubmed

14) Kellner R, Buckman MT, Fava GA, et al:Hyperprolactinemia, distress, and hostility. Am J Psychiatry 141:759-763 (1984)
pubmed

15) Kelly WF, Kelly MJ, Faragher B:A prospective study of psychiatric and psychological aspects of Cushing's syndrome. Clin Endocrinol 45:715-720 (1996)
pubmed

16) Lampl Y, Barak Y, Achiron A, et al:Intracranial meningiomas;Correlation of peritumoral edema and psychiatric disturbances. Psychiatry Res 58:177-180 (1995)
pubmed

17) Logsdon RG, Teri L:Depression in Alzheimer's disease patients;Caregivers as surrogate reporters. J Am Geriatr Soc 43:150-155 (1995)
pubmed

18) Luban-Plozza B, Poldinger W, Kroger F:Psychosomatic Disorders in General Practice, 3rd ed. pp 1-255, Springer-Verlag, Berlin (1992)

19) Massie MJ, Gagnon P, Holland JC:Depression and suicide in patients with cancer. J Pain Sympom Manage 9:325-340 (1994)

20) Mayne TJ, Vittinghoff E, Chesney MA, et al:Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med 156:2233-2238 (1996)
pubmed

21) McDaniel JS, Musselman DL, Porter MR, et al:Depression in patients with cancer;Diagnosis, biology, and treatment. Arch Gen Psychiatry 52:89-99 (1995)
pubmed

22) Morton MV, Wehman P:Psychosocial and emotional sequelae of individuals with traumatic brain injury. Brain Inj 9:81-92 (1995)
pubmed

23) Nakagawara M, Witzke W, Matussek N:Hypertension and depression. Psychiatry Res 21:85-86 (1987)
pubmed

24) 中河原通夫:他の精神神経疾患とうつ病. うつ病, 広瀬徹也(編), pp197-218, 同朋舎出版, 東京(1990)

25) 中河原通夫:産褥期精神病の情動障害. 神精薬理14:283-291(1992)

26) 中河原通夫:精神科治療薬の上手な使い方. pp 1-206, 金剛出版, 東京(1995)

27) 中河原通夫:新版こころの治療薬. pp 1-262, 弘文堂, 東京(1996)

28) 中河原通夫:甲状腺機能亢進症・低下症. 今日の精神科治療指針, 大原健士郎, 広瀬徹也(監修), pp 170-171, 星和書店, 東京(1997)

29) Noble P:Depressive illness and hyperparathyroidism. Proc Roy Soc Med 67:1066-1067 (1974)
pubmed

30) Pearlstein TB:Hormone and depression;What are the facts about premenstrualsyndrome, menopause, and hormone replacement therapy? Am J Obstet Gynecol 173:646-653 (1995)
pubmed

31) Orth DN:Cushing's syndrome. N Engl J Med 332:791-803 (1995)
pubmed

32) Palmer FJ:The clinical manifestations of primary hyperparathyroidism. Compr Ther 9:56-64 (1983)
pubmed

33) Rodin G, Voshart K:Depression in the medically ill;An overview. Am J Psychiatry 143:696-705 (1986)
pubmed

34) Scott TF, Allen D, Price TR, et al:Characterization of major depression symptoms in multiple sclerosis. J Neuropsychiatry Clin Neurosci 8:318-323 (1996)
pubmed

35) Shafran SD:The chronic fatigue syndrome. Am J Med 90:730-739 (1991)
pubmed

36) Sensky T, Leger C, Gilmour S:Psychosocial and cognitive factors associated with adherence to fluid restriction regimens by people on chronic haemodialysis. Psychother Psychosom 65:36-42 (1996)
pubmed

37) Starkstein SE, Berthier ML, Bolduc PL, et al:Depression in patients with early versus late onset of Parkinson's disease. Neurology 39:1441-1445 (1989)
pubmed

38) Starkstein SE, Obinson RG:Affective disorders and cerebral vascular disease. Br J Psychiatry 154:170-182 (1989)

39) Starkstein SE, Mayberg HS, Leiguarda R, et al:A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 55:377-382 (1992)
pubmed

40) Steinlin MI, Blaser SI, Gilday DL:Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol 13:191-197 (1995)
pubmed

41) Surwit RS, Schneider MS:Role of stress in the etiology and treatment of diabetes mellitus. Psychosom Med 55:380-393 (1993)
pubmed

42) Tueth MJ:How to manage depression and psychosis in Alzheimer's disease. Geriatrics 50:43-46 (1995)
pubmed

43) Winokur A, Maislin G, Phillips JL, et al:Insulin resistance after oral glucose tolerance testing in patient with major depression. Am J Psychiatry 145:325-330 (1988)
pubmed

P.481 掲載の参考文献

1) Buhler C:The course of human life as a psychological problem. Hum Development 11:184-200 (1968)
pubmed

2) Colarusso CA, Nemiroff RA:Adult Development-A New Dimension in Psychodynamic Theory and Practice. Plenum Press, New York (1981)

3) Ellenberger HF:The Discovery of the Unconscious. Basic Books, New York (1970)-木村敏, 中井久夫(訳):無意識の発見. 弘文堂, 東京(1980)

4) Erikson EH:Identity and the Life Cycle. International Univ Press, New York (1950)-小此木啓吾(訳):自我同一性. 誠信書房, 東京(1973)

5) Freud S:Drei Abhandlung zur Sexualtheorie. (1905)-懸田克躬, 高橋義孝 (訳):フロイト著作集5, 性欲論・症例研究. 人文書院, 京都(1969)

6) Goth N, Spate HF:Leistungsversagen im mittleren Lebensalter-Aufgabe Kunftiger Forschung. Psychiatr Neurol Med Psychol 38(4):207-214 (1986)
pubmed

7) Grassler VW:Zu Besonderheiten der Depressivitat im mittleren Lebensalter. Z Gesamte Med 21 (Jahrg 44):646-649 (1989)

8) 橋本雅雄:中年期(Middle Adulthood)の発達課題と精神療法;早期幼児期と青年期の再構成. 精神分析研究27(3):127-135 (1983)

9) 広瀬徹也(編):うつ病. 同朋舎出版, 京都(1990)

10) Howells JG (ed):Modern Perspectives in the Psychiatry of Middle Age. Brunner/Mazel, New York (1981)

11) 飯田真:中年期の精神医学. 医学書院, 東京(1990)

12) 飯田真, 吉松和哉, 町沢静夫(編):中年期の心の危機. 有斐閣, 東京(1986)

13) 池田由子:妻が危ない-主婦の精神衛生相談. 弘文堂, 東京(1984)

14) Jaques E:Death and mid-life crisis. Int J Psychoanal 46:502-514 (1965)
pubmed

15) Jung CG:Uber die Psychologie des Unbewussten. ZUrich (1916)高橋義孝 (訳):無意識の心理. 人文書院, 東京(1980)

16) Jung CG:Seele und Tod. Zurich (1934) 江野専次郎(訳):こころの構造. ユング著作集3, 日本教文社, 東京(1979)

17) Klein M:Some theoretical conclusions regarding the emotional life of the infant. Developments in Psychoanalysis, Hogarth Press, London (1952)

18) Kraus A:Sozialverhalten und Psycose Manisch-Depressiver-Eine exisitenzund rollenanalytische Untersuchung. Ferdinand Enke Verlag, Stuttgart (1977)-岡本進(訳):躁うつ病と対人行動-実存分析と役割分析. みすず書房, 東京(1983)

19) Levinson DL:The Seasons of a Man's Life. Alfred A Knoff, New York (1978)

20) 円より子:主婦症候群. 文化出版局, 東京(1982)

21) 南博文, やまだようこ(責任編集):講座生涯発達心理学5. 老いることの意味中年・老年期. 金子書房, 東京(1995)

22) 中脩三:初老期憂鬱症(宿題報告). 神経誌34:655-680 (1932)

23) Neugarten BL:Time, age and life cycle. Am J Psychiatry 136(7):887-894 (1979)
pubmed

24) Neugarten BL, Datan N:The middle years. American Handbook of Psychiatry, 2nd ed. Vol 1, Arieti S (ed), Basic Book, New York (1974)

25) Norman WH, Scaramella TJ (ed):Mid Life-Developmental and Clinical Issues. Brunner/Mazel, New York (1980)

26) 小木曽英一(監修), 生命保険文化センター(編):'80年代女性の生活-現在と将来, 日本放送出版協会, 東京(1983)

27) 小此木啓吾:モラトリアム人間の時代. 中央公論社, 東京(1978)

28) 小此木啓吾:中年の危機. 精神の科学6, ライフサイクル, 岩波書店, 東京(1983)

29) 奥村幸夫:高齢者の精神的危機と病態. 星和書店, 東京(1985)

30) 小野博行, 丸田伯子, 松浪克文:中年の抑うつ. こころの科学50:51-58 (1993)

31) 大森健一:ライフサイクルにおけるうつ状態-中高年. 現代精神医学大系, 年刊版'88-B, pp 33-51, 中山書店, 東京(1988)

32) Pollock GH:Mourning and adaptation. Int J Psychoanal 42(4-5):341-361 (1961)

33) 下田光造:躁鬱病の病前性格に就いて-丸井教授の質疑に対して. 精神経誌45:101-102 (1941)

34) 下田光造:躁うつ病に就いて. 米子医誌2:1-2 (1950)

35) 巽信夫:自己創造過程としての中年危機-遷延性うつ病者に対する内観療法の経験から. 精神科治療学12:1213-1218 (1997)

36) Tellenbach H:Melancholie. Springer-Verlag, Berlin, Heiderberg (1961)木村敏(訳):メランコリー. みすず書房, 東京(1978)

37) 矢野喜夫, 落合正行:発達心理学への招待. サイエンス社, 東京(1991)

38) 吉松和哉:精神分裂病の発病・再発状況-"適応"の観点から. 分裂病の精神病理 11, 吉松和哉(編), pp 1-28, 東京大学出版会, 東京(1982)

39) Yoshimatsu K:Suicide in Japan from the viewpoint of social psychiatry. Proceeding of the Second Cultural Psychiatric Symposium Between Korea and Japan, Suicide in Korea and Japan, pp 37-61 (1988)

40) 吉松和哉(編):中年期のこころ. こころの科学39 (1991)

41) Yoshimatsu K:Suicidal Behaviour in Japan. Suicidal Behaviour in the Asia-Pacific Region, Peng KL, Tseng WS (ed), pp 15-40, Singapore Univ Press, Singapore (1992)

42) 吉松和哉:精神分裂病者の入院治療-すべてのスタッフのために. 第2版, 医学書院, 東京(1993)

43) 吉松和哉, 三宅由子, 尾崎新ほか:現代中年男性世代の生活意識と戦争体験. 社会精神医学9:66-73 (1986)

44) 吉松和哉, 箕口雅博, 三宅由子ほか:性格傾向の世代間相違について-「うつ病親和性性格傾向尺度」 (DRP) を用いて. 社会精神医学12:90-97 (1989)

45) 湯沢千尋:中年危機的心性を伴ううつ病について. 精神経誌84:412-423 (1982)

P.498 掲載の参考文献

1) Abas MA, Sahakian BJ, Levy R:Neuropsychological deficits and CT scan changes in elderly depressive. Psychol Med 20:507-520 (1990)
pubmed

2) Alexopoulos GS, Young RC, Shindledecker RD:Brain computed tomography findings in geriatric depression and primary degenerative dementia. Biol Psychiatry 31:591-599 (1992)
pubmed

3) Allen NHP, Burns A:The non-cognitive features of dementia. Rev Clin Gerontol 5:57-75 (1995)

4) Barldwin RC:Antidepressants in geriatric depression;what difference have they made? Int Psychogeriatr 7 (suppl):55-68 (1995)

5) Barldwin RC, Jolley DJ:The prognosis of depression in lid age. Br J psychiatry 149:574-583 (1986)

6) Bench CJ, Friston KJ, Brown RG, et al:The anatomy of depression-focal abnormalities of cerebral blood flow in major depression. Psychol Med 22:607-615 (1992)
pubmed

7) Bernstein JG:Handbook of Drug Therapy in Psychiatry. John Wright, Bristol (1983)

8) Blazer D, Williams CV:Epidemiology of dysphoria and depression in an elderly population. Am J Psychiatry 137:439-444 (1980)

9) Bonner D, Howard R:Treatment-resistant depression in the elderly. Int Psychogeriatr 7 (suppl):83-94 (1995)

10) Brodaty H, Peters K, Boyce P, et al:Age and depression. Affect Disord 23:137-149 (1991)
pubmed

11) Brown GW, Harris TO:The Social Origins of Depression. Tavistock, London (1978)

12) Conwell Y, Nelson JC, Kim KM, et al:Depression in late life;age of onset as marker of subtype. J Affect Disord 17:189-195 (1989)
pubmed

13) Copeland JRM, Dewey ME, Wood N, et al:Range of mental illness among the elderly in the community;prevalence in Liverpool using the GMS-AGECAT package. Br J Psychiatry 150:815-823 (1987)

14) Dolan RJ, Bench CJ, Brown RG, et al:Regional cerebral blood flow abnormalities in depressed patients with cognitive impairrnent. J Neurol Neurosurg Psychiatry 55:768-773 (1992)
pubmed

15) Gurland BJ:The comparative frequency of depression in various adult age group. J Gerontol 31:283-292 (1976)
pubmed

16) Harris D:The Myth and Reality of Aging in America. The National Council on Aging Inc, Washington DC (1975)

17) Hopkinson G:A genetic study of affective illness inpatients over 50. Br J Psychiatry 110:244-254 (1964)

18) Jacoby RJ, Levy R:Computed tomography in the elderly 3;Affective disorder. Br J Psychiatry 136:270-275 (1980)
pubmed

19) 笠原洋勇, 本間正一:老年期うつ病を考える-薬物療法のガイドライン. 老年精神医学雑誌4:856-864 (1993)

20) Kivela SL, Pahkala K:Delusional depression in the elderly;a community study. Z Gerontol 22:236-241 (1989)
pubmed

21) Kivela SL, Pahkala K, Laippala P:Prevalence of depression in an elderly Finnish population. Acta Psychiatr Scand 78:401-413 (1988)

22) Kivela SL, Pahkala K, Eronen P:Depressive symptoms and sign that differentiate major and atypical depression from dysthymic disorder in elderly Finns. Int J Geriatr Psychiatry 4:79-85 (1989)

23) Kivela SL:Long-term prognosis of major depression in old age;A comparison with prognosis of dysthymic disorder. Int Psychogeriatr 7 (suppl):69-82 (1995)

24) Kral VA, Emery OB:Long-term follow-up of depressive pseudodementia of the aged. Can J Psychiatry 34:445-446 (1989)
pubmed

25) Lindesay J, Briggs K, Murphy E:The Guy's/age concern survey;prevalence rates of cognitive impairment, depression and anxiety in an urban elderly community. Br J Psychiatry 155:317-329 (1989)

26) Lishman WA:Organic Psychiatry, 2nd ed. Blackwell, Oxford (1987)

27) Morgen K, Dallosso HM, Arie T, et al:Mental health and psychological well-being among the old and very old home. Br J Psychiatry 150:801-807 (1987)

28) Murphy E:Social origins depression in old age. Br J Psychiatry 141:135-142 (1982)
pubmed

29) Murphy E:The prognosis of depression in old age. Br J Psychiatry 142:111-119 (1983)
pubmed

30) Post F:The Significance of Affective Symptoms in Old Age. Oxford Univ Press, London (1962)

31) Post F:The factor of ageing in affective disorder. Recent Developments in Affective Disorders, Kent A, Walk CA (ed), Royal Medico-Psychological Association Publication No 2, Headley Brothers, London (1968)

32) Post F:Functional disorders. The Psychiatry of Late Life, Levy R, Post F (ed), pp 176-221, Blackwell, Oxford (1982)

33) Reynolds CF, Buysse DJ, Kupfer DJ, et al:Rapid eye movement sleep deprivation as a probe in elderly subjects. Arch Gen Psychiatry 47:1128-1136 (1990)
pubmed

34) Roth M, Morrissey JD:Problems in the diagnosis and classification of mental disorder in old age. J Ment Sci 98:66-88 (1952)

35) Schneider LS:Psychobiologic features of geriatric affective disorders. Clin Geriatr Med 8:253-265 (1992)
pubmed

36) 篠原学, 假屋哲彦:躁うつ病の病因論. 日本臨床52:14-18 (1994)

37) Snowdon J:The prevalence of depression in old age. Int J Geriatr Psychiatry 5:141-144 (1990)

38) Weingartner H, Cohen RM, Bunney WE, et al:Memory-learning impairments in progressive dementia and depression. Am J Psychiatry 139:135-136 (1982)
pubmed

39) Yesavage JA, Brink TL, Rose TL, et al:Development and validation of a geriatric depression screening scale;a preliminary report. J Psychiatr Res 17:37-49 (1983)

P.513 掲載の参考文献

1) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorder DSM-III-R, 3rd ed;Revised. American Psychiatric Association, Washington DC (1987)

2) American Psychiatric Association:Quick Reference to the Diagnostic Criteria from DSM-IV. American Psychiatric Association, Washington DC (1994)

3) Anderson JC, Williams S, McGee R, et al:DSM-III disorders in preadolescent children. Prevalence in a large sample from general population. Arch Gen Psychiatry 44:69-76 (1987)

4) Angold A:Childhood depression and adolescent depression. I. Epidemiological and aetiological aspects. Br J Psychiatry 152:601-617 (1988)
pubmed

5) Bernstein GA:Comorbidity and severity of anxiety and depressive disorders in a clinic population. J Am Acad Child Adolesc Psychiatry 30:43-50 (1991)

6) Birleson P:The validity of depressive disorder in childhood and the development of a self-rating scale. J Child Psychol Psychiatry 22:47-53 (1981)

7) Birleson P, Hudson I, Buchanan DG, et al:Clinical evaluation of a self-rating scale for depressive disorder in childhood (Depressive self-rating scale). J Child Psychol Psychiatry 28:43-60 (1987)
pubmed

8) Bowlby J:Attachment and Loss. Vol I;Attachment. Hargarth Press, London (1969)

9) Emslie G, Rush AJ, Weinberg AW, et al:A double blind, randomized placebo-controlled trial of fluoxetine in depressed children and adolescents. Arch Gen Psychiatry (in press)

10) Harrington R, Fudge H, Rutter M, et al:Adult outcomes of childhood and adolescent depression. Arch Gen Psychiatry 47:465-473 (1990)
pubmed

11) Harrington R:Depressive Disorder in Childhood and Adolescence. John Wiley & Sons, Chichester (1993)

12) Harter S:Manual for the self-perception profile for children. Unpublished manuscript, Univ Denver (1985)

13) Harter S:Processes underlying the construction, maintenance and enhancement of the self-concept in children. Psychological Perspectives on the Self, Lehy R (ed), Lawrence Erlbaum Associate, Vol 3, pp 136-182, Hillsdale NJ (1986)

14) Harter S, Marold D:A model of determinants and mediational role of self-worth;Imprication for adolescent depression and suicidal idetion. Stanley Hall Symposium on the Self, In Goethals A, Strauss J (ed), Williams College (1990)

15) Kazdin AE:Assessment techniques for childhood depression. J Am Acad Child Adolesc Psychiatry 20:358-375 (1981)

16) Kazdin AE:Childhood depression. J Child Psychol Psychiatry 31:121-160 (1990)
pubmed

17) Kashani JH, Sigmond JF:The incidence of depression in children. Am J Psychiatry 136:1203-1205 (1979)

18) Kashani JH, Carlson GA, Beck NC, et al:Depression, depressive symptoms, and depressed mood among a community sample of adolescents. Am J Psychiatry 144:931-934 (1987)
pubmed

19) Kovacs M:Children's Depression Inventory. Unpublished manuscript, Univ Pittsburg, School of Medecine (1983)

20) Kovacs M:Presentation and course of major depressive disorder during childhood and later years of life span. J Am Acad Child Adolesc Psychiatry 35:705-715 (1996)
pubmed

21) 上林靖子, 中田洋二郎, 藤井和子ほか:ライフイベント法による児童・思春期精神障害の成因に関する研究-ライフイベント一覧表の開発とパイロットスタデー. 厚生省「精神・神経研究委託費」62公-3児童・思春期精神障害の成因及び治療に関する研究, 昭和63度報告書, pp 111-124 (1989)

22) Marttunen MJ, Aro HM, Henrikson MM, et al:Mental disorders in adolescent suicide. DSM-III-R Axis I and II diagnosis in suicide among 13-to 19-years-old in Finland. Arch Gen Psychiatry 48:834-839 (1991)

23) 村田豊久, 堤龍喜, 皿田洋子ほか:児童・思春期の抑うつ状態に関する臨床的研究. II. CDIを用いての検討, 厚生省「精神・神経研究委託費」63公-3児童・思春期精神障害の成因及び治療に関する研究, 昭和63年度報告書, pp 69-76 (1989)

24) 村田豊久, 皿田洋子, 堤龍喜ほか:児童・思春期の抑うつ状態に関する臨床的研究. III. 中学生における抑うつ傾向, 厚生省「精神・神経研究委託費」62公-3児童・思春期精神障害の成因及び治療に関する研究, 平成元年度報告書, pp 57-66 (1990)

25) 村田豊久, 皿田洋子, 堤龍喜ほか:児童・思春期の抑うつ状態の成因に関する研究, 厚生省「精神・神経研究委託費」2指-15児童・思春期精神障害の成因及び治療に関する研究, 平成2年度報告書, pp 13-21 (1991)

26) 村田豊久:下田の性格状況論にもとついての思春期の抑うつ状態の考察. 思春期青年期精神医学41:142-151 (1994)

27) Murata T:Childhood depressive disorder. Asian Med J 113:1413-1416 (1995)

28) 村田豊久:学校における子どものうつ病-Birlesonの小児期うつ病のスケールからの検討. 最新精神医学1:131-138 (1996)

29) Poznanski EO, Grossman JA, Buchsbaum Y, et al:Preliminary studies of reliability and the children's depression rating scale. J Am Acad Child Adolesc Psychiatry 23:191-197 (1984)

30) Poznanski EO, Freeman LN, Padian N, et al:Children's depression rating scale-revised. Psychopharmacol Bull 21:979-989 (1985)

31) Reynolds WM, Johnson HE:The nature and study of depressive in children and adolescents. Handbook of Depression in Children and Adolescents, Reynolds WM, Johnson HE (ed), Plenum Press, New York (1994)

32) 下田光造:異常児論. 大道学館(1929) (下田光造先生生誕百年記念事業会, 1985)

33) Spitz R:Anaclitic depression. Psychoanal Study Child 2:313-342 (1946)
pubmed

34) Wierzbicki M:A parent form of the children's depression inventory;Reliability and validity in nonclinical population. J Clin Psychol 43:390-397 (1987)

35) World Health Organization:The ICD-10 Classification of Mental and Behavioural Disorders;Clinical Description and Diagnostic Guideline. Geneva (1992)

P.524 掲載の参考文献

1) Akiyama H, Ikeda K, Katoh M, et al:Expression of MRP14, 27E10, interferon-a and leukocyte common antigen by reactive microglia in postmortem human brain tissue. J Neuroimmunol 50:195-201 (1994)

2) Arthur CK, Ma DDF:Combined interferon alfa-2a and cytosine arabinoside as first-line treatment for chronic myeloid leukemia. Acta Haematol 89:15-21 (1993)

3) Blalock JE, Smith EM:Human leukocyte interferon (HU IFN-α);potent endorphin-like opioid activity. Biochem Biophys Res Commun 101:472-478 (1981)

4) Feinstein DL, Galea E, Roberts S, et al:Induction of nitric oxide synthase in rat C6 glioma cells. J Neurochem 62:315-321 (1994)

5) Gisslinger H, Svoboda T, Clodi M, et al:Interferon-α stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology 57:489-495 (1993)

6) 日比野康英:インターフェロンレセプターファミリー. 最新医学からのアプローチ・5-サイトカインレセプター, 宮坂昌之, 田中稔之 (編), pp 82-93, メジカルビュー社, 東京 (1992)

7) 樋口輝彦, 飯田真, 岩波明ほか:感情障害の薬物療法の新しい指針. 総病精医9:7-16 (1997)

8) 堀口淳, 日域広昭, 小鶴俊郎ほか:インターフェロン療法で不可逆性のパーキンソニスムを呈したと考えられるC型慢性活動性肝炎の1例. 精神医学38:1227-1229 (1996)

9) 堀川直史, 山崎友子, 大和央ほか:インターフェロン-α使用中に生じた精神障害-C型慢性肝炎の症例の集計から. 精神科治療学9:1095-1103 (1994)

10) 飯野四郎:アンケート調査集計;インターフェロンの副作用. 厚生省特定疾患難治性の肝炎調査研究班平成5年度研究報告, pp 7-11 (1994)

11) 石郷岡純:薬剤性精神障害-その概念の変遷. 精神科治療学11:111-119 (1996)

12) 伊東勉, 高橋克朗, 太田保之ほか:インターフェロン投与中に発現した精神身体症状-C型慢性活動性肝炎患者を対象として. 臨床精神医学24:705-711 (1995)

13) Janssen HLA, Berk L, Vermeulen M, et al:Seizures associated with low-dose α-interferon. Lancet 336:1580 (1990)

14) 加賀谷有行, 内富庸介:Psychoimmunologyからみた慢性疲労症候群. 精神科治療学9:23-30 (1994)

15) 加賀谷有行:インターフェロンとうつ状態-臨床と基礎. 躁うつ病の脳科学, 神庭重信 (編), pp 269-282, 星和書店, 東京 (1995)

16) Kagaya A, Uchitomi Y, Takezaki E, et al:Plasma levels of cyclic GMP, immune parameters and depressive status during interferon therapy-A prospective study in Japan. Neuropsychobiology 35:128-131 (1997)
pubmed

17) 上島国利:インターフェロンとうつ病・自殺企図. medicina 31:852-854 (1994)

18) 上島国利:一般治療薬による精神神経症状. 精神科治療学11:109-110 (1996)

19) 岸田綱太郎:プロローグ. インターフェロンの臨床応用, 岸田綱太郎, 川俣順一(編), pp 1-8, 日本医学館, 東京 (1992)

20) Kugaya A, Kagaya A, Uchitomi Y, et al:Effect of interferon-α on DOI-induced wet-dog shakes in rats. J Neural Transm 103:947-955 (1996)

21) Kuzel TM, Gilyon K, Springer E, et al:Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst 82:203-207 (1990)
pubmed

22) Lewis ML, Davis J, Chuang E:Interferon alfa-2a in the treatment of exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 231:615-618 (1993)
pubmed

23) McDonald EM, Mann AH, Thomas HC:Interferons as mediators of psychiatric morbidity. Lancet ii:1175-1177 (1987)

24) Merimsky O, Reider-Groswasser I, Inbar M, et al:Interferon-related mental deterioration and behavioral changes in patients with renal cell carcinoma. Eur J Cancer 26:596-600 (1990)
pubmed

25) Meyers CA, Scheibel RS, Forman AD:Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 41:672-676 (1991)
pubmed

26) 三国雅彦, 加賀谷有行, 黒田安計ほか:セロトニン受容体機能とうつ病の成因. 躁うつ病の薬理生化学[II], 躁うつ病の薬理・生化学的研究懇話会三国雅彦, 樋口輝彦, 加藤進昌ほか(編), pp 15-32 (1992)

27) Muller H, Hammes E, Hiemke C, et al:Interferon-alpha-2-induced stimulation of ACTH and cortisol secretion in man. Neuroendocrinology 54:499-503 (1991)
pubmed

28) Muller H, Hiemke C, Mammes E, et al:Sub-acute effects of interferon-α2 on adrenocorticotrophic hormone, cortisol, growth hormone and prolactin in humans. Psychoneuroendocrinology 17:459-465 (1992)

29) 大坪天平, 宮岡等, 松村大:腎細胞癌患者に対するインターフェロン療法中にみられる精神症状-prospecitve研究. 臨床精神医学25:1581-1589 (1996)

30) 大坪天平, 宮岡等, 上島国利ほか:C型慢性肝炎患者のインターフェロン療法中にみられる抑うつ状態に関して-前方視的研究. 精神経誌99:101-127 (1997)

31) Renault PF, Hoofnagle JH, Park Y, et al:Psychiatric complications of long term interferon alpha therapy. Arch Intern Med 147:1577-1580 (1987)

32) Rohatiner AZS, Prior PF, Burton AC, et al:Central nervous system toxicity of interferon. Br J Cancer 47:419-422 (1983)

33) Roosth J, Pollard RB, Brown SL, et al:Cortisol stimulation by recombinant interferon-α2. J Neuroimmunol 12:311-316 (1986)

34) 笹野友寿, 渡辺昌祐:免疫調節剤と精神障害-インターフェロンによる精神障害について. 臨床精神医学22:1705-1713 (1993)

35) 澤田康文:インターフェロン-α. 薬の神経・精神に対する副作用中枢性けいれんとせん妄の実際症例と発現メカニズム, 伊賀立二 (監修), pp 67-74, 南山堂, 東京 (1997)

36) Schnittman SM, Vogel S, Baseler M, et al:A phase I study of interferon-α2b in combination with interleukin-2 in patients with human immunodeficiency virus infection. J Infect Dis 169:981-989(1994)

37) 荘司貞志, 三宅和彦:インターフェロンの副作用とその対策. 実験治療632:31-36 (1993)

38) Shuto H, Kataoka Y, Horikawa T, et al:Repeated interferon-α administration inhibits dopaminergic neural activity in the mouse brain. Brain Res 747:348-351 (1997)

39) Simmons ML, Murphy S:Cytokines regulate L-arginin-dependent cyclic GMP production in rat glial cells. Eur J Neurosci 5:825-831 (1993)
pubmed

40) Smedley H, Katrak M, Sikora K, et al:Neurological effects of recombinant human interferon. Br Med J 286:262-264 (1983)

41) 高木洲一郎, 横山章光:インターフェロンの臨床-C型肝炎の治療中に見られる精神症状を中心に. 総合病院精神医学6:83-89 (1994)

42) 高木洲一郎:インターフェロン療法中の精神症状. 精神医学37:344-358 (1995)

43) 高田知二, 高木千浩, 野嵜理ほか:日本におけるインターフェロン療法に伴う精神症状;文献的検討. 総病精医8:20-28 (1996)

44) 高橋清久:躁うつ病における神経内分泌機能の変化. 日本生物学的精神医学会野村純一, 前田潔 (編), 生物学的精神医学, Vol 3 躁うつ病の神経内分泌, pp 15-33 (1993)

45) Take S, Mori T, Katafuchi T, et al:Central interferon-α inhibits natural killer cytotoxicity through sympathetic innervation. Am J Physiol. 265:R453-R459 (1993)

46) Talpaz M, Kantarjian HM, McCredie K, et al:Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. N Engl J Med 17:1065-1069 (1986)
pubmed

47) 立山萬里:薬物惹起性のうつ病. 今日のうつ病治療, 上島国利 (編), pp 201-211金剛出版, 東京 (1990)

48) Tedeschi B, Barrett J N, Keane RW:Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells. J Cell Biol 102:2244-2253 (1986)

49) Thomas MA, Ibanez HE:Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization. Am J Ophthalmol 115:563-568 (1993)
pubmed

50) 内富庸介, 皆川英明, 岡村仁ほか:終末期がん患者のコンサルテーション-リエゾン精神医学-うつと器質性精神症候群の精神科コンサルテーション. 臨床精神医学24:149-159 (1995)

51) Vilcek J, 原田久士:インターフェロン再考. 細胞工学13:5-10 (1994)

52) 渡邊衡一郎, 八木剛平:内科治療薬による精神症状-抗潰瘍剤, 降圧剤, ステロイド剤ほか. 精神科治療学11:141-146 (1996)

53) Yamawaki S, Kagaya A, Hayakawa H, et al:Pathophysiology of affective disorders;Serotonin receptor function and intracellular calcium signaling. Serotonin in the Central Nervous System and Periphery, Takada A, Curzon G (ed), pp 31-39, Elsevier, Amsterdam (1995)

54) Yoshida R, Imanishi J, Oku T, et al:Induction of pulmonary indoleamine 2, 3-dioxygenase by interferon. Proc Natl Acad Sci 78:129-132 (1981)
pubmed

55) 吉澤佳子, 笠原敏彦:抗がん剤治療中に生じる精神神経症状. 精神科治療学11:133-139 (1996)

はじめての方へ

個人／法人会員登録のご案内

書籍詳細

目次

参考文献

総論

P.17 掲載の参考文献

P.37 掲載の参考文献

P.54 掲載の参考文献

P.81 掲載の参考文献

P.105 掲載の参考文献

P.123 掲載の参考文献

P.137 掲載の参考文献

P.152 掲載の参考文献

P.166 掲載の参考文献

P.178 掲載の参考文献

各論

P.207 掲載の参考文献

P.223 掲載の参考文献

P.238 掲載の参考文献

P.254 掲載の参考文献

P.269 掲載の参考文献

P.287 掲載の参考文献

P.301 掲載の参考文献

P.319 掲載の参考文献

P.342 掲載の参考文献

P.357 掲載の参考文献

P.370 掲載の参考文献

P.383 掲載の参考文献

P.395 掲載の参考文献

P.409 掲載の参考文献

P.421 掲載の参考文献

P.436 掲載の参考文献

P.454 掲載の参考文献

P.466 掲載の参考文献

P.481 掲載の参考文献

P.498 掲載の参考文献

P.513 掲載の参考文献

P.524 掲載の参考文献